Introdução
Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Baker Bros. Advisors Lp. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.
Rentabilidade Média de Negociação
A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.
Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.
Frequência de Atualização: Diariamente
Empresas com Posições Internas Reportadas
As declarações à SEC indicam que Baker Bros. Advisors Lp reportou posses ou negociações nas seguintes empresas:
Como Interpretar os Gráficos
Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Baker Bros. Advisors Lp. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.
Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.
No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.
O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.
Compras Internas ACAD / ACADIA Pharmaceuticals Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ACAD / ACADIA Pharmaceuticals Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas ACAD / ACADIA Pharmaceuticals Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ACAD / ACADIA Pharmaceuticals Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas BCRX / BioCryst Pharmaceuticals, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ACAD / ACADIA Pharmaceuticals Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas BCRX / BioCryst Pharmaceuticals, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ACAD / ACADIA Pharmaceuticals Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ACAD / ACADIA Pharmaceuticals Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ACAD / ACADIA Pharmaceuticals Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas CELC / Celcuity Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ACAD / ACADIA Pharmaceuticals Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas CELC / Celcuity Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ACAD / ACADIA Pharmaceuticals Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ACAD / ACADIA Pharmaceuticals Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ACAD / ACADIA Pharmaceuticals Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas KALA / KALA BIO, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ACAD / ACADIA Pharmaceuticals Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas KALA / KALA BIO, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ACAD / ACADIA Pharmaceuticals Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas KNSA / Kiniksa Pharmaceuticals International, plc - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ACAD / ACADIA Pharmaceuticals Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas KNSA / Kiniksa Pharmaceuticals International, plc - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ACAD / ACADIA Pharmaceuticals Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas KOD / Kodiak Sciences Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ACAD / ACADIA Pharmaceuticals Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas KOD / Kodiak Sciences Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ACAD / ACADIA Pharmaceuticals Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas KYMR / Kymera Therapeutics, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ACAD / ACADIA Pharmaceuticals Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas KYMR / Kymera Therapeutics, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ACAD / ACADIA Pharmaceuticals Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas MDGL / Madrigal Pharmaceuticals, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ACAD / ACADIA Pharmaceuticals Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas MDGL / Madrigal Pharmaceuticals, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ACAD / ACADIA Pharmaceuticals Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas NTLA / Intellia Therapeutics, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ACAD / ACADIA Pharmaceuticals Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas NTLA / Intellia Therapeutics, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ACAD / ACADIA Pharmaceuticals Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas PRLD / Prelude Therapeutics Incorporated - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ACAD / ACADIA Pharmaceuticals Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas PRLD / Prelude Therapeutics Incorporated - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ACAD / ACADIA Pharmaceuticals Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas REPL / Replimune Group, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ACAD / ACADIA Pharmaceuticals Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Máx |
Preço em Máx |
Lucro Máx ($) |
Retorno Máx (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas REPL / Replimune Group, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ACAD / ACADIA Pharmaceuticals Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas RYTM / Rhythm Pharmaceuticals, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ACAD / ACADIA Pharmaceuticals Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas RYTM / Rhythm Pharmaceuticals, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ACAD / ACADIA Pharmaceuticals Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas SERA / Sera Prognostics, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ACAD / ACADIA Pharmaceuticals Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Máx |
Preço em Máx |
Lucro Máx ($) |
Retorno Máx (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas SERA / Sera Prognostics, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ACAD / ACADIA Pharmaceuticals Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas SYRE / Spyre Therapeutics, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ACAD / ACADIA Pharmaceuticals Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Máx |
Preço em Máx |
Lucro Máx ($) |
Retorno Máx (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas SYRE / Spyre Therapeutics, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ACAD / ACADIA Pharmaceuticals Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas TCRX / TScan Therapeutics, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ACAD / ACADIA Pharmaceuticals Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas TCRX / TScan Therapeutics, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ACAD / ACADIA Pharmaceuticals Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas TRDA / Entrada Therapeutics, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ACAD / ACADIA Pharmaceuticals Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas TRDA / Entrada Therapeutics, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ACAD / ACADIA Pharmaceuticals Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas VTVT / vTv Therapeutics Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ACAD / ACADIA Pharmaceuticals Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Máx |
Preço em Máx |
Lucro Máx ($) |
Retorno Máx (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas VTVT / vTv Therapeutics Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ACAD / ACADIA Pharmaceuticals Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas XOMAO / XOMA Royalty Corporation - Preferred Stock - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ACAD / ACADIA Pharmaceuticals Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas XOMAO / XOMA Royalty Corporation - Preferred Stock - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ACAD / ACADIA Pharmaceuticals Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas ZYME / Zymeworks Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ACAD / ACADIA Pharmaceuticals Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Máx |
Preço em Máx |
Lucro Máx ($) |
Retorno Máx (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas ZYME / Zymeworks Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ACAD / ACADIA Pharmaceuticals Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Histórico de Negociações Insider
Esta tabela mostra a lista completa de negociações insider realizadas por Baker Bros. Advisors Lp conforme divulgadas para a Comissão de Valores Mobiliários (SEC).
| Data do Arquivo | Data da Transação | Formulário | Ticker | Ativo | Código | Ações | Ações Restantes | Variação Percentual |
Preço da Ação |
Valor da Transação |
Valor Restante |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 6,408 | 3,422,366 | 0.19 | ||||
| 2026-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 6,408 | 343,275 | 1.90 | ||||
| 2026-06-02 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 6,078 | 2,744,894 | 0.22 | ||||
| 2026-06-02 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 6,078 | 143,277 | 4.43 | ||||
| 2026-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18,622 | 39,384,587 | 0.05 | ||||
| 2026-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18,622 | 3,677,357 | 0.51 | ||||
| 2026-05-27 |
|
4 | ONC |
BeOne Medicines Ltd.
Ordinary Shares |
S - Sale | -2,756 | 142,570 | -1.90 | 23.79 | -65,567 | 3,391,812 | |
| 2026-05-27 |
|
4 | ONC |
BeOne Medicines Ltd.
Ordinary Shares |
S - Sale | -2,756 | 142,566 | -1.90 | 23.79 | -65,567 | 3,391,716 | |
| 2026-05-27 |
|
4 | ONC |
BeOne Medicines Ltd.
Ordinary Shares |
S - Sale | -2,743 | 145,326 | -1.85 | 23.85 | -65,424 | 3,466,199 | |
| 2026-05-27 |
|
4 | ONC |
BeOne Medicines Ltd.
Ordinary Shares |
S - Sale | -2,743 | 145,322 | -1.85 | 23.85 | -65,424 | 3,466,104 | |
| 2026-05-11 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15,000 | 28,203,718 | 0.05 | 84.53 | 1,267,950 | 2,384,060,283 | |
| 2026-05-11 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15,000 | 2,833,039 | 0.53 | 84.53 | 1,267,950 | 239,476,787 | |
| 2026-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 421 | 28,188,718 | 0.00 | ||||
| 2026-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 421 | 2,818,039 | 0.01 | ||||
| 2026-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 19,000 | 10,018,674 | 0.19 | ||||
| 2026-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 19,000 | 10,018,674 | 0.19 | ||||
| 2026-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 328 | 28,188,297 | 0.00 | ||||
| 2026-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 328 | 28,188,297 | 0.00 | ||||
| 2025-12-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,391,268 | 18,358,772 | 14.98 | 23.00 | 54,999,164 | 422,251,756 | |
| 2025-12-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 217,428 | 1,560,414 | 16.19 | 23.00 | 5,000,844 | 35,889,522 | |
| 2025-12-11 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 1,838,621 | 7,955,916 | 30.06 | 86.00 | 158,121,406 | 684,208,776 | |
| 2025-12-11 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 167,192 | 701,326 | 31.30 | 86.00 | 14,378,512 | 60,314,036 | |
| 2025-11-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 13,082 | 4,691,392 | 0.28 | 9.07 | 118,690 | 42,564,061 | |
| 2025-11-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 1,186 | 381,338 | 0.31 | 9.07 | 10,760 | 3,459,803 | |
| 2025-11-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 13,386 | 4,678,310 | 0.29 | 9.07 | 121,395 | 42,426,658 | |
| 2025-11-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 1,213 | 380,152 | 0.32 | 9.07 | 11,000 | 3,447,522 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 11,494 | 4,664,924 | 0.25 | 7.95 | 91,431 | 37,108,071 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 1,040 | 378,939 | 0.28 | 7.95 | 8,273 | 3,014,346 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 80,881 | 4,653,430 | 1.77 | 7.73 | 625,331 | 35,977,994 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7,321 | 377,899 | 1.98 | 7.73 | 56,602 | 2,921,726 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 30,879 | 4,572,549 | 0.68 | 7.54 | 232,812 | 34,474,733 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,795 | 370,578 | 0.76 | 7.54 | 21,073 | 2,793,973 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 11,701 | 4,541,670 | 0.26 | 7.39 | 86,481 | 33,567,029 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 1,059 | 367,783 | 0.29 | 7.39 | 7,827 | 2,718,247 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,947 | 4,529,969 | 0.07 | 7.22 | 21,290 | 32,726,308 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 267 | 366,724 | 0.07 | 7.22 | 1,929 | 2,649,361 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 25,364 | 4,527,022 | 0.56 | 7.21 | 182,973 | 32,657,484 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,296 | 366,457 | 0.63 | 7.21 | 16,563 | 2,643,584 | |
| 2025-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 388 | 28,187,969 | 0.00 | ||||
| 2025-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 388 | 2,817,290 | 0.01 | ||||
| 2025-10-02 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
S - Sale | -462,967 | 425,006 | -52.14 | 1.38 | -640,654 | 588,123 | |
| 2025-10-02 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
S - Sale | -50,640 | 46,480 | -52.14 | 1.38 | -70,076 | 64,319 | |
| 2025-10-02 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
S - Sale | -195,425 | 887,973 | -18.04 | 1.60 | -311,879 | 1,417,116 | |
| 2025-10-02 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
S - Sale | -21,376 | 97,120 | -18.04 | 1.60 | -34,114 | 154,994 | |
| 2025-09-10 |
|
4 | CELC |
Celcuity Inc.
Common Stock |
P - Purchase | 4,212 | 7,211,484 | 0.06 | 58.02 | 244,395 | 418,436,263 | |
| 2025-09-10 |
|
4 | CELC |
Celcuity Inc.
Common Stock |
P - Purchase | 388 | 704,308 | 0.06 | 58.02 | 22,513 | 40,866,486 | |
| 2025-09-10 |
|
4 | CELC |
Celcuity Inc.
Common Stock |
P - Purchase | 151,524 | 7,207,272 | 2.15 | 56.22 | 8,518,679 | 405,192,832 | |
| 2025-09-10 |
|
4 | CELC |
Celcuity Inc.
Common Stock |
P - Purchase | 13,976 | 703,920 | 2.03 | 56.22 | 785,731 | 39,574,382 | |
| 2025-09-05 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
A - Award | 46,692 | 135,946 | 52.31 | ||||
| 2025-09-05 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
A - Award | 4,308 | 12,368 | 53.45 | ||||
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,128 | 1,859,091 | 0.55 | 372.16 | 3,769,209 | 691,874,287 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 933 | 194,625 | 0.48 | 372.16 | 347,223 | 72,431,115 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,494 | 1,848,963 | 0.30 | 371.00 | 2,038,301 | 685,974,518 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 506 | 193,692 | 0.26 | 371.00 | 187,729 | 71,860,700 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,747 | 1,843,469 | 0.15 | 369.34 | 1,014,563 | 680,857,623 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 253 | 193,186 | 0.13 | 369.34 | 93,442 | 71,350,351 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,419 | 1,840,722 | 0.08 | 368.84 | 523,384 | 678,931,902 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 131 | 192,933 | 0.07 | 368.84 | 48,318 | 71,161,408 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,798 | 1,839,303 | 0.26 | 367.77 | 1,764,565 | 676,442,304 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 442 | 192,802 | 0.23 | 367.77 | 162,555 | 70,906,984 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,289 | 1,834,505 | 0.12 | 366.30 | 838,459 | 671,977,714 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 211 | 192,360 | 0.11 | 366.30 | 77,289 | 70,461,314 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,772 | 1,832,216 | 0.15 | 363.75 | 1,008,308 | 666,463,806 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 255 | 192,149 | 0.13 | 363.75 | 92,756 | 69,893,699 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,587 | 1,829,444 | 0.31 | 362.39 | 2,024,662 | 662,968,735 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 515 | 191,894 | 0.27 | 362.39 | 186,630 | 69,540,102 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,443 | 1,823,857 | 0.30 | 361.37 | 1,966,957 | 659,093,770 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 502 | 191,379 | 0.26 | 361.37 | 181,410 | 69,159,318 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8,514 | 1,818,414 | 0.47 | 359.39 | 3,059,873 | 653,525,445 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 784 | 190,877 | 0.41 | 359.39 | 281,764 | 68,599,877 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,472 | 1,809,900 | 0.14 | 358.21 | 885,495 | 648,324,279 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 228 | 190,093 | 0.12 | 358.21 | 81,672 | 68,093,214 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8,328 | 1,807,428 | 0.46 | 357.02 | 2,973,289 | 645,293,728 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 767 | 189,865 | 0.41 | 357.02 | 273,837 | 67,786,210 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 916 | 1,799,100 | 0.05 | 355.00 | 325,180 | 638,680,500 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 84 | 189,098 | 0.04 | 355.00 | 29,820 | 67,129,790 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,923 | 1,798,184 | 0.11 | 353.88 | 680,503 | 636,333,262 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 177 | 189,014 | 0.09 | 353.88 | 62,636 | 66,887,424 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9,362 | 1,947,968 | 0.48 | 392.24 | 3,672,178 | 764,076,617 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 862 | 202,813 | 0.43 | 392.24 | 338,113 | 79,551,959 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,506 | 1,938,606 | 0.13 | 389.89 | 977,059 | 755,838,828 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 231 | 201,951 | 0.11 | 389.89 | 90,064 | 78,738,231 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 366 | 1,936,100 | 0.02 | 389.00 | 142,374 | 753,142,900 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 34 | 201,720 | 0.02 | 389.00 | 13,226 | 78,469,080 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,441 | 1,935,734 | 0.23 | 387.07 | 1,718,969 | 749,260,688 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 409 | 201,686 | 0.20 | 387.07 | 158,311 | 78,066,197 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13,545 | 1,931,293 | 0.71 | 385.06 | 5,215,601 | 743,658,468 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,248 | 201,277 | 0.62 | 385.06 | 480,552 | 77,503,178 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,049 | 1,917,748 | 0.21 | 383.79 | 1,553,954 | 736,007,135 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 373 | 200,029 | 0.19 | 383.79 | 143,153 | 76,768,570 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,838 | 1,913,699 | 0.15 | 382.82 | 1,086,447 | 732,604,739 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 262 | 199,656 | 0.13 | 382.82 | 100,299 | 76,432,569 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,136 | 1,910,861 | 0.06 | 382.29 | 434,280 | 730,501,332 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 105 | 199,394 | 0.05 | 382.29 | 40,140 | 76,226,153 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9,477 | 1,909,725 | 0.50 | 381.12 | 3,611,889 | 727,837,448 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 873 | 199,289 | 0.44 | 381.12 | 332,719 | 75,953,343 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,919 | 1,900,248 | 0.10 | 380.78 | 730,717 | 723,576,433 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 198,416 | 0.09 | 380.78 | 67,017 | 75,552,844 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,209 | 1,898,329 | 0.28 | 380.44 | 1,981,694 | 722,193,641 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 480 | 198,240 | 0.24 | 380.44 | 182,610 | 75,417,732 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7,325 | 1,893,120 | 0.39 | 374.43 | 2,742,728 | 708,848,115 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 675 | 197,760 | 0.34 | 374.43 | 252,743 | 74,048,028 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26,704 | 1,885,795 | 1.44 | 372.87 | 9,957,102 | 703,155,062 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,460 | 197,085 | 1.26 | 372.87 | 917,258 | 73,486,946 | |
| 2025-08-18 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
U - Other | -3,763,362 | 0 | -100.00 | ||||
| 2025-08-18 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
U - Other | -357,048 | 0 | -100.00 | ||||
| 2025-08-01 | 3 | CELC |
Celcuity Inc.
Common Stock |
689,944 | ||||||||
| 2025-08-01 | 3 | CELC |
Celcuity Inc.
Common Stock |
7,055,748 | ||||||||
| 2025-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 492 | 28,187,581 | 0.00 | ||||
| 2025-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 492 | 28,187,581 | 0.00 | ||||
| 2025-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3,763,362 | 0.03 | ||||
| 2025-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3,763,362 | 0.03 | ||||
| 2025-06-30 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 600,309 | 6,117,295 | 10.88 | 44.00 | 26,413,596 | 269,160,980 | |
| 2025-06-30 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 55,191 | 534,134 | 11.52 | 44.00 | 2,428,404 | 23,501,896 | |
| 2025-06-24 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,430 | 1,796,261 | 0.08 | ||||
| 2025-06-24 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,430 | 1,796,261 | 0.08 | ||||
| 2025-06-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,518 | 28,187,089 | 0.01 | ||||
| 2025-06-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,518 | 28,187,089 | 0.01 | ||||
| 2025-06-05 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
326,302 | ||||||||
| 2025-06-05 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
3,405,393 | ||||||||
| 2025-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 10,565 | 3,415,958 | 0.31 | ||||
| 2025-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 10,565 | 3,415,958 | 0.31 | ||||
| 2025-06-05 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 8,397 | 2,738,816 | 0.31 | ||||
| 2025-06-05 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 8,397 | 2,738,816 | 0.31 | ||||
| 2025-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 16,214 | 39,365,965 | 0.04 | ||||
| 2025-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 16,214 | 39,365,965 | 0.04 | ||||
| 2025-05-22 |
|
4 | ONC |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 21,970 | 148,069 | 17.42 | ||||
| 2025-05-22 |
|
4 | ONC |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 21,970 | 148,065 | 17.42 | ||||
| 2025-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 487 | 28,184,571 | 0.00 | ||||
| 2025-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 487 | 2,813,892 | 0.02 | ||||
| 2025-04-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3,762,409 | 0.03 | ||||
| 2025-04-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 356,095 | 0.27 | ||||
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 92,349 | 2,144,060 | 4.50 | 29.56 | 2,729,864 | 63,379,057 | |
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 8,589 | 178,596 | 5.05 | 29.56 | 253,893 | 5,279,351 | |
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 646,290 | 2,051,711 | 45.99 | 29.74 | 19,221,699 | 61,021,168 | |
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 60,110 | 170,007 | 54.70 | 29.74 | 1,787,768 | 5,056,280 | |
| 2025-03-07 | 3 | REPL |
Replimune Group, Inc.
Common Stock |
929,241 | ||||||||
| 2025-03-07 | 3 | REPL |
Replimune Group, Inc.
Common Stock |
10,116,095 | ||||||||
| 2025-02-28 |
|
4 | ONC |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -671,976 | 8,068,411 | -7.69 | 260.00 | -174,713,760 | 2,097,786,860 | |
| 2025-02-28 |
|
4 | ONC |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -60,851 | 730,642 | -7.69 | 260.00 | -15,821,260 | 189,966,920 | |
| 2025-02-14 | 3 | SERA |
SERA PROGNOSTICS, INC.
Common Stock |
432,434 | ||||||||
| 2025-02-14 | 3 | SERA |
SERA PROGNOSTICS, INC.
Common Stock |
5,065,736 | ||||||||
| 2025-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 4,400 | 9,999,674 | 0.04 | ||||
| 2025-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 4,400 | 918,483 | 0.48 | ||||
| 2025-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 446 | 28,184,084 | 0.00 | ||||
| 2025-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 446 | 28,184,084 | 0.00 | ||||
| 2025-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,761,456 | 0.05 | ||||
| 2025-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 355,142 | 0.56 | ||||
| 2024-12-31 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
P - Purchase | 279,939 | 1,083,398 | 34.84 | 6.44 | 1,802,807 | 6,977,083 | |
| 2024-12-31 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
P - Purchase | 30,620 | 118,496 | 34.84 | 6.44 | 197,193 | 763,114 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 457,631 | 9,995,274 | 4.80 | 15.34 | 7,020,883 | 153,345,495 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 42,369 | 914,083 | 4.86 | 15.34 | 650,017 | 14,023,679 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 566,814 | 9,537,643 | 6.32 | 13.80 | 7,824,300 | 131,657,624 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 52,656 | 871,714 | 6.43 | 13.80 | 726,863 | 12,033,140 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 244,587 | 8,970,829 | 2.80 | 13.72 | 3,356,761 | 123,117,451 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 22,722 | 819,058 | 2.85 | 13.72 | 311,841 | 11,240,916 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 59,995 | 8,726,242 | 0.69 | 13.63 | 817,660 | 118,928,207 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 5,573 | 796,336 | 0.70 | 13.63 | 75,953 | 10,853,104 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 30,241 | 8,666,247 | 0.35 | 13.50 | 408,190 | 116,976,135 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 2,809 | 790,763 | 0.36 | 13.50 | 37,916 | 10,673,640 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -916,964 | 8,740,387 | -9.49 | 186.50 | -171,013,786 | 1,630,082,176 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -83,036 | 791,493 | -9.49 | 186.50 | -15,486,214 | 147,613,444 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -33,943 | 9,657,351 | -0.35 | 208.01 | -7,060,609 | 2,008,861,314 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -3,074 | 874,529 | -0.35 | 208.01 | -639,434 | 181,914,013 | |
| 2024-10-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 4,730 | 2,730,419 | 0.17 | ||||
| 2024-10-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 4,730 | 2,730,419 | 0.17 | ||||
| 2024-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 496 | 28,183,638 | 0.00 | ||||
| 2024-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 496 | 2,812,959 | 0.02 | ||||
| 2024-10-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,759,462 | 0.05 | ||||
| 2024-10-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 353,148 | 0.57 | ||||
| 2024-08-22 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 1 | 5,516,986 | 0.00 | 46.41 | 46 | 256,043,320 | |
| 2024-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 537 | 28,183,142 | 0.00 | ||||
| 2024-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 537 | 28,183,142 | 0.00 | ||||
| 2024-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,757,468 | 0.05 | ||||
| 2024-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,757,468 | 0.05 | ||||
| 2024-06-28 | 3 | KALA |
KALA BIO, Inc.
Common Stock |
87,876 | ||||||||
| 2024-06-28 | 3 | KALA |
KALA BIO, Inc.
Common Stock |
803,459 | ||||||||
| 2024-06-27 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,428 | 1,794,831 | 0.08 | ||||
| 2024-06-27 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,428 | 1,794,831 | 0.08 | ||||
| 2024-06-20 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
C - Conversion | 2,186,686 | 8,636,006 | 33.91 | ||||
| 2024-06-20 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
C - Conversion | 196,098 | 787,954 | 33.13 | ||||
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
D - Sale to Issuer | -5,283,206 | 28,182,605 | -15.79 | 60.00 | -316,992,360 | 1,690,956,300 | |
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
D - Sale to Issuer | -175,977 | 2,811,926 | -5.89 | 60.00 | -10,558,620 | 168,715,560 | |
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,830 | 33,465,811 | 0.01 | ||||
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,830 | 33,465,811 | 0.01 | ||||
| 2024-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 32,682 | 126,099 | 34.99 | ||||
| 2024-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 32,682 | 126,099 | 34.99 | ||||
| 2024-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 6,346 | 2,725,689 | 0.23 | ||||
| 2024-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 6,346 | 2,725,689 | 0.23 | ||||
| 2024-05-31 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18,774 | 39,349,751 | 0.05 | ||||
| 2024-05-31 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18,774 | 39,349,751 | 0.05 | ||||
| 2024-05-29 | 3 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
109,897 | ||||||||
| 2024-05-29 | 3 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
1,405,421 | ||||||||
| 2024-05-09 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15,000 | 33,462,981 | 0.04 | 49.01 | 735,150 | 1,640,020,699 | |
| 2024-05-09 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15,000 | 2,985,073 | 0.51 | 49.01 | 735,150 | 146,298,428 | |
| 2024-04-22 |
|
4 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
A - Award | 12,000 | 6,449,320 | 0.19 | ||||
| 2024-04-22 |
|
4 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
A - Award | 12,000 | 6,449,320 | 0.19 | ||||
| 2024-04-18 | 3 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
579,856 | ||||||||
| 2024-04-18 | 3 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
6,437,320 | ||||||||
| 2024-04-01 | 3 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
478,943 | ||||||||
| 2024-04-01 | 3 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
5,516,985 | ||||||||
| 2024-04-01 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,755,474 | 0.05 | ||||
| 2024-04-01 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1,994 | 3,755,474 | 0.05 | ||||
| 2024-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 543 | 33,447,981 | 0.00 | ||||
| 2024-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 543 | 2,970,073 | 0.02 | ||||
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 89,407 | 3,753,480 | 2.44 | 9.62 | 860,042 | 36,106,226 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 8,066 | 347,166 | 2.38 | 9.62 | 77,590 | 3,339,529 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 8,439 | 3,664,073 | 0.23 | 9.27 | 78,207 | 33,956,064 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 761 | 339,100 | 0.22 | 9.27 | 7,052 | 3,142,541 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 17,101 | 3,655,634 | 0.47 | 9.22 | 157,683 | 33,707,504 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 1,543 | 338,339 | 0.46 | 9.22 | 14,228 | 3,119,722 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 247,656 | 3,638,533 | 7.30 | 8.26 | 2,046,159 | 30,061,923 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 22,344 | 336,796 | 7.11 | 8.26 | 184,608 | 2,782,642 | |
| 2024-03-07 | 3 | VTVT |
vTv Therapeutics Inc.
Common Stock |
12,836 | ||||||||
| 2024-03-07 | 3 | VTVT |
vTv Therapeutics Inc.
Common Stock |
142,135 | ||||||||
| 2024-03-07 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
D - Sale to Issuer | -52,881 | 89,254 | -37.20 | ||||
| 2024-03-07 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
D - Sale to Issuer | -4,776 | 8,060 | -37.21 | ||||
| 2024-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 556 | 33,447,438 | 0.00 | ||||
| 2024-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 556 | 33,447,438 | 0.00 | ||||
| 2024-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 3,390,877 | 0.02 | ||||
| 2024-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 3,390,877 | 0.02 | ||||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -42,977,301 | 0 | -100.00 | 229.00 | -9,841,801,929 | ||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -1,731,202 | 0 | -100.00 | 229.00 | -396,445,258 | ||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -23,277 | 0 | -100.00 | 229.00 | -5,330,433 | ||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -23,280 | 0 | -100.00 | 229.00 | -5,331,120 | ||
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 214,025 | 3,390,323 | 6.74 | 6.60 | 1,412,565 | 22,376,132 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 17,066 | 313,898 | 5.75 | 6.60 | 112,636 | 2,071,727 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 52,528 | 3,176,298 | 1.68 | 6.37 | 334,399 | 20,220,631 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 4,188 | 296,832 | 1.43 | 6.37 | 26,661 | 1,889,662 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 185 | 3,123,770 | 0.01 | 6.36 | 1,176 | 19,851,558 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 15 | 292,644 | 0.01 | 6.36 | 95 | 1,859,753 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 145,749 | 3,123,585 | 4.89 | 6.50 | 947,602 | 20,308,300 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 11,621 | 292,629 | 4.14 | 6.50 | 75,555 | 1,902,557 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 71,219 | 2,977,836 | 2.45 | 5.99 | 426,751 | 17,843,491 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 5,679 | 281,008 | 2.06 | 5.99 | 34,029 | 1,683,828 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 9,649 | 2,906,617 | 0.33 | 5.76 | 55,567 | 16,738,626 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 769 | 275,329 | 0.28 | 5.76 | 4,429 | 1,585,565 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,857 | 1,699,129 | 0.23 | 221.24 | 853,330 | 375,918,358 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 308 | 178,461 | 0.17 | 221.24 | 68,142 | 39,483,033 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,408 | 1,695,272 | 0.26 | 220.65 | 972,645 | 374,069,565 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 352 | 178,153 | 0.20 | 220.65 | 77,670 | 39,310,279 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15,005 | 1,690,864 | 0.90 | 219.24 | 3,289,711 | 370,706,714 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,195 | 177,801 | 0.68 | 219.24 | 261,993 | 38,981,269 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,873 | 1,675,859 | 0.17 | 217.91 | 626,049 | 365,182,748 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 229 | 176,606 | 0.13 | 217.91 | 49,901 | 38,483,825 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 185 | 1,672,986 | 0.01 | 217.90 | 40,312 | 364,543,649 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15 | 176,377 | 0.01 | 217.90 | 3,268 | 38,432,548 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,769 | 1,672,801 | 0.11 | 216.67 | 383,286 | 362,442,949 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 141 | 176,362 | 0.08 | 216.67 | 30,550 | 38,212,055 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 668 | 1,671,032 | 0.04 | 214.72 | 143,434 | 358,807,834 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 53 | 176,221 | 0.03 | 214.72 | 11,380 | 37,838,578 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 515 | 1,670,364 | 0.03 | 213.80 | 110,107 | 357,122,821 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 41 | 176,168 | 0.02 | 213.80 | 8,766 | 37,664,613 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 185 | 1,669,849 | 0.01 | 213.62 | 39,521 | 356,721,493 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15 | 176,127 | 0.01 | 213.62 | 3,204 | 37,625,130 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 648 | 1,669,664 | 0.04 | 212.04 | 137,403 | 354,037,892 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 52 | 176,112 | 0.03 | 212.04 | 11,026 | 37,343,035 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 1,669,016 | 0.01 | 209.76 | 19,508 | 350,101,141 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 | 176,060 | 0.00 | 209.76 | 1,468 | 36,931,226 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 370 | 1,668,923 | 0.02 | 208.69 | 77,216 | 348,289,710 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 30 | 176,053 | 0.02 | 208.69 | 6,261 | 36,740,729 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 648 | 1,668,553 | 0.04 | 206.93 | 134,092 | 345,277,176 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 52 | 176,023 | 0.03 | 206.93 | 10,760 | 36,424,809 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 708 | 1,667,905 | 0.04 | 205.60 | 145,565 | 342,921,268 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 56 | 175,971 | 0.03 | 205.60 | 11,514 | 36,179,638 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 1,667,197 | 0.01 | 205.32 | 19,095 | 342,308,888 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 | 175,915 | 0.00 | 205.32 | 1,437 | 36,118,868 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,960 | 1,793,403 | 0.22 | 229.86 | 910,264 | 412,240,043 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 316 | 185,979 | 0.17 | 229.86 | 72,637 | 42,750,007 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,204 | 1,789,443 | 0.12 | 228.79 | 504,252 | 409,405,411 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 185,663 | 0.09 | 228.79 | 40,267 | 42,477,708 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 11,602 | 1,787,239 | 0.65 | 227.86 | 2,643,597 | 407,234,917 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 925 | 185,487 | 0.50 | 227.86 | 210,768 | 42,264,511 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,343 | 1,775,637 | 0.08 | 226.97 | 304,822 | 403,018,106 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 107 | 184,562 | 0.06 | 226.97 | 24,286 | 41,890,222 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,594 | 1,774,294 | 0.32 | 224.91 | 1,258,156 | 399,059,480 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 446 | 184,455 | 0.24 | 224.91 | 100,311 | 41,486,088 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 363 | 1,768,700 | 0.02 | 223.94 | 81,289 | 396,078,079 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 29 | 184,009 | 0.02 | 223.94 | 6,494 | 41,206,497 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9,262 | 1,768,337 | 0.53 | 222.68 | 2,062,425 | 393,766,210 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 738 | 183,980 | 0.40 | 222.68 | 164,335 | 40,967,930 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,532 | 1,759,075 | 0.26 | 221.78 | 1,005,101 | 390,125,367 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 361 | 183,242 | 0.20 | 221.78 | 80,062 | 40,639,173 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,518 | 1,754,543 | 0.26 | 219.87 | 993,351 | 385,762,948 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 360 | 182,881 | 0.20 | 219.87 | 79,151 | 40,209,168 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 29,738 | 1,750,025 | 1.73 | 218.46 | 6,496,513 | 382,307,486 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,373 | 182,521 | 1.32 | 218.46 | 518,402 | 39,873,227 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,894 | 1,720,287 | 0.64 | 217.52 | 2,369,611 | 374,188,571 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 869 | 180,148 | 0.48 | 217.52 | 189,021 | 39,184,928 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,264 | 1,709,393 | 0.60 | 216.70 | 2,224,203 | 370,424,437 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 818 | 179,279 | 0.46 | 216.70 | 177,260 | 38,849,652 | |
| 2023-11-24 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
X - Other | 1,941,607 | 2,168,818 | 854.54 | 0.00 | 194 | 217 | |
| 2023-11-24 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
X - Other | 174,742 | 196,654 | 797.47 | 0.00 | 17 | 20 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7,917 | 1,667,104 | 0.48 | 190.14 | 1,505,308 | 316,976,653 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 655 | 175,908 | 0.37 | 190.14 | 124,539 | 33,446,461 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15,620 | 1,659,187 | 0.95 | 188.70 | 2,947,539 | 313,093,399 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,291 | 175,253 | 0.74 | 188.70 | 243,615 | 33,070,749 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13,505 | 1,643,567 | 0.83 | 188.46 | 2,545,218 | 309,754,690 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,117 | 173,962 | 0.65 | 188.46 | 210,515 | 32,785,731 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13,011 | 1,630,062 | 0.80 | 188.32 | 2,450,273 | 306,978,492 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,076 | 172,845 | 0.63 | 188.32 | 202,636 | 32,550,724 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,712 | 1,617,051 | 0.29 | 187.27 | 882,420 | 302,826,273 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 388 | 171,769 | 0.23 | 187.27 | 72,661 | 32,167,301 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,124 | 1,612,339 | 0.13 | 187.24 | 397,706 | 301,900,642 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 171,381 | 0.10 | 187.24 | 32,955 | 32,090,047 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,385 | 1,610,215 | 0.09 | 186.59 | 258,431 | 300,454,847 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 115 | 171,205 | 0.07 | 186.59 | 21,458 | 31,945,655 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 647 | 1,608,830 | 0.04 | 186.32 | 120,547 | 299,752,540 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 53 | 171,090 | 0.03 | 186.32 | 9,875 | 31,876,993 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 369 | 1,608,183 | 0.02 | 183.16 | 67,586 | 294,554,798 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 31 | 171,037 | 0.02 | 183.16 | 5,678 | 31,327,137 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 146 | 1,607,814 | 0.01 | 185.94 | 27,148 | 298,963,688 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12 | 171,006 | 0.01 | 185.94 | 2,231 | 31,797,574 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,022 | 1,607,668 | 0.19 | 189.70 | 573,267 | 304,971,083 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 250 | 170,994 | 0.15 | 189.70 | 47,424 | 32,437,186 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,147 | 1,604,646 | 0.07 | 188.84 | 216,595 | 303,014,772 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 95 | 170,744 | 0.06 | 188.84 | 17,939 | 32,242,597 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,895 | 1,603,499 | 0.31 | 187.34 | 917,054 | 300,407,520 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 405 | 170,649 | 0.24 | 187.34 | 75,875 | 31,970,237 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,206 | 1,598,604 | 0.08 | 185.86 | 224,153 | 297,124,532 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 100 | 170,244 | 0.06 | 185.86 | 18,586 | 31,642,401 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7,010 | 1,597,398 | 0.44 | 183.40 | 1,285,633 | 292,962,633 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 579 | 170,144 | 0.34 | 183.40 | 106,189 | 31,204,393 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,847 | 1,590,388 | 0.12 | 181.93 | 336,025 | 289,339,289 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 153 | 169,565 | 0.09 | 181.93 | 27,835 | 30,848,960 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,715 | 1,588,541 | 0.68 | 175.82 | 1,883,889 | 279,293,943 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 903 | 169,412 | 0.54 | 175.82 | 158,764 | 29,785,662 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,923 | 1,577,826 | 0.31 | 175.72 | 865,062 | 277,253,218 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 415 | 168,509 | 0.25 | 175.72 | 72,923 | 29,610,149 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 18,125 | 1,572,903 | 1.17 | 174.87 | 3,169,606 | 275,061,098 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,528 | 168,094 | 0.92 | 174.87 | 267,209 | 29,395,405 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 978 | 1,554,778 | 0.06 | 174.67 | 170,827 | 271,572,762 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 82 | 166,566 | 0.05 | 174.67 | 14,323 | 29,094,050 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,660 | 1,553,800 | 0.11 | 173.75 | 288,422 | 269,969,798 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 140 | 166,484 | 0.08 | 173.75 | 24,325 | 28,926,279 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,151 | 1,552,140 | 0.27 | 173.20 | 718,960 | 268,833,131 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 350 | 166,344 | 0.21 | 173.20 | 60,621 | 28,811,047 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 461 | 1,547,989 | 0.03 | 171.79 | 79,195 | 265,929,030 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 39 | 165,994 | 0.02 | 171.79 | 6,700 | 28,516,109 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,107 | 1,547,528 | 0.07 | 168.78 | 186,842 | 261,195,645 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 165,955 | 0.06 | 168.78 | 15,697 | 28,010,300 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 646 | 1,546,421 | 0.04 | 167.63 | 108,289 | 259,226,552 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 54 | 165,862 | 0.03 | 167.63 | 9,052 | 27,803,447 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13,548 | 1,500,227 | 0.91 | 154.78 | 2,096,961 | 232,205,285 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,142 | 161,969 | 0.71 | 154.78 | 176,759 | 25,069,578 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8,098 | 1,486,679 | 0.55 | 153.97 | 1,246,878 | 228,909,318 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 683 | 160,827 | 0.43 | 153.97 | 105,164 | 24,763,112 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,877 | 1,478,581 | 0.19 | 153.25 | 440,907 | 226,595,939 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 242 | 160,144 | 0.15 | 153.25 | 37,087 | 24,542,436 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 646 | 1,475,704 | 0.04 | 152.21 | 98,330 | 224,621,185 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 54 | 159,902 | 0.03 | 152.21 | 8,219 | 24,339,147 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 6,022 | 1,475,058 | 0.41 | 152.48 | 918,235 | 224,916,844 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 507 | 159,848 | 0.32 | 152.48 | 77,307 | 24,373,623 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,542 | 1,469,036 | 0.24 | 154.60 | 547,582 | 227,108,412 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 299 | 159,341 | 0.19 | 154.60 | 46,224 | 24,633,625 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26,426 | 1,465,494 | 1.84 | 146.21 | 3,863,756 | 214,270,464 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,228 | 159,042 | 1.42 | 146.21 | 325,757 | 23,253,594 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,994 | 1,439,068 | 0.21 | 145.98 | 437,057 | 210,071,549 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 252 | 156,814 | 0.16 | 145.98 | 36,786 | 22,891,316 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 6,369 | 1,436,074 | 0.45 | 145.46 | 926,430 | 208,890,175 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 537 | 156,562 | 0.34 | 145.46 | 78,112 | 22,773,383 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,291 | 1,429,705 | 0.09 | 142.86 | 184,429 | 204,244,082 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 109 | 156,025 | 0.07 | 142.86 | 15,571 | 22,289,341 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,790 | 1,428,414 | 0.76 | 141.44 | 1,526,192 | 202,042,018 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 910 | 155,916 | 0.59 | 141.44 | 128,715 | 22,053,539 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,072 | 1,417,624 | 0.36 | 140.90 | 714,657 | 199,746,624 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 427 | 155,006 | 0.28 | 140.90 | 60,165 | 21,840,717 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,631 | 1,412,552 | 0.33 | 137.69 | 637,622 | 194,487,928 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 390 | 154,579 | 0.25 | 137.69 | 53,697 | 21,283,287 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,693 | 1,407,921 | 0.26 | 136.91 | 505,605 | 192,756,915 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 311 | 154,189 | 0.20 | 136.91 | 42,579 | 21,109,846 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,144 | 1,404,228 | 0.22 | 136.18 | 428,151 | 191,228,471 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 265 | 153,878 | 0.17 | 136.18 | 36,088 | 20,955,183 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 14,018 | 1,545,775 | 0.92 | 161.97 | 2,270,439 | 250,362,994 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,181 | 165,808 | 0.72 | 161.97 | 191,282 | 26,855,259 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 31,530 | 1,531,757 | 2.10 | 156.42 | 4,932,061 | 239,604,170 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,658 | 164,627 | 1.64 | 156.42 | 415,776 | 25,751,680 | |
| 2023-11-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -1,008,660 | 9,691,294 | -9.43 | 180.50 | -182,063,130 | 1,749,278,567 | |
| 2023-11-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -91,340 | 877,603 | -9.43 | 180.50 | -16,486,870 | 158,407,342 | |
| 2023-10-23 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
S - Sale | -251,902 | 2,971,128 | -7.82 | 0.40 | -101,391 | 1,195,879 | |
| 2023-10-23 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
S - Sale | -22,837 | 286,893 | -7.37 | 0.40 | -9,192 | 115,474 | |
| 2023-10-10 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
X - Other | 535,601 | 1,658,190 | 47.71 | ||||
| 2023-10-10 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
X - Other | 57,049 | 155,874 | 57.73 | ||||
| 2023-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 510 | 33,446,882 | 0.00 | ||||
| 2023-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 510 | 2,968,974 | 0.02 | ||||
| 2023-10-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2,896,968 | 0.02 | ||||
| 2023-10-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 274,560 | 0.20 | ||||
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 61,134 | 5,612,949 | 1.10 | 0.69 | 42,354 | 3,888,651 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 5,041 | 494,133 | 1.03 | 0.69 | 3,492 | 342,335 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 93,091 | 5,551,815 | 1.71 | 0.69 | 64,456 | 3,844,077 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 7,676 | 489,092 | 1.59 | 0.69 | 5,315 | 338,647 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 4,434 | 5,458,724 | 0.08 | 0.68 | 3,028 | 3,727,217 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 366 | 481,416 | 0.08 | 0.68 | 250 | 328,711 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 207,676 | 5,454,290 | 3.96 | 0.68 | 141,324 | 3,711,644 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 17,124 | 481,050 | 3.69 | 0.68 | 11,653 | 327,355 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 4,342 | 5,246,614 | 0.08 | 0.66 | 2,887 | 3,488,998 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 358 | 463,926 | 0.08 | 0.66 | 238 | 308,511 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 1,740,581 | 5,242,272 | 49.71 | 0.63 | 1,097,958 | 3,306,825 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 143,519 | 463,568 | 44.84 | 0.63 | 90,532 | 292,419 | |
| 2023-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 512 | 33,446,372 | 0.00 | ||||
| 2023-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 512 | 33,446,372 | 0.00 | ||||
| 2023-07-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2,896,414 | 0.02 | ||||
| 2023-07-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2,896,414 | 0.02 | ||||
| 2023-06-20 | 3 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
148,821 | ||||||||
| 2023-06-20 | 3 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
1,396,292 | ||||||||
| 2023-06-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4,792 | 1,401,084 | 0.34 | ||||
| 2023-06-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4,792 | 1,401,084 | 0.34 | ||||
| 2023-06-20 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 25,844 | 93,417 | 38.25 | ||||
| 2023-06-20 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 25,844 | 93,417 | 38.25 | ||||
| 2023-06-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,505 | 33,445,860 | 0.01 | ||||
| 2023-06-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,505 | 33,445,860 | 0.01 | ||||
| 2023-06-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 8,746 | 2,719,343 | 0.32 | ||||
| 2023-06-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 8,746 | 2,719,343 | 0.32 | ||||
| 2023-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 13,304 | 39,330,977 | 0.03 | ||||
| 2023-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 13,304 | 39,330,977 | 0.03 | ||||
| 2023-06-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 2,044 | 42,977,301 | 0.00 | ||||
| 2023-06-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 2,044 | 42,977,301 | 0.00 | ||||
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 259,109 | 39,317,673 | 0.66 | 25.65 | 6,646,146 | 1,008,498,312 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24,113 | 3,610,443 | 0.67 | 25.65 | 618,498 | 92,607,863 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28,878 | 39,058,564 | 0.07 | 25.51 | 736,788 | 996,532,390 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,688 | 3,586,330 | 0.08 | 25.51 | 68,581 | 91,500,906 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 218,171 | 39,029,686 | 0.56 | 25.27 | 5,513,683 | 986,369,933 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 20,304 | 3,583,642 | 0.57 | 25.27 | 513,129 | 90,566,876 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 74,582 | 38,811,515 | 0.19 | 25.54 | 1,904,824 | 991,246,093 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 6,941 | 3,563,338 | 0.20 | 25.54 | 177,273 | 91,007,653 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 116,672 | 38,736,933 | 0.30 | 25.33 | 2,955,325 | 981,214,260 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 10,858 | 3,556,397 | 0.31 | 25.33 | 275,035 | 90,084,247 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12,500 | 38,620,261 | 0.03 | 17.01 | 212,625 | 656,930,640 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12,500 | 38,620,261 | 0.03 | 17.01 | 212,625 | 656,930,640 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 40,632 | 38,607,761 | 0.11 | 24.80 | 1,007,674 | 957,472,473 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,781 | 3,533,039 | 0.11 | 24.80 | 93,769 | 87,619,367 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 82,148 | 38,567,129 | 0.21 | 24.46 | 2,009,373 | 943,367,402 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7,645 | 3,529,258 | 0.22 | 24.46 | 187,000 | 86,327,062 | |
| 2023-05-05 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
21,912 | ||||||||
| 2023-05-05 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
227,211 | ||||||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -209,175 | 23,277 | -89.99 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -209,175 | 23,277 | -89.99 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | 209,175 | 232,452 | 898.63 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | 209,175 | 232,452 | 898.63 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | -2,368,357 | 1,729,158 | -57.80 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8,750 | 42,975,257 | 0.02 | 36.70 | 321,125 | 1,577,191,932 | |
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8,750 | 42,975,257 | 0.02 | 36.70 | 321,125 | 1,577,191,932 | |
| 2023-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 429 | 33,443,355 | 0.00 | ||||
| 2023-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 429 | 33,443,355 | 0.00 | ||||
| 2023-04-04 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2,895,860 | 0.02 | ||||
| 2023-04-04 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2,895,860 | 0.02 | ||||
| 2023-03-15 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 33,442,926 | 0.06 | 22.74 | 454,800 | 760,492,137 | |
| 2023-03-15 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 33,442,926 | 0.06 | 22.74 | 454,800 | 760,492,137 | |
| 2023-01-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15,000 | 38,484,981 | 0.04 | 5.22 | 78,300 | 200,891,601 | |
| 2023-01-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15,000 | 38,484,981 | 0.04 | 5.22 | 78,300 | 200,891,601 | |
| 2023-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 397 | 33,422,926 | 0.00 | ||||
| 2023-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 397 | 33,422,926 | 0.00 | ||||
| 2022-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 457 | 33,422,529 | 0.00 | ||||
| 2022-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 457 | 33,422,529 | 0.00 | ||||
| 2022-07-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 433 | 33,422,072 | 0.00 | ||||
| 2022-07-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 433 | 33,422,072 | 0.00 | ||||
| 2022-06-30 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 10,000 | 2,710,597 | 0.37 | ||||
| 2022-06-30 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 10,000 | 2,710,597 | 0.37 | ||||
| 2022-06-24 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 33,384 | 67,573 | 97.65 | ||||
| 2022-06-24 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 33,384 | 67,569 | 97.66 | ||||
| 2022-06-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,144 | 33,421,639 | 0.01 | ||||
| 2022-06-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2,144 | 33,421,639 | 0.01 | ||||
| 2022-06-13 |
|
4 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
A - Award | 10,622,568 | 14,575,984 | 268.69 | ||||
| 2022-06-13 |
|
4 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
A - Award | 1,252,432 | 1,585,054 | 376.53 | ||||
| 2022-06-09 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 17,104 | 38,469,981 | 0.04 | ||||
| 2022-06-09 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 17,104 | 38,469,981 | 0.04 | ||||
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 26,450 | 4,501,658 | 0.59 | 6.42 | 169,849 | 28,907,397 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 3,118 | 364,161 | 0.86 | 6.42 | 20,022 | 2,338,460 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7,815 | 4,475,208 | 0.17 | 6.35 | 49,654 | 28,434,129 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 921 | 361,043 | 0.26 | 6.35 | 5,852 | 2,293,959 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,364 | 4,467,393 | 0.05 | 5.82 | 13,759 | 26,001,121 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 279 | 360,122 | 0.08 | 5.82 | 1,624 | 2,095,982 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 170,549 | 15,967,504 | 1.08 | 7.78 | 1,327,008 | 124,239,955 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 20,108 | 1,342,986 | 1.52 | 7.78 | 156,456 | 10,449,505 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 101,315 | 15,796,955 | 0.65 | 7.75 | 785,070 | 122,407,445 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11,945 | 1,322,878 | 0.91 | 7.75 | 92,559 | 10,250,717 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 78,271 | 15,695,640 | 0.50 | 7.95 | 622,466 | 124,822,716 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,224 | 1,310,933 | 0.71 | 7.95 | 73,356 | 10,425,457 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13,155 | 15,617,369 | 0.08 | 7.93 | 104,363 | 123,897,273 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,550 | 1,301,709 | 0.12 | 7.93 | 12,297 | 10,326,848 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 138,122 | 15,604,214 | 0.89 | 7.68 | 1,060,680 | 119,829,441 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 16,278 | 1,300,159 | 1.27 | 7.68 | 125,004 | 9,984,311 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,585 | 15,466,092 | 0.07 | 7.51 | 79,540 | 116,218,402 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,247 | 1,283,881 | 0.10 | 7.51 | 9,370 | 9,647,595 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 88,046 | 15,455,507 | 0.57 | 6.92 | 609,278 | 106,952,108 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,386 | 1,282,634 | 0.82 | 6.92 | 71,871 | 8,875,827 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 51,082 | 15,367,461 | 0.33 | 6.78 | 346,367 | 104,200,606 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,026 | 1,272,248 | 0.48 | 6.78 | 40,860 | 8,626,605 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 358 | 15,316,379 | 0.00 | 6.64 | 2,375 | 101,624,175 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42 | 1,266,222 | 0.00 | 6.64 | 279 | 8,401,383 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 984 | 15,316,021 | 0.01 | 6.76 | 6,647 | 103,459,722 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116 | 1,266,180 | 0.01 | 6.76 | 784 | 8,553,046 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 53,401 | 15,315,037 | 0.35 | 6.75 | 360,521 | 103,394,878 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,299 | 1,266,064 | 0.50 | 6.75 | 42,526 | 8,547,451 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29,090 | 15,261,636 | 0.19 | 6.71 | 195,089 | 102,350,636 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,432 | 1,259,765 | 0.27 | 6.71 | 23,016 | 8,448,488 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42,250 | 15,232,546 | 0.28 | 6.60 | 279,002 | 100,589,641 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,984 | 1,256,333 | 0.40 | 6.60 | 32,912 | 8,296,321 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 48,222 | 15,190,296 | 0.32 | 6.53 | 315,058 | 99,245,799 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,688 | 1,251,349 | 0.46 | 6.53 | 37,163 | 8,175,689 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 19,789 | 4,465,029 | 0.45 | 5.74 | 113,619 | 25,635,964 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,334 | 359,843 | 0.65 | 5.74 | 13,401 | 2,066,039 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 1,521 | 4,445,240 | 0.03 | 5.93 | 9,020 | 26,360,273 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 179 | 357,509 | 0.05 | 5.93 | 1,061 | 2,120,028 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7,010 | 4,443,719 | 0.16 | 5.99 | 41,972 | 26,606,323 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 827 | 357,330 | 0.23 | 5.99 | 4,952 | 2,139,478 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7,772 | 4,436,709 | 0.18 | 5.84 | 45,405 | 25,919,698 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 946 | 356,503 | 0.27 | 5.84 | 5,527 | 2,082,726 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7,248 | 4,428,937 | 0.16 | 5.84 | 42,335 | 25,868,978 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 883 | 355,557 | 0.25 | 5.84 | 5,158 | 2,076,773 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,489 | 15,142,074 | 0.05 | 5.97 | 44,701 | 90,381,525 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 912 | 1,245,661 | 0.07 | 5.97 | 5,444 | 7,435,226 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 182,827 | 15,134,585 | 1.22 | 5.97 | 1,091,221 | 90,332,284 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,266 | 1,244,749 | 1.82 | 5.97 | 132,897 | 7,429,409 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,157 | 14,951,758 | 0.06 | 5.95 | 54,518 | 89,018,282 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,115 | 1,222,483 | 0.09 | 5.95 | 6,638 | 7,278,297 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 90,674 | 14,942,601 | 0.61 | 5.99 | 542,929 | 89,471,812 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11,043 | 1,221,368 | 0.91 | 5.99 | 66,122 | 7,313,185 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8,118 | 14,851,927 | 0.05 | 5.99 | 48,599 | 88,912,546 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 989 | 1,210,325 | 0.08 | 5.99 | 5,921 | 7,245,732 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15,154 | 14,843,809 | 0.10 | 5.75 | 87,098 | 85,314,792 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,846 | 1,209,336 | 0.15 | 5.75 | 10,610 | 6,950,659 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 93,690 | 14,828,655 | 0.64 | 5.71 | 534,979 | 84,673,103 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11,410 | 1,207,490 | 0.95 | 5.71 | 65,152 | 6,894,889 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 30,003 | 4,421,689 | 0.68 | 6.00 | 180,018 | 26,530,134 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 3,654 | 354,674 | 1.04 | 6.00 | 21,924 | 2,128,044 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 692 | 4,391,686 | 0.02 | 5.92 | 4,095 | 25,989,998 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 84 | 351,020 | 0.02 | 5.92 | 497 | 2,077,336 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 16,501 | 4,390,994 | 0.38 | 6.13 | 101,153 | 26,917,232 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,010 | 350,936 | 0.58 | 6.13 | 12,322 | 2,151,273 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 16,937 | 4,374,493 | 0.39 | 5.83 | 98,673 | 25,485,359 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2,063 | 348,926 | 0.59 | 5.83 | 12,019 | 2,032,808 | |
| 2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 3,676 | 3,676 | |||||
| 2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1,503 | 42,966,507 | 0.00 | ||||
| 2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1,503 | 42,966,507 | 0.00 | ||||
| 2022-05-16 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25,000 | 25,000 | |||||
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 22,983 | 2,528,583 | 0.92 | 1.99 | 45,628 | 5,019,996 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 2,882 | 256,209 | 1.14 | 1.99 | 5,722 | 508,652 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 758,094 | 2,505,600 | 43.38 | 1.95 | 1,478,283 | 4,885,920 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 95,060 | 253,327 | 60.06 | 1.95 | 185,367 | 493,988 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 101,831 | 1,747,506 | 6.19 | 1.93 | 196,962 | 3,380,026 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 12,769 | 158,267 | 8.78 | 1.93 | 24,698 | 306,120 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 325,373 | 1,645,675 | 24.64 | 1.70 | 553,134 | 2,797,648 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 40,800 | 145,498 | 38.97 | 1.70 | 69,360 | 247,347 | |
| 2022-04-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
P - Purchase | 2,592,497 | 4,674,392 | 124.53 | 23.00 | 59,627,431 | 107,511,016 | |
| 2022-04-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
P - Purchase | 233,590 | 421,532 | 124.29 | 23.00 | 5,372,570 | 9,695,236 | |
| 2022-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 440 | 33,419,495 | 0.00 | ||||
| 2022-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 440 | 33,419,495 | 0.00 | ||||
| 2022-03-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 29,497 | 29,497 | |||||
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17,500 | 42,965,004 | 0.04 | 20.06 | 351,050 | 861,877,980 | |
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17,500 | 42,965,004 | 0.04 | 20.06 | 351,050 | 861,877,980 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 175,795 | 33,419,055 | 0.53 | 73.31 | 12,887,303 | 2,449,907,477 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 14,490 | 2,941,147 | 0.50 | 73.31 | 1,062,243 | 215,611,663 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1,017 | 33,243,260 | 0.00 | 71.95 | 73,177 | 2,391,975,557 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 84 | 2,926,657 | 0.00 | 71.95 | 6,044 | 210,583,800 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 25,107 | 33,242,243 | 0.08 | 71.90 | 1,805,126 | 2,390,027,518 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,070 | 2,926,573 | 0.07 | 71.90 | 148,827 | 210,412,697 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 65,147 | 33,217,136 | 0.20 | 71.72 | 4,672,408 | 2,382,366,211 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5,370 | 2,924,503 | 0.18 | 71.72 | 385,142 | 209,748,280 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 92,385 | 33,151,989 | 0.28 | 70.68 | 6,529,310 | 2,343,016,823 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,615 | 2,919,133 | 0.26 | 70.68 | 538,190 | 206,309,725 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 33,059,604 | 0.06 | 22.05 | 441,000 | 728,964,268 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 33,059,604 | 0.06 | 22.05 | 441,000 | 728,964,268 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 92,234 | 33,039,604 | 0.28 | 68.07 | 6,278,507 | 2,249,055,404 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,566 | 2,891,518 | 0.26 | 68.07 | 515,029 | 196,829,968 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 22,178 | 32,947,370 | 0.07 | 68.43 | 1,517,656 | 2,254,611,592 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1,827 | 2,883,952 | 0.06 | 68.43 | 125,023 | 197,350,854 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 100,731 | 32,925,192 | 0.31 | 68.37 | 6,886,696 | 2,251,003,187 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8,296 | 2,882,125 | 0.29 | 68.37 | 567,174 | 197,042,816 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 285,672 | 32,824,461 | 0.88 | 67.74 | 19,352,821 | 2,223,689,828 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,300 | 32,538,789 | 0.02 | 67.40 | 491,984 | 2,192,951,685 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 271,997 | 14,734,965 | 1.88 | 54.57 | 14,843,883 | 804,141,559 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,403 | 1,196,080 | 1.91 | 54.57 | 1,222,615 | 65,274,511 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,174 | 14,462,968 | 0.04 | 53.82 | 278,457 | 778,376,690 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 426 | 1,173,677 | 0.04 | 53.82 | 22,927 | 63,165,653 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 64,119 | 14,457,794 | 0.45 | 54.26 | 3,479,200 | 784,503,035 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,281 | 1,173,251 | 0.45 | 54.26 | 286,556 | 63,662,476 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 23,804 | 14,393,675 | 0.17 | 53.73 | 1,279,048 | 773,408,142 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,961 | 1,167,970 | 0.17 | 53.73 | 105,369 | 62,757,948 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,359 | 14,369,871 | 0.04 | 54.16 | 290,217 | 778,200,364 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 441 | 1,166,009 | 0.04 | 54.16 | 23,882 | 63,145,217 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 182,326 | 32,531,489 | 0.56 | 66.04 | 12,040,390 | 2,148,304,711 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 320,526 | 32,349,163 | 1.00 | 66.02 | 21,159,973 | 2,135,575,284 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 10,985 | 32,028,637 | 0.03 | 66.95 | 735,433 | 2,144,278,813 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 265,522 | 32,017,652 | 0.84 | 66.81 | 17,740,295 | 2,139,192,181 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 772,751 | 31,752,130 | 2.49 | 67.54 | 52,192,839 | 2,144,589,664 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6,100 | 30,979,379 | 0.02 | 67.20 | 409,899 | 2,081,705,841 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 40,164 | 30,973,279 | 0.13 | 66.57 | 2,673,577 | 2,061,782,777 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 27,841 | 14,364,512 | 0.19 | 57.22 | 1,593,076 | 821,944,559 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,307 | 1,165,568 | 0.20 | 57.22 | 132,008 | 66,694,384 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11,526 | 14,336,671 | 0.08 | 51.61 | 594,898 | 739,967,202 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 953 | 1,163,261 | 0.08 | 51.61 | 49,188 | 60,040,088 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 17,119 | 14,325,145 | 0.12 | 50.56 | 865,460 | 724,214,868 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,414 | 1,162,308 | 0.12 | 50.56 | 71,485 | 58,761,062 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,395 | 14,308,026 | 0.16 | 49.70 | 1,113,056 | 711,124,631 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,851 | 1,160,894 | 0.16 | 49.70 | 91,997 | 57,697,709 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 54,024 | 14,285,631 | 0.38 | 51.67 | 2,791,490 | 738,157,125 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,465 | 1,159,043 | 0.39 | 51.67 | 230,712 | 59,889,259 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 117,291 | 14,231,607 | 0.83 | 51.59 | 6,050,820 | 734,181,565 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 86,479 | 14,114,316 | 0.62 | 52.04 | 4,500,497 | 734,530,176 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,500 | 14,027,837 | 0.04 | 58.90 | 323,934 | 826,198,919 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 57,547 | 14,022,337 | 0.41 | 58.87 | 3,387,844 | 825,507,599 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,350 | 13,964,790 | 0.07 | 58.76 | 549,368 | 820,513,805 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 132,367 | 13,955,440 | 0.96 | 58.13 | 7,693,938 | 811,171,114 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 25,900 | 13,823,073 | 0.19 | 57.59 | 1,491,519 | 796,037,599 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116,083 | 13,797,173 | 0.85 | 56.86 | 6,601,060 | 784,576,243 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,200 | 13,681,090 | 0.01 | 56.60 | 67,914 | 774,281,289 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 19,750 | 13,679,890 | 0.14 | 56.39 | 1,113,649 | 771,372,061 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 31,207 | 13,660,140 | 0.23 | 57.53 | 1,795,292 | 785,847,364 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 102,207 | 13,628,933 | 0.76 | 56.57 | 5,782,279 | 771,045,981 | |
| 2022-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 419 | 30,933,115 | 0.00 | ||||
| 2022-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 419 | 30,933,115 | 0.00 | ||||
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 193,997 | 30,932,696 | 0.63 | 72.91 | 14,144,224 | 2,255,287,399 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 881,875 | 30,738,699 | 2.95 | 72.77 | 64,177,924 | 2,236,990,377 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 29,703 | 29,856,824 | 0.10 | 72.00 | 2,138,616 | 2,149,691,328 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 139,612 | 29,827,121 | 0.47 | 71.96 | 10,045,795 | 2,146,213,474 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 288,368 | 29,687,509 | 0.98 | 71.91 | 20,736,197 | 2,134,793,147 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5,382 | 29,399,141 | 0.02 | 71.03 | 382,302 | 2,088,323,882 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9,893 | 29,393,759 | 0.03 | 70.24 | 694,840 | 2,064,485,360 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 36,476 | 29,383,866 | 0.12 | 69.63 | 2,539,700 | 2,045,898,684 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9,352 | 29,347,390 | 0.03 | 68.52 | 640,841 | 2,011,015,226 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 861 | 29,338,038 | 0.00 | 67.90 | 58,460 | 1,991,999,972 | |
| 2021-12-16 | 3 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
346,863 | ||||||||
| 2021-12-16 | 3 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
4,357,556 | ||||||||
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -51,399 | 42,947,504 | -0.12 | 161.39 | -8,295,146 | 6,931,181,712 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -4,738 | 4,069,762 | -0.12 | 161.39 | -764,653 | 656,807,901 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -8,332 | 42,998,903 | -0.02 | 161.34 | -1,344,327 | 6,937,658,005 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -768 | 4,074,500 | -0.02 | 161.34 | -123,913 | 657,400,202 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -25,833 | 43,007,235 | -0.06 | 160.80 | -4,154,029 | 6,915,701,011 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -2,381 | 4,075,268 | -0.06 | 160.80 | -382,872 | 655,316,135 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1,007 | 43,033,068 | 0.00 | 165.68 | -166,844 | 7,129,895,142 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -93 | 4,077,649 | 0.00 | 165.68 | -15,409 | 675,601,605 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -9,618 | 43,034,075 | -0.02 | 164.82 | -1,585,266 | 7,092,996,737 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -886 | 4,077,742 | -0.02 | 164.82 | -146,033 | 672,104,854 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1,337 | 43,043,693 | 0.00 | 163.39 | -218,449 | 7,032,809,999 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -123 | 4,078,628 | 0.00 | 163.39 | -20,097 | 666,397,648 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -20,154 | 43,045,030 | -0.05 | 160.96 | -3,243,986 | 6,928,523,724 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1,858 | 4,078,751 | -0.05 | 160.96 | -299,063 | 656,515,353 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -29,432 | 43,065,184 | -0.07 | 160.53 | -4,724,631 | 6,913,124,792 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -2,713 | 4,080,609 | -0.07 | 160.53 | -435,510 | 655,047,921 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -5,860 | 43,094,616 | -0.01 | 160.08 | -938,044 | 6,898,400,822 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -540 | 4,083,322 | -0.01 | 160.08 | -86,441 | 653,640,627 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -208,597 | 43,100,476 | -0.48 | 160.00 | -33,375,520 | 6,896,076,160 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -19,226 | 4,083,862 | -0.47 | 160.00 | -3,076,160 | 653,417,920 | |
| 2021-11-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 50,000 | 7,053,176 | 0.71 | 4.36 | 218,250 | 30,787,113 | |
| 2021-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 393 | 29,337,177 | 0.00 | ||||
| 2021-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 393 | 29,337,177 | 0.00 | ||||
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 86,932 | 13,526,726 | 0.65 | 95.83 | 8,330,572 | 1,296,247,215 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
M - Exercise | -138,815 | 0 | -100.00 | ||||
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
M - Exercise | -11,184 | 0 | -100.00 | ||||
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
F - Taxes | -14 | 13,439,794 | 0.00 | 102.00 | -1,428 | 1,370,858,988 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
M - Exercise | 138,815 | 13,439,808 | 1.04 | 0.01 | 1,388 | 134,398 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
F - Taxes | -2 | 1,154,578 | 0.00 | 102.00 | -204 | 117,766,956 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
M - Exercise | 11,184 | 1,154,580 | 0.98 | 0.01 | 112 | 11,546 | |
| 2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,153 | 13,300,993 | 0.01 | 94.59 | 109,064 | 1,258,164,870 | |
| 2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13,299,840 | 0.00 | 94.48 | 37,791 | 1,256,535,634 | |
| 2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 30,285 | 13,299,440 | 0.23 | 94.38 | 2,858,425 | 1,255,257,005 | |
| 2021-09-09 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 52,201 | 13,269,155 | 0.39 | 93.35 | 4,872,948 | 1,238,671,639 | |
| 2021-09-09 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,300 | 13,216,954 | 0.04 | 92.88 | 492,279 | 1,227,629,017 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 73,635 | 13,211,654 | 0.56 | 87.61 | 6,451,464 | 1,157,527,175 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,396 | 13,138,019 | 0.02 | 87.48 | 209,607 | 1,149,341,492 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,649 | 13,135,623 | 0.04 | 87.07 | 404,793 | 1,143,731,830 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,968 | 13,130,974 | 0.02 | 86.94 | 258,033 | 1,141,587,183 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13,128,006 | 0.00 | 89.66 | 35,863 | 1,177,008,444 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,100 | 13,127,606 | 0.01 | 88.16 | 96,982 | 1,157,395,383 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8,186 | 13,126,506 | 0.06 | 87.91 | 719,659 | 1,153,995,773 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 12,898 | 13,118,320 | 0.10 | 87.79 | 1,132,303 | 1,151,644,194 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,764 | 13,105,422 | 0.06 | 85.95 | 667,333 | 1,126,439,853 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13,097,658 | 0.00 | 84.80 | 33,921 | 1,110,714,143 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13,097,258 | 0.00 | 88.82 | 35,526 | 1,163,232,969 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 16,269 | 13,096,858 | 0.12 | 88.76 | 1,444,017 | 1,162,461,400 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 21,595 | 13,080,589 | 0.17 | 88.59 | 1,913,036 | 1,158,770,138 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,086 | 13,058,994 | 0.05 | 88.01 | 535,634 | 1,149,333,815 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,600 | 13,052,908 | 0.04 | 86.44 | 397,646 | 1,128,354,716 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 300 | 13,048,308 | 0.00 | 85.58 | 25,674 | 1,116,674,199 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,500 | 13,048,008 | 0.03 | 88.00 | 395,990 | 1,148,195,998 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 44,700 | 13,043,508 | 0.34 | 86.07 | 3,847,481 | 1,122,699,081 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 600 | 12,998,808 | 0.00 | 85.72 | 51,434 | 1,114,295,518 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,723 | 12,998,208 | 0.03 | 84.39 | 314,185 | 1,096,922,673 | |
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Non-Voting Common Stock |
C - Conversion | 3,960,811 | 3,960,811 | |||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -3,960,811 | 0 | -100.00 | ||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Non-Voting Common Stock |
C - Conversion | 315,777 | 315,777 | |||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -315,777 | 0 | -100.00 | ||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 1,320,302 | 1,320,302 | 15.00 | 19,804,530 | 19,804,530 | ||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 104,698 | 104,698 | 15.00 | 1,570,470 | 1,570,470 | ||
| 2021-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 345 | 29,336,784 | 0.00 | ||||
| 2021-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 345 | 29,336,784 | 0.00 | ||||
| 2021-07-01 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 66,474 | 66,474 | |||||
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 7,368 | 7,368 | |||||
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 121,612 | 12,994,485 | 0.94 | 92.75 | 11,279,014 | 1,205,185,206 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,009 | 12,872,873 | 0.05 | 91.64 | 642,276 | 1,179,617,303 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,353 | 12,865,864 | 0.17 | 90.20 | 2,016,332 | 1,160,553,683 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,603 | 12,843,511 | 0.04 | 89.74 | 413,070 | 1,152,566,402 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 30,221 | 12,838,908 | 0.24 | 90.70 | 2,741,157 | 1,164,536,460 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,200 | 12,808,687 | 0.01 | 90.40 | 108,474 | 1,157,841,261 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11,731 | 12,807,487 | 0.09 | 90.39 | 1,060,378 | 1,157,682,838 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,847 | 12,795,756 | 0.03 | 89.90 | 345,828 | 1,150,282,163 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,079 | 12,791,909 | 0.06 | 89.87 | 636,196 | 1,149,620,375 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,459 | 12,784,830 | 0.08 | 91.87 | 960,845 | 1,174,514,205 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,445 | 12,774,371 | 0.18 | 91.80 | 2,060,393 | 1,172,654,044 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,170 | 12,751,926 | 0.08 | 90.76 | 923,046 | 1,157,386,482 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,200 | 12,741,756 | 0.04 | 90.27 | 469,420 | 1,150,237,814 | |
| 2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Options (right to buy) |
A - Award | 23,274 | 23,274 | |||||
| 2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 12,782 | 38,452,877 | 0.03 | ||||
| 2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 12,782 | 38,452,877 | 0.03 | ||||
| 2021-06-22 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
A - Award | 23,344 | 23,344 | |||||
| 2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 34,996 | 34,996 | |||||
| 2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 15,600 | 34,189 | 83.92 | ||||
| 2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 15,600 | 34,189 | 83.92 | ||||
| 2021-06-10 |
|
4 | AGLE |
Aeglea BioTherapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 40,000 | 40,000 | |||||
| 2021-05-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 8,010 | 8,010 | |||||
| 2021-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,923 | 29,336,439 | 0.01 | ||||
| 2021-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,923 | 29,336,439 | 0.01 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 3,462 | 3,462 | |||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1,402 | 43,309,073 | 0.00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1,402 | 43,309,073 | 0.00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17,500 | 43,307,671 | 0.04 | 19.02 | 332,850 | 823,711,902 | |
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17,500 | 43,307,671 | 0.04 | 19.02 | 332,850 | 823,711,902 | |
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 29,334,516 | 0.07 | 18.97 | 379,400 | 556,475,769 | |
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 2,870,749 | 0.70 | 18.97 | 379,400 | 54,458,109 | |
| 2021-05-13 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25,000 | 25,000 | |||||
| 2021-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29,314,516 | 0.00 | ||||
| 2021-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29,314,516 | 0.00 | ||||
| 2021-02-25 |
|
4 | AGLE |
Aeglea BioTherapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 47,200 | 47,200 | |||||
| 2021-02-25 | 3 | AGLE |
Aeglea BioTherapeutics, Inc.
Common Stock |
315,516 | ||||||||
| 2021-02-25 | 3 | AGLE |
Aeglea BioTherapeutics, Inc.
Common Stock |
3,094,590 | ||||||||
| 2021-02-23 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 6,423 | 6,423 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 6,427,576 | 27,511,741 | 30.49 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 536,438 | 2,345,481 | 29.65 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 7,286,794 | 21,084,165 | 52.81 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 536,414 | 1,809,043 | 42.15 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 1,941 | 5,420 | 55.79 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 6,654,603 | 13,797,371 | 93.17 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 598,860 | 1,272,629 | 88.88 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 7,142,768 | 7,142,768 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 673,769 | 673,769 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 3,479 | 3,479 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
M - Exercise | -9,191,433 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
M - Exercise | -767,106 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-2 Convertible Preferred Stock |
M - Exercise | -10,420,117 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-2 Convertible Preferred Stock |
M - Exercise | -767,072 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-1 Convertible Preferred Stock |
M - Exercise | -2,776 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series D-2 Convertible Preferred Stock |
M - Exercise | -9,516,082 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series D-2 Convertible Preferred Stock |
M - Exercise | -856,370 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -10,214,159 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -963,490 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -4,975 | 0 | -100.00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 5,792,538 | 7,003,176 | 478.47 | 16.00 | 92,680,608 | 112,050,816 | |
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 457,462 | 571,659 | 400.59 | 16.00 | 7,319,392 | 9,146,544 | |
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
A - Award | 9,191,433 | 9,191,433 | 8.55 | 78,586,752 | 78,586,752 | ||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
A - Award | 767,106 | 767,106 | 8.55 | 6,558,756 | 6,558,756 | ||
| 2021-02-16 |
|
5 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -158,456 | 23,277 | -87.19 | ||||
| 2021-02-16 |
|
5 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -158,460 | 23,280 | -87.19 | ||||
| 2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
590 | ||||||||
| 2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
114,197 | ||||||||
| 2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
1,210,638 | ||||||||
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,188 | 41,500 | -11.11 | ||||
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,188 | 41,500 | -11.11 | ||||
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 5,188 | 9,252,951 | 0.06 | 12.85 | 66,666 | 118,900,420 | |
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 5,188 | 9,252,951 | 0.06 | 12.85 | 66,666 | 118,900,420 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,833 | 2,527 | -69.77 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,833 | 2,527 | -69.77 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,377 | 6,723 | -44.44 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5,377 | 6,723 | -44.44 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5,833 | 2,895,306 | 0.20 | 40.27 | 234,895 | 116,593,973 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5,833 | 2,895,306 | 0.20 | 40.27 | 234,895 | 116,593,973 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5,377 | 2,889,473 | 0.19 | 16.00 | 86,032 | 46,231,568 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5,377 | 2,889,473 | 0.19 | 16.00 | 86,032 | 46,231,568 | |
| 2021-01-13 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
P - Purchase | 154,222 | 5,212,371 | 3.05 | 60.00 | 9,253,320 | 312,742,260 | |
| 2021-01-13 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
P - Purchase | 12,444 | 509,480 | 2.50 | 60.00 | 746,640 | 30,568,800 | |
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
332,622 | ||||||||
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
3,953,416 | ||||||||
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
American Depositary Shares |
1,200,369 | ||||||||
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
American Depositary Shares |
13,413,895 | ||||||||
| 2021-01-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -111,094 | 10,699,954 | -1.03 | 220.50 | -24,496,227 | 2,359,339,857 | |
| 2021-01-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -10,060 | 968,943 | -1.03 | 220.50 | -2,218,230 | 213,651,932 | |
| 2021-01-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,884,096 | 0.01 | ||||
| 2021-01-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,884,096 | 0.01 | ||||
| 2021-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 343 | 29,314,152 | 0.00 | ||||
| 2021-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 343 | 29,314,152 | 0.00 | ||||
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-Funded Warrants |
P - Purchase | 518,555 | 10,283,888 | 5.31 | ||||
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-Funded Warrants |
P - Purchase | 38,974 | 1,199,122 | 3.36 | ||||
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 394,360 | 3,501,691 | 12.69 | 15.25 | 6,013,990 | 53,400,788 | |
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 29,640 | 320,049 | 10.21 | 15.25 | 452,010 | 4,880,747 | |
| 2020-12-11 |
|
4 | IGMS |
IGM Biosciences, Inc.
Pre-funded Warrants |
P - Purchase | 616,846 | 616,846 | 89.99 | 55,509,972 | 55,509,972 | ||
| 2020-12-11 |
|
4 | IGMS |
IGM Biosciences, Inc.
Pre-funded Warrants |
P - Purchase | 49,820 | 49,820 | 89.99 | 4,483,302 | 4,483,302 | ||
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -1,386,033 | 10,811,048 | -11.36 | 220.50 | -305,620,276 | 2,383,836,084 | |
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -125,513 | 979,003 | -11.36 | 220.50 | -27,675,616 | 215,870,162 | |
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
G - Gift | -13,516 | 10,418 | -56.47 | ||||
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
G - Gift | -13,516 | 10,418 | -56.47 | ||||
| 2020-11-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,411,619 | 12,736,556 | 12.46 | 108.00 | 152,454,852 | 1,375,548,048 | |
| 2020-11-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116,158 | 1,143,396 | 11.31 | 108.00 | 12,545,064 | 123,486,768 | |
| 2020-10-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,873 | 0.01 | ||||
| 2020-10-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,873 | 0.01 | ||||
| 2020-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 317 | 29,313,809 | 0.00 | ||||
| 2020-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 317 | 29,313,809 | 0.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 382,884 | 5,058,149 | 8.19 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -382,884 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 30,349 | 497,036 | 6.50 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -30,349 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -574,327 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -45,524 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 2,698,424 | 4,675,265 | 136.50 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -2,698,424 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 247,034 | 466,687 | 112.47 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -247,034 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -4,047,634 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -370,552 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 1,976,841 | 1,976,841 | |||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -1,976,841 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 219,653 | 219,653 | |||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -219,653 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -2,965,263 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -329,478 | 0 | -100.00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
P - Purchase | 1,474,319 | 9,247,763 | 18.97 | 19.00 | 28,012,061 | 175,707,497 | |
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
P - Purchase | 104,628 | 870,873 | 13.65 | 19.00 | 1,987,932 | 16,546,587 | |
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 574,327 | 7,773,444 | 7.98 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 45,524 | 766,245 | 6.32 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 4,047,634 | 7,199,117 | 128.44 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 370,552 | 720,721 | 105.82 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 2,965,263 | 3,151,483 | 1,592.34 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 329,478 | 350,169 | 1,592.37 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Option (right to buy) |
A - Award | 46,688 | 46,688 | |||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Preferred Stock |
P - Purchase | 957,211 | 957,211 | 14.52 | 13,898,321 | 13,898,321 | ||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Preferred Stock |
P - Purchase | 75,873 | 75,873 | 14.52 | 1,101,646 | 1,101,646 | ||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Preferred Stock |
P - Purchase | 3,373,029 | 3,373,029 | 3.93 | 13,264,099 | 13,264,099 | ||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Preferred Stock |
P - Purchase | 308,793 | 308,793 | 3.93 | 1,214,298 | 1,214,298 | ||
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,843 | 11,324,937 | 0.07 | 58.09 | 455,565 | 657,814,628 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 557 | 1,027,238 | 0.05 | 58.09 | 32,354 | 59,667,633 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 19,235 | 11,317,094 | 0.17 | 56.92 | 1,094,854 | 644,167,859 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,365 | 1,026,681 | 0.13 | 56.92 | 77,696 | 58,438,580 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,705 | 11,297,859 | 0.04 | 56.76 | 267,055 | 641,265,347 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 334 | 1,025,316 | 0.03 | 56.76 | 18,958 | 58,196,834 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13,153 | 11,293,154 | 0.12 | 55.35 | 728,057 | 625,108,824 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 933 | 1,024,982 | 0.09 | 55.35 | 51,644 | 56,735,726 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29,327 | 11,280,001 | 0.26 | 52.11 | 1,528,374 | 587,856,124 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,081 | 1,024,049 | 0.20 | 52.11 | 108,451 | 53,368,211 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4,306 | 11,250,674 | 0.04 | 51.41 | 221,368 | 578,388,150 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 306 | 1,021,968 | 0.03 | 51.41 | 15,731 | 52,538,557 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 74,381 | 11,246,368 | 0.67 | 52.44 | 3,900,235 | 589,713,428 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,278 | 1,021,662 | 0.52 | 52.44 | 276,757 | 53,571,766 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,467 | 11,171,987 | 0.09 | 52.40 | 548,468 | 585,408,767 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 743 | 1,016,384 | 0.07 | 52.40 | 38,933 | 53,258,217 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,120 | 11,161,520 | 0.01 | 51.97 | 58,206 | 580,064,194 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 80 | 1,015,641 | 0.01 | 51.97 | 4,158 | 52,782,863 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22,361 | 11,160,400 | 0.20 | 51.98 | 1,162,235 | 580,072,950 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,587 | 1,015,561 | 0.16 | 51.98 | 82,486 | 52,784,799 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 36,647 | 11,138,039 | 0.33 | 50.15 | 1,837,909 | 558,591,591 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,601 | 1,013,974 | 0.26 | 50.15 | 130,445 | 50,852,520 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,983 | 11,101,392 | 0.10 | 49.72 | 546,102 | 551,988,964 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 779 | 1,011,373 | 0.08 | 49.72 | 38,734 | 50,287,994 | |
| 2020-09-24 | 3 | PRLD |
Prelude Therapeutics Inc
Common Stock |
20,691 | ||||||||
| 2020-09-24 | 3 | PRLD |
Prelude Therapeutics Inc
Common Stock |
186,220 | ||||||||
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15,172 | 11,090,409 | 0.14 | 47.47 | 720,200 | 526,450,625 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,220 | 1,010,594 | 0.12 | 47.47 | 57,912 | 47,971,887 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 76,473 | 11,075,237 | 0.70 | 47.39 | 3,623,857 | 524,826,686 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,151 | 1,009,374 | 0.61 | 47.39 | 291,480 | 47,831,609 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15,807 | 10,998,764 | 0.14 | 47.04 | 743,482 | 517,326,865 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,272 | 1,003,223 | 0.13 | 47.04 | 59,829 | 47,186,594 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 185 | 10,982,957 | 0.00 | 45.88 | 8,487 | 503,843,152 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15 | 1,001,951 | 0.00 | 45.88 | 688 | 45,964,502 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,101 | 10,982,772 | 0.08 | 47.50 | 432,281 | 521,661,901 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 712 | 1,001,936 | 0.07 | 47.50 | 33,819 | 47,590,157 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 26,238 | 10,973,671 | 0.24 | 47.26 | 1,239,984 | 518,605,815 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,054 | 1,001,224 | 0.21 | 47.26 | 97,070 | 47,316,945 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29,319 | 10,947,433 | 0.27 | 46.62 | 1,366,767 | 510,337,579 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,295 | 999,170 | 0.23 | 46.62 | 106,986 | 46,578,408 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 12,132 | 10,918,114 | 0.11 | 45.30 | 549,535 | 494,550,167 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 950 | 996,875 | 0.10 | 45.30 | 43,031 | 45,154,749 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 32,088 | 10,905,982 | 0.30 | 49.00 | 1,572,312 | 534,393,118 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,512 | 995,925 | 0.25 | 49.00 | 123,088 | 48,800,325 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 77,456 | 10,873,894 | 0.72 | 47.60 | 3,686,658 | 517,562,558 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,062 | 993,413 | 0.61 | 47.60 | 288,532 | 47,283,280 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,987 | 10,796,438 | 0.03 | 47.45 | 141,725 | 512,260,753 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 234 | 987,351 | 0.02 | 47.45 | 11,103 | 46,847,040 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,359 | 10,793,451 | 0.02 | 46.97 | 110,798 | 506,947,886 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 185 | 987,117 | 0.02 | 46.97 | 8,689 | 46,363,010 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 83,832 | 10,791,092 | 0.78 | 49.08 | 4,114,734 | 529,660,248 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,645 | 986,932 | 0.68 | 49.08 | 326,157 | 48,441,682 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,286 | 10,707,260 | 0.02 | 48.74 | 111,430 | 521,922,177 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 181 | 980,287 | 0.02 | 48.74 | 8,823 | 47,783,796 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42,714 | 10,704,974 | 0.40 | 47.74 | 2,039,256 | 511,077,939 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,386 | 980,106 | 0.35 | 47.74 | 161,655 | 46,792,319 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 754 | 10,662,260 | 0.01 | 47.82 | 36,058 | 509,896,995 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 60 | 976,720 | 0.01 | 47.82 | 2,869 | 46,709,290 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 41,155 | 10,661,506 | 0.39 | 47.72 | 1,963,970 | 508,780,926 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,262 | 976,660 | 0.34 | 47.72 | 155,667 | 46,607,485 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,640 | 10,620,351 | 0.10 | 46.50 | 494,716 | 493,802,778 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 843 | 973,398 | 0.09 | 46.50 | 39,196 | 45,259,016 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,576 | 10,609,711 | 0.03 | 46.30 | 165,575 | 491,248,717 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 283 | 972,555 | 0.03 | 46.30 | 13,103 | 45,031,047 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,585 | 10,606,135 | 0.03 | 46.99 | 168,447 | 498,345,162 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 284 | 972,272 | 0.03 | 46.99 | 13,344 | 45,683,658 | |
| 2020-07-28 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1,335,362 | 11,638,314 | 12.96 | 21.00 | 28,042,602 | 244,404,594 | |
| 2020-07-28 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 93,210 | 1,143,650 | 8.87 | 21.00 | 1,957,410 | 24,016,650 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 728,370 | 6,173,327 | 13.38 | 16.00 | 11,653,920 | 98,773,232 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 52,880 | 542,114 | 10.81 | 16.00 | 846,080 | 8,673,824 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 728,370 | 6,173,327 | 13.38 | 16.00 | 11,653,920 | 98,773,232 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 52,880 | 542,114 | 10.81 | 16.00 | 846,080 | 8,673,824 | |
| 2020-07-17 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 13,589,904 | 18,840,379 | 258.83 | 14.23 | 193,395,206 | 268,113,665 | |
| 2020-07-17 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 994,276 | 1,021,851 | 3,605.72 | 14.23 | 14,149,343 | 14,541,757 | |
| 2020-07-06 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,650 | 0.01 | ||||
| 2020-07-06 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,650 | 0.01 | ||||
| 2020-07-02 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 7,106 | 7,106 | |||||
| 2020-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 294 | 29,313,492 | 0.00 | ||||
| 2020-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 294 | 29,313,492 | 0.00 | ||||
| 2020-07-02 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37,520 | 37,520 | |||||
| 2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Options (right to buy) |
A - Award | 11,158 | 11,158 | |||||
| 2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 6,118 | 38,440,095 | 0.02 | ||||
| 2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 6,118 | 38,440,095 | 0.02 | ||||
| 2020-06-19 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 90,766 | 90,766 | |||||
| 2020-06-10 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 4,135 | 4,135 | |||||
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 | 29,313,198 | 0.00 | 102.55 | 103 | 3,006,068,455 | |
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 | 29,313,198 | 0.00 | 102.55 | 103 | 3,006,068,455 | |
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 10,514 | 10,514 | |||||
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,282 | 29,313,197 | 0.00 | ||||
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,282 | 29,313,197 | 0.00 | ||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 3,171 | 3,171 | |||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 1,335 | 43,290,171 | 0.00 | ||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 1,335 | 43,290,171 | 0.00 | ||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -1,602,312 | 43,288,836 | -3.57 | 160.00 | -256,369,920 | 6,926,213,760 | |
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -147,688 | 4,082,851 | -3.49 | 160.00 | -23,630,080 | 653,256,160 | |
| 2020-05-18 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1,465,603 | 10,302,952 | 16.58 | 18.25 | 26,747,255 | 188,028,874 | |
| 2020-05-18 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 134,397 | 1,050,440 | 14.67 | 18.25 | 2,452,745 | 19,170,530 | |
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,189 | 7,846,213 | 0.02 | ||||
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1,189 | 7,846,213 | 0.02 | ||||
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,468 | 7,845,024 | 0.04 | ||||
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,468 | 7,845,024 | 0.04 | ||||
| 2020-05-12 |
|
4 | ZYME |
Zymeworks Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 9,000 | 9,000 | |||||
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -457,803 | 44,891,148 | -1.01 | 158.50 | -72,561,776 | 7,115,246,958 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -42,197 | 4,230,539 | -0.99 | 158.50 | -6,688,224 | 670,540,432 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4,343 | 45,348,951 | -0.01 | 166.15 | -721,610 | 7,534,941,349 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -400 | 4,272,736 | -0.01 | 166.15 | -66,462 | 709,935,168 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -48,880 | 45,353,294 | -0.11 | 164.96 | -8,063,118 | 7,481,361,460 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4,505 | 4,273,136 | -0.11 | 164.96 | -743,133 | 704,885,404 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -84,663 | 45,402,174 | -0.19 | 164.19 | -13,901,157 | 7,454,764,558 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -7,805 | 4,277,641 | -0.18 | 164.19 | -1,281,534 | 702,362,986 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -16,159 | 45,486,837 | -0.04 | 163.41 | -2,640,610 | 7,433,195,079 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -1,489 | 4,285,446 | -0.03 | 163.41 | -243,324 | 700,302,730 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -41,072 | 45,502,996 | -0.09 | 166.62 | -6,843,564 | 7,581,873,004 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -3,786 | 4,286,935 | -0.09 | 166.62 | -630,837 | 714,304,543 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -91,613 | 45,544,068 | -0.20 | 165.70 | -15,180,641 | 7,546,834,244 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -8,444 | 4,290,721 | -0.20 | 165.70 | -1,399,205 | 710,989,633 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -178,862 | 45,635,681 | -0.39 | 164.60 | -29,440,041 | 7,511,468,804 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -16,485 | 4,299,165 | -0.38 | 164.60 | -2,713,372 | 707,627,082 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -45,606 | 45,814,543 | -0.10 | 164.06 | -7,482,107 | 7,516,320,180 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4,204 | 4,315,650 | -0.10 | 164.06 | -689,707 | 708,024,244 | |
| 2020-05-07 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25,000 | 25,000 | |||||
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 29,311,915 | 0.07 | 13.34 | 266,800 | 391,020,946 | |
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 29,311,915 | 0.07 | 13.34 | 266,800 | 391,020,946 | |
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -17,500 | 0 | -100.00 | ||||
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 17,500 | 45,860,149 | 0.04 | 12.76 | 223,300 | 585,175,501 | |
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 17,500 | 45,860,149 | 0.04 | 12.76 | 223,300 | 585,175,501 | |
| 2020-04-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,427 | 0.01 | ||||
| 2020-04-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2,883,427 | 0.01 | ||||
| 2020-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 392 | 29,291,915 | 0.00 | 73.23 | 28,706 | 2,145,046,935 | |
| 2020-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 392 | 29,291,915 | 0.00 | 73.23 | 28,706 | 2,145,046,935 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 42,473 | 38,433,977 | 0.11 | 34.47 | 1,463,896 | 1,324,684,668 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,837 | 3,470,609 | 0.11 | 34.47 | 132,248 | 119,619,745 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 33,464 | 38,391,504 | 0.09 | 33.63 | 1,125,465 | 1,291,186,902 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,023 | 3,466,772 | 0.09 | 33.63 | 101,670 | 116,594,823 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,201 | 38,358,040 | 0.01 | 32.85 | 72,302 | 1,260,053,942 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 199 | 3,463,749 | 0.01 | 32.85 | 6,537 | 113,783,462 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 46,225 | 38,355,839 | 0.12 | 32.61 | 1,507,268 | 1,250,676,513 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4,175 | 3,463,550 | 0.12 | 32.61 | 136,135 | 112,936,668 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 275 | 38,309,614 | 0.00 | 31.94 | 8,782 | 1,223,417,523 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25 | 3,459,375 | 0.00 | 31.94 | 798 | 110,475,141 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 93,006 | 38,309,339 | 0.24 | 33.86 | 3,149,406 | 1,297,246,161 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 8,402 | 3,459,350 | 0.24 | 33.86 | 284,512 | 117,141,893 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24,223 | 38,216,333 | 0.06 | 32.32 | 782,873 | 1,235,128,953 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,188 | 3,450,948 | 0.06 | 32.32 | 70,715 | 111,532,569 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 29,624 | 38,192,110 | 0.08 | 32.19 | 953,620 | 1,229,434,575 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,676 | 3,448,760 | 0.08 | 32.19 | 86,143 | 111,018,343 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7,612 | 38,162,486 | 0.02 | 31.83 | 242,290 | 1,214,711,929 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 688 | 3,446,084 | 0.02 | 31.83 | 21,899 | 109,688,854 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43,212 | 38,154,874 | 0.11 | 31.74 | 1,371,359 | 1,210,867,819 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,903 | 3,445,396 | 0.11 | 31.74 | 123,864 | 109,341,709 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,913 | 38,111,662 | 0.01 | 31.00 | 121,285 | 1,181,290,020 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 353 | 3,441,493 | 0.01 | 31.00 | 10,941 | 106,670,796 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 631,281 | 38,107,749 | 1.68 | 31.51 | 19,893,937 | 1,200,912,359 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 57,022 | 3,441,140 | 1.68 | 31.51 | 1,796,968 | 108,442,710 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5,503 | 37,476,468 | 0.01 | 31.19 | 171,613 | 1,168,714,898 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 497 | 3,384,118 | 0.01 | 31.19 | 15,499 | 105,534,735 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,172 | 10,602,550 | 0.09 | 38.38 | 352,019 | 406,922,688 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 828 | 971,988 | 0.09 | 38.38 | 31,778 | 37,304,608 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,237 | 10,593,378 | 0.06 | 37.75 | 235,433 | 399,876,714 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 563 | 971,160 | 0.06 | 37.75 | 21,252 | 36,659,153 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 17,058 | 10,587,141 | 0.16 | 36.69 | 625,914 | 388,477,141 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,542 | 970,597 | 0.16 | 36.69 | 56,581 | 35,614,407 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9,172 | 10,570,083 | 0.09 | 38.98 | 357,570 | 412,074,686 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 828 | 969,055 | 0.09 | 38.98 | 32,280 | 37,778,609 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 95,934 | 10,560,911 | 0.92 | 39.97 | 3,834,588 | 422,131,230 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8,666 | 968,227 | 0.90 | 39.97 | 346,390 | 38,701,098 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 14,731 | 7,841,556 | 0.19 | 83.14 | 1,224,797 | 651,979,900 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,331 | 994,296 | 0.13 | 83.14 | 110,665 | 82,669,945 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,321 | 7,826,825 | 0.02 | 82.92 | 109,537 | 648,995,633 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 119 | 992,965 | 0.01 | 82.92 | 9,867 | 82,336,062 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15,928 | 7,825,504 | 0.20 | 82.13 | 1,308,149 | 642,700,035 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,439 | 992,846 | 0.15 | 82.13 | 118,183 | 81,541,350 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 25,640 | 7,809,576 | 0.33 | 81.79 | 2,097,003 | 638,717,107 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,314 | 991,407 | 0.23 | 81.79 | 189,254 | 81,083,609 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,203 | 7,783,936 | 0.05 | 81.47 | 342,438 | 634,193,850 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 380 | 989,093 | 0.04 | 81.47 | 30,960 | 80,586,055 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12,815 | 7,779,733 | 0.16 | 81.09 | 1,039,177 | 630,863,995 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1,158 | 988,713 | 0.12 | 81.09 | 93,903 | 80,175,429 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3,298 | 7,766,918 | 0.04 | 80.91 | 266,845 | 628,431,432 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 298 | 987,555 | 0.03 | 80.91 | 24,112 | 79,904,359 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10,285 | 7,763,620 | 0.13 | 79.87 | 821,429 | 620,054,709 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 929 | 987,257 | 0.09 | 79.87 | 74,196 | 78,848,959 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26,022 | 7,753,335 | 0.34 | 79.72 | 2,074,362 | 618,062,527 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,351 | 986,328 | 0.24 | 79.72 | 187,412 | 78,625,827 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,888 | 7,727,313 | 0.04 | 79.29 | 228,980 | 612,673,148 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 261 | 983,977 | 0.03 | 79.29 | 20,694 | 78,016,289 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,191 | 7,724,425 | 0.05 | 79.16 | 331,760 | 611,467,028 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 379 | 983,716 | 0.04 | 79.16 | 30,002 | 77,871,155 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 565 | 7,720,234 | 0.01 | 78.66 | 44,443 | 607,273,606 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 51 | 983,337 | 0.01 | 78.66 | 4,012 | 77,349,288 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 65,505 | 7,719,669 | 0.86 | 76.67 | 5,022,445 | 591,887,865 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,917 | 983,286 | 0.61 | 76.67 | 453,672 | 75,391,192 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 27,866 | 7,654,164 | 0.37 | 76.10 | 2,120,480 | 582,448,202 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,517 | 977,369 | 0.26 | 76.10 | 191,533 | 74,373,480 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 62,129 | 7,626,298 | 0.82 | 79.76 | 4,955,720 | 608,311,660 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5,612 | 974,852 | 0.58 | 79.76 | 447,641 | 77,759,070 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 133,042 | 7,564,169 | 1.79 | 79.14 | 10,529,170 | 598,641,194 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12,017 | 969,240 | 1.26 | 79.14 | 951,046 | 76,707,301 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7,612 | 7,431,127 | 0.10 | 77.94 | 593,260 | 579,163,461 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 688 | 957,223 | 0.07 | 77.94 | 53,621 | 74,603,568 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8,309 | 7,423,515 | 0.11 | 77.89 | 647,203 | 578,230,946 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 750 | 956,535 | 0.08 | 77.89 | 58,419 | 74,506,233 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 32,228 | 7,415,206 | 0.44 | 75.66 | 2,438,422 | 561,046,350 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,911 | 955,785 | 0.31 | 75.66 | 220,251 | 72,316,222 | |
| 2020-03-16 |
|
4 | ZYME |
Zymeworks Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 18,000 | 18,000 | |||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1,876,724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3,248,692 | ||||||||
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 82,740 | 10,464,977 | 0.80 | 57.82 | 4,783,944 | 605,074,505 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,460 | 959,561 | 0.78 | 57.82 | 431,330 | 55,480,857 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8,989 | 10,382,237 | 0.09 | 59.61 | 535,824 | 618,873,727 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 811 | 952,101 | 0.09 | 59.61 | 48,343 | 56,753,693 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14,631 | 10,373,248 | 0.14 | 59.99 | 877,642 | 622,240,319 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,319 | 951,290 | 0.14 | 59.99 | 79,120 | 57,063,226 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 145,994 | 10,358,617 | 1.43 | 57.68 | 8,421,518 | 597,526,463 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13,164 | 949,971 | 1.41 | 57.68 | 759,352 | 54,798,127 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14,051 | 10,212,623 | 0.14 | 57.22 | 803,980 | 584,353,012 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,267 | 936,807 | 0.14 | 57.22 | 72,496 | 53,602,879 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14,402 | 10,198,572 | 0.14 | 58.80 | 846,819 | 599,662,775 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,298 | 935,540 | 0.14 | 58.80 | 76,321 | 55,008,536 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8,623 | 10,184,170 | 0.08 | 60.77 | 524,043 | 618,919,508 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 777 | 934,242 | 0.08 | 60.77 | 47,220 | 56,776,409 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6,788 | 10,175,547 | 0.07 | 58.54 | 397,393 | 595,711,118 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 612 | 933,465 | 0.07 | 58.54 | 35,829 | 54,648,215 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7,122 | 10,168,759 | 0.07 | 58.39 | 415,826 | 593,714,180 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 642 | 932,853 | 0.07 | 58.39 | 37,484 | 54,465,649 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3,577 | 10,161,637 | 0.04 | 57.62 | 206,108 | 585,517,589 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 323 | 932,211 | 0.03 | 57.62 | 18,611 | 53,714,371 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 21,301 | 10,158,060 | 0.21 | 56.69 | 1,207,513 | 575,841,121 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,921 | 931,888 | 0.21 | 56.69 | 108,898 | 52,826,960 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5,804 | 10,136,759 | 0.06 | 56.62 | 328,631 | 573,958,500 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 523 | 929,967 | 0.06 | 56.62 | 29,613 | 52,656,126 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10,121 | 10,130,955 | 0.10 | 56.25 | 569,277 | 569,836,839 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 912 | 929,444 | 0.10 | 56.25 | 51,297 | 52,278,530 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 92 | 10,120,834 | 0.00 | 55.45 | 5,102 | 561,225,547 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8 | 928,532 | 0.00 | 55.45 | 444 | 51,489,421 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,813 | 10,120,742 | 0.02 | 55.77 | 101,117 | 564,468,192 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 164 | 928,524 | 0.02 | 55.77 | 9,147 | 51,786,940 | |
| 2020-02-07 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 10,000 | 10,000 | |||||
| 2020-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 316 | 29,291,523 | 0.00 | 87.32 | 27,593 | 2,557,735,788 | |
| 2020-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 316 | 29,291,523 | 0.00 | 87.32 | 27,593 | 2,557,735,788 | |
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-funded Warrants |
A - Award | 9,765,333 | 9,765,333 | |||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-funded Warrants |
A - Award | 1,160,148 | 1,161,048 | 128,905.33 | ||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | -9,765,333 | 3,107,331 | -75.86 | ||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | -1,160,148 | 290,409 | -79.98 | ||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 2,767,505 | 12,872,664 | 27.39 | 8.40 | 23,247,042 | 108,130,378 | |
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 250,037 | 1,450,557 | 20.83 | 8.40 | 2,100,311 | 12,184,679 | |
| 2019-12-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1,743,993 | 10,118,929 | 20.82 | 46.00 | 80,223,678 | 465,470,734 | |
| 2019-12-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 158,180 | 928,360 | 20.54 | 46.00 | 7,276,280 | 42,704,560 | |
| 2019-10-15 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 22,000 | 22,000 | |||||
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 7,642,042 | 0.00 | 67.28 | 24,894 | 514,156,586 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 7,642,042 | 0.00 | 67.28 | 24,894 | 514,156,586 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 1,217,279 | 0.03 | 67.28 | 24,894 | 81,898,531 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 244,595 | 0.15 | 67.28 | 24,894 | 16,456,352 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 160,223 | 0.23 | 67.28 | 24,894 | 10,779,803 | |
| 2019-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29,291,207 | 0.00 | 74.23 | 27,020 | 2,174,286,296 | |
| 2019-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29,291,207 | 0.00 | 74.23 | 27,020 | 2,174,286,296 | |
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
C - Conversion | 2,081,895 | 2,081,895 | |||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Series C Convertible Preferred |
C - Conversion | -2,081,895 | 0 | -100.00 | ||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
C - Conversion | 187,942 | 187,942 | |||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Series C Convertible Preferred |
C - Conversion | -187,942 | 0 | -100.00 | ||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 2,883,204 | 2,883,204 | 16.00 | 46,131,264 | 46,131,264 | ||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 260,796 | 260,796 | 16.00 | 4,172,736 | 4,172,736 | ||
| 2019-09-20 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,494,025 | 37,470,965 | 4.15 | 40.00 | 59,761,000 | 1,498,838,600 | |
| 2019-09-20 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 68,475 | 3,383,621 | 2.07 | 40.00 | 2,739,000 | 135,344,840 | |
| 2019-09-20 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
X - Other | -1 | 138,815 | 0.00 | ||||
| 2019-09-20 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
X - Other | 1 | 8,374,936 | 0.00 | 0.01 | 0 | 83,749 | |
| 2019-09-19 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 12,100 | 12,100 | |||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | -95,289 | 0 | -100.00 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | -95,289 | 0 | -100.00 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | 8,341 | 95,289 | 9.59 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | 8,340 | 95,289 | 9.59 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | -8,866 | 43,361 | -16.98 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | -7,815 | 165,610 | -4.51 | ||||
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 50,436 | 10,105,159 | 0.50 | 3.15 | 159,020 | 31,860,556 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4,564 | 1,200,520 | 0.38 | 3.15 | 14,390 | 3,785,120 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 209,382 | 10,054,723 | 2.13 | 3.02 | 633,255 | 30,409,504 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 18,943 | 1,195,956 | 1.61 | 3.02 | 57,291 | 3,617,049 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,869 | 9,845,341 | 0.06 | 2.96 | 17,358 | 29,118,581 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 531 | 1,177,013 | 0.05 | 2.96 | 1,570 | 3,481,134 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 65,568 | 9,839,472 | 0.67 | 2.85 | 186,666 | 28,011,993 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,932 | 1,176,482 | 0.51 | 2.85 | 16,888 | 3,349,327 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9,445 | 9,773,904 | 0.10 | 2.83 | 26,756 | 27,687,515 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 855 | 1,170,550 | 0.07 | 2.83 | 2,422 | 3,315,934 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 7,641,672 | 0.01 | 58.86 | 24,957 | 449,788,814 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 7,641,672 | 0.01 | 58.86 | 24,957 | 449,788,814 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 1,390,806 | 0.03 | 58.86 | 24,957 | 81,862,841 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 418,122 | 0.10 | 58.86 | 24,957 | 24,610,661 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 333,750 | 0.13 | 58.86 | 24,957 | 19,644,525 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 226,124 | 0.19 | 58.86 | 24,957 | 13,309,659 | |
| 2019-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,964 | 4,290,995 | 0.07 | 2.61 | 7,736 | 11,199,497 | |
| 2019-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,964 | 4,290,995 | 0.07 | 2.61 | 7,736 | 11,199,497 | |
| 2019-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 310 | 29,290,843 | 0.00 | 84.96 | 26,338 | 2,488,550,021 | |
| 2019-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 310 | 29,290,843 | 0.00 | 84.96 | 26,338 | 2,488,550,021 | |
| 2019-06-28 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30,000 | 30,000 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
P - Purchase | 1,904,850 | 5,444,957 | 53.81 | 17.00 | 32,382,450 | 92,564,269 | |
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
P - Purchase | 95,150 | 489,234 | 24.14 | 17.00 | 1,617,550 | 8,316,978 | |
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
C - Conversion | 3,540,107 | 3,540,107 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series C2 Preferred Stock |
C - Conversion | -3,540,107 | 0 | -100.00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
C - Conversion | 394,084 | 394,084 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series C2 Preferred Stock |
C - Conversion | -394,084 | 0 | -100.00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series B Preferred Stock |
C - Conversion | -920,361 | 0 | -100.00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series B Preferred Stock |
C - Conversion | -89,878 | 0 | -100.00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series A Preferred Stock |
C - Conversion | -2,302,669 | 0 | -100.00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series A Preferred Stock |
C - Conversion | -219,852 | 0 | -100.00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
C - Conversion | 3,223,030 | 3,223,030 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
C - Conversion | 309,730 | 309,730 | |||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 13,166 | 13,166 | |||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 7,641,248 | 0.03 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 7,641,248 | 0.03 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 1,390,382 | 0.14 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 417,698 | 0.46 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 333,326 | 0.58 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1,910 | 225,700 | 0.85 | ||||
| 2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 74,229 | 181,733 | 69.05 | ||||
| 2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 74,229 | 181,733 | 69.05 | ||||
| 2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -1,002,483 | 4,302,354 | -18.90 | ||||
| 2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | 14,840 | 14,840 | |||||
| 2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | 14,840 | 14,840 | |||||
| 2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | -200,423 | 98,980 | -66.94 | ||||
| 2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 31,229 | 102,876 | 43.59 | ||||
| 2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 31,229 | 102,876 | 43.59 | ||||
| 2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | -421,756 | 3,315,146 | -11.29 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 880 | 880 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 880 | 880 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 1,660 | 1,660 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 1,660 | 1,660 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 6,256 | 6,256 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 6,256 | 6,256 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | -6,009 | 0 | -100.00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | -11,337 | 0 | -100.00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | -42,724 | 0 | -100.00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | 21,929 | 21,929 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | 21,929 | 21,929 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | -59,267 | 0 | -100.00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | -178,967 | 347,757 | -33.98 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | 43,109 | 43,109 | |||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | 43,109 | 43,109 | |||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | -582,200 | 18,591 | -96.91 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 13,516 | 20,618 | 190.31 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 13,516 | 20,618 | 190.31 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | -182,539 | 1,028,034 | -15.08 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Shares Option (Right to Buy) |
A - Award | 129,220 | 129,220 | |||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | 220,141 | 281,190 | 360.60 | ||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | 220,141 | 281,190 | 360.60 | ||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | -692,706 | 0 | -100.00 | ||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | -1,603,238 | 2,826,766 | -36.19 | ||||
| 2019-06-05 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 24,747 | 24,747 | |||||
| 2019-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37,520 | 37,520 | |||||
| 2019-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37,520 | 37,520 | |||||
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -22,720 | 7,382,978 | -0.31 | 120.77 | -2,743,928 | 891,653,328 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2,729 | 952,874 | -0.29 | 120.77 | -329,585 | 115,080,022 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -13,213 | 7,405,698 | -0.18 | 122.31 | -1,616,054 | 905,775,370 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1,587 | 955,603 | -0.17 | 122.31 | -194,103 | 116,877,796 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -15,355 | 7,418,911 | -0.21 | 120.12 | -1,844,459 | 891,167,750 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1,845 | 957,190 | -0.19 | 120.12 | -221,623 | 114,978,716 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -35,796 | 7,434,266 | -0.48 | 122.37 | -4,380,432 | 909,746,742 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -4,300 | 959,035 | -0.45 | 122.37 | -526,200 | 117,359,127 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -30,766 | 7,470,062 | -0.41 | 123.06 | -3,786,036 | 919,259,107 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -3,696 | 963,335 | -0.38 | 123.06 | -454,826 | 118,547,138 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -39,732 | 7,500,828 | -0.53 | 121.37 | -4,822,189 | 910,359,743 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -4,772 | 967,031 | -0.49 | 121.37 | -579,168 | 117,366,522 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -71,819 | 7,540,560 | -0.94 | 127.06 | -9,125,258 | 958,096,767 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -8,627 | 971,803 | -0.88 | 127.06 | -1,096,139 | 123,476,415 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -22,886 | 7,612,379 | -0.30 | 125.05 | -2,861,901 | 951,930,278 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2,749 | 980,430 | -0.28 | 125.05 | -343,763 | 122,603,066 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -15,541 | 7,635,265 | -0.20 | 126.25 | -1,962,085 | 963,969,004 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1,867 | 983,179 | -0.19 | 126.25 | -235,713 | 124,128,512 | |
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 7,038 | 7,038 | |||||
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 7,038 | 7,038 | |||||
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 2,963 | 45,842,649 | 0.01 | ||||
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 2,963 | 45,842,649 | 0.01 | ||||
| 2019-05-17 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,726 | 7,650,806 | 0.04 | ||||
| 2019-05-17 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,726 | 7,650,806 | 0.04 | ||||
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 45,839,686 | 0.02 | 8.38 | 83,800 | 384,136,569 | |
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 45,839,686 | 0.02 | 8.38 | 83,800 | 384,136,569 | |
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12,472 | 12,472 | |||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12,472 | 12,472 | |||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12,472 | 12,472 | |||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,520 | 812,602 | 0.19 | ||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,520 | 812,602 | 0.19 | ||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1,520 | 812,602 | 0.19 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 529,758 | 529,758 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series D Preferred Stock |
C - Conversion | -529,758 | 0 | -100.00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 60,194 | 60,194 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series D Preferred Stock |
C - Conversion | -60,194 | 0 | -100.00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 2,905,359 | 2,905,359 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series C Preferred Stock |
C - Conversion | -2,905,359 | 0 | -100.00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 324,421 | 324,421 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series C Preferred Stock |
C - Conversion | -324,421 | 0 | -100.00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Common Stock |
P - Purchase | 820,729 | 820,729 | 14.00 | 11,490,206 | 11,490,206 | ||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Common Stock |
P - Purchase | 72,128 | 72,128 | 14.00 | 1,009,792 | 1,009,792 | ||
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,232 | 7,639,338 | -0.12 | 65.32 | -603,070 | 499,031,352 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,417 | 1,214,575 | -0.12 | 65.32 | -92,564 | 79,340,776 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -244 | 241,891 | -0.10 | 65.32 | -15,939 | 15,801,263 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -142 | 157,519 | -0.09 | 65.32 | -9,276 | 10,289,755 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 49,893 | -0.02 | 65.32 | -719 | 3,259,205 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -158 | 171,091 | -0.09 | 65.32 | -10,321 | 11,176,331 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63,775 | 7,648,570 | -0.83 | 67.13 | -4,281,177 | 513,443,915 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,791 | 1,215,992 | -0.80 | 67.13 | -657,264 | 81,628,813 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,688 | 242,135 | -0.69 | 67.13 | -113,314 | 16,254,377 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -979 | 157,661 | -0.62 | 67.13 | -65,720 | 10,583,688 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 49,904 | -0.15 | 67.13 | -4,968 | 3,350,026 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,093 | 171,249 | -0.63 | 67.13 | -73,372 | 11,495,843 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -173,085 | 7,712,345 | -2.19 | 64.62 | -11,184,701 | 498,369,420 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -26,575 | 1,225,783 | -2.12 | 64.62 | -1,717,269 | 79,209,730 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,581 | 243,823 | -1.84 | 64.62 | -296,023 | 15,755,769 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,656 | 158,640 | -1.65 | 64.62 | -171,630 | 10,251,269 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -202 | 49,978 | -0.40 | 64.62 | -13,053 | 3,229,563 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,966 | 172,342 | -1.69 | 64.62 | -191,662 | 11,136,688 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -106,054 | 7,885,430 | -1.33 | 66.61 | -7,063,981 | 525,227,990 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16,282 | 1,252,358 | -1.28 | 66.61 | -1,084,502 | 83,416,310 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,807 | 248,404 | -1.12 | 66.61 | -186,967 | 16,545,545 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,628 | 161,296 | -1.00 | 66.61 | -108,437 | 10,743,507 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -124 | 50,180 | -0.25 | 66.61 | -8,259 | 3,342,359 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,817 | 175,308 | -1.03 | 66.61 | -121,026 | 11,676,810 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -60,618 | 7,991,484 | -0.75 | 67.42 | -4,086,914 | 538,792,244 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,307 | 1,268,640 | -0.73 | 67.42 | -627,485 | 85,532,724 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,604 | 251,211 | -0.63 | 67.42 | -108,143 | 16,936,847 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -930 | 162,924 | -0.57 | 67.42 | -62,701 | 10,984,466 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 50,304 | -0.14 | 67.42 | -4,787 | 3,391,536 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,039 | 177,125 | -0.58 | 67.42 | -70,050 | 11,941,909 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10,832 | 8,052,102 | -0.13 | 69.12 | -748,735 | 556,581,420 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,663 | 1,277,947 | -0.13 | 69.12 | -114,951 | 88,334,892 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -287 | 252,815 | -0.11 | 69.12 | -19,838 | 17,475,205 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -166 | 163,854 | -0.10 | 69.12 | -11,474 | 11,325,998 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 50,375 | -0.03 | 69.12 | -899 | 3,482,046 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -185 | 178,164 | -0.10 | 69.12 | -12,788 | 12,315,141 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -102,618 | 8,062,934 | -1.26 | 68.70 | -7,049,918 | 553,928,404 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,755 | 1,279,610 | -1.22 | 68.70 | -1,082,378 | 87,909,975 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,716 | 253,102 | -1.06 | 68.70 | -186,591 | 17,388,259 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,575 | 164,020 | -0.95 | 68.70 | -108,203 | 11,268,272 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -120 | 50,388 | -0.24 | 68.70 | -8,244 | 3,461,686 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,758 | 178,349 | -0.98 | 68.70 | -120,776 | 12,252,683 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,543 | 8,165,552 | -0.19 | 67.68 | -1,051,888 | 552,611,897 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,386 | 1,295,365 | -0.18 | 67.68 | -161,475 | 87,665,122 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -411 | 255,818 | -0.16 | 67.68 | -27,815 | 17,312,739 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -239 | 165,595 | -0.14 | 67.68 | -16,175 | 11,206,807 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 50,508 | -0.04 | 67.68 | -1,218 | 3,418,179 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -266 | 180,107 | -0.15 | 67.68 | -18,002 | 12,188,921 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,813 | 8,181,095 | -0.02 | 67.87 | -123,047 | 555,244,373 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -278 | 1,297,751 | -0.02 | 67.87 | -18,868 | 88,077,322 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 256,229 | -0.02 | 67.87 | -3,258 | 17,390,057 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 165,834 | -0.02 | 67.87 | -1,900 | 11,255,021 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 50,526 | 0.00 | 67.87 | -136 | 3,429,159 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -31 | 180,373 | -0.02 | 67.87 | -2,104 | 12,241,771 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18,661 | 8,182,908 | -0.23 | 67.90 | -1,267,017 | 555,590,813 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,865 | 1,298,029 | -0.22 | 67.90 | -194,523 | 88,131,626 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -494 | 256,277 | -0.19 | 67.90 | -33,541 | 17,400,311 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -286 | 165,862 | -0.17 | 67.90 | -19,418 | 11,261,449 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22 | 50,528 | -0.04 | 67.90 | -1,494 | 3,430,674 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -320 | 180,404 | -0.18 | 67.90 | -21,727 | 12,248,800 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42,863 | 8,201,569 | -0.52 | 68.72 | -2,945,370 | 563,578,195 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,581 | 1,300,894 | -0.50 | 68.72 | -452,219 | 89,392,102 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,134 | 256,771 | -0.44 | 68.72 | -77,924 | 17,644,250 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -658 | 166,148 | -0.39 | 68.72 | -45,215 | 11,417,009 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -50 | 50,550 | -0.10 | 68.72 | -3,436 | 3,473,589 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -734 | 180,724 | -0.40 | 68.72 | -50,437 | 12,418,612 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21,116 | 8,244,432 | -0.26 | 68.63 | -1,449,147 | 565,798,055 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,242 | 1,307,475 | -0.25 | 68.63 | -222,492 | 89,729,264 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -559 | 257,905 | -0.22 | 68.63 | -38,363 | 17,699,479 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -324 | 166,806 | -0.19 | 68.63 | -22,235 | 11,447,545 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 50,600 | -0.05 | 68.63 | -1,716 | 3,472,572 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -362 | 181,458 | -0.20 | 68.63 | -24,843 | 12,453,081 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66,784 | 8,265,548 | -0.80 | 66.64 | -4,450,459 | 550,812,813 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10,253 | 1,310,717 | -0.78 | 66.64 | -683,256 | 87,345,657 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,768 | 258,464 | -0.68 | 66.64 | -117,819 | 17,223,938 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,025 | 167,130 | -0.61 | 66.64 | -68,306 | 11,137,476 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -78 | 50,625 | -0.15 | 66.64 | -5,198 | 3,373,630 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,145 | 181,820 | -0.63 | 66.64 | -76,302 | 12,116,412 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -80,146 | 8,332,332 | -0.95 | 68.90 | -5,521,963 | 574,087,676 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12,305 | 1,320,970 | -0.92 | 68.90 | -847,800 | 91,013,248 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,121 | 260,232 | -0.81 | 68.90 | -146,134 | 17,929,673 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,230 | 168,155 | -0.73 | 68.90 | -84,746 | 11,585,678 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -93 | 50,703 | -0.18 | 68.90 | -6,408 | 3,493,376 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,374 | 182,965 | -0.75 | 68.90 | -94,667 | 12,606,069 | |
| 2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4,161 | 89,233 | 4.89 | 2.59 | 10,777 | 231,113 | |
| 2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4,161 | 89,233 | 4.89 | 2.59 | 10,777 | 231,113 | |
| 2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4,161 | 4,288,031 | 0.10 | 2.59 | 10,777 | 11,106,000 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 8,412,478 | 0.00 | 66.84 | 19,918 | 562,290,030 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 8,412,478 | 0.00 | 66.84 | 19,918 | 562,290,030 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 1,507,172 | 0.02 | 66.84 | 19,918 | 100,739,376 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 436,250 | 0.07 | 66.84 | 19,918 | 29,158,950 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 343,282 | 0.09 | 66.84 | 19,918 | 22,944,969 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 224,693 | 0.13 | 66.84 | 19,918 | 15,018,480 | |
| 2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811,082 | 0.03 | 86.01 | 18,922 | 69,761,163 | |
| 2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811,082 | 0.03 | 86.01 | 18,922 | 69,761,163 | |
| 2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811,082 | 0.03 | 86.01 | 18,922 | 69,761,163 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46,678 | 8,412,180 | -0.55 | 74.71 | -3,487,122 | 628,439,478 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7,167 | 1,332,977 | -0.53 | 74.71 | -535,417 | 99,581,246 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,235 | 262,055 | -0.47 | 74.71 | -92,262 | 19,577,055 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -716 | 169,087 | -0.42 | 74.71 | -53,489 | 12,631,797 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -55 | 50,498 | -0.11 | 74.71 | -4,109 | 3,772,499 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -800 | 184,041 | -0.43 | 74.71 | -59,765 | 13,748,949 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41,281 | 8,458,858 | -0.49 | 74.34 | -3,068,962 | 628,858,572 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,338 | 1,340,144 | -0.47 | 74.34 | -471,187 | 99,630,593 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,092 | 263,290 | -0.41 | 74.34 | -81,183 | 19,573,821 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -634 | 169,803 | -0.37 | 74.34 | -47,134 | 12,623,698 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 50,553 | -0.09 | 74.34 | -3,568 | 3,758,272 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -707 | 184,841 | -0.38 | 74.34 | -52,561 | 13,741,671 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -86,620 | 8,500,139 | -1.01 | 74.63 | -6,464,529 | 634,373,024 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,298 | 1,346,482 | -0.98 | 74.63 | -992,442 | 100,489,163 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,293 | 264,382 | -0.86 | 74.63 | -171,129 | 19,731,067 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,329 | 170,437 | -0.77 | 74.63 | -99,184 | 12,719,867 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -101 | 50,601 | -0.20 | 74.63 | -7,538 | 3,776,398 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,485 | 185,548 | -0.79 | 74.63 | -110,827 | 13,847,614 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -90,251 | 8,586,759 | -1.04 | 74.19 | -6,695,487 | 637,029,325 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,856 | 1,359,780 | -1.01 | 74.19 | -1,027,941 | 100,878,543 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,388 | 266,675 | -0.89 | 74.19 | -177,160 | 19,783,925 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,385 | 171,766 | -0.80 | 74.19 | -102,750 | 12,742,873 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -106 | 50,702 | -0.21 | 74.19 | -7,864 | 3,761,450 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,547 | 187,033 | -0.82 | 74.19 | -114,768 | 13,875,492 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -413 | 8,677,010 | 0.00 | 74.56 | -30,795 | 647,001,251 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 1,373,636 | 0.00 | 74.56 | -4,698 | 102,425,168 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 269,063 | 0.00 | 74.56 | -820 | 20,062,683 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 173,151 | 0.00 | 74.56 | -447 | 12,911,004 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7 | 188,580 | 0.00 | 74.56 | -522 | 14,061,468 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42,124 | 8,677,423 | -0.48 | 74.50 | -3,138,238 | 646,468,014 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,467 | 1,373,699 | -0.47 | 74.50 | -481,792 | 102,340,576 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,115 | 269,074 | -0.41 | 74.50 | -83,068 | 20,046,013 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -647 | 173,157 | -0.37 | 74.50 | -48,202 | 12,900,196 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -49 | 50,808 | -0.10 | 74.50 | -3,650 | 3,785,196 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -722 | 188,587 | -0.38 | 74.50 | -53,789 | 14,049,732 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,068 | 8,719,547 | -0.04 | 76.57 | -234,915 | 667,649,610 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -471 | 1,380,166 | -0.03 | 76.57 | -36,064 | 105,678,345 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -81 | 270,189 | -0.03 | 76.57 | -6,202 | 20,688,183 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -47 | 173,804 | -0.03 | 76.57 | -3,599 | 13,308,051 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 50,857 | -0.01 | 76.57 | -306 | 3,894,085 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -52 | 189,309 | -0.03 | 76.57 | -3,982 | 14,495,258 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41,281 | 8,458,858 | -0.49 | 74.34 | -3,068,962 | 628,858,572 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,338 | 1,340,144 | -0.47 | 74.34 | -471,187 | 99,630,593 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,092 | 263,290 | -0.41 | 74.34 | -81,183 | 19,573,821 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -634 | 169,803 | -0.37 | 74.34 | -47,134 | 12,623,698 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 50,553 | -0.09 | 74.34 | -3,568 | 3,758,272 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -707 | 184,841 | -0.38 | 74.34 | -52,561 | 13,741,671 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,648 | 8,722,615 | -0.02 | 76.03 | -125,301 | 663,197,864 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1,380,637 | -0.02 | 76.03 | -19,236 | 104,972,592 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 270,270 | -0.02 | 76.03 | -3,345 | 20,549,169 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 173,851 | -0.01 | 76.03 | -1,901 | 13,218,239 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 50,861 | 0.00 | 76.03 | -152 | 3,867,064 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 189,361 | -0.01 | 76.03 | -2,129 | 14,397,496 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51,987 | 8,724,263 | -0.59 | 76.50 | -3,977,031 | 667,410,482 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7,982 | 1,380,890 | -0.57 | 76.50 | -610,627 | 105,638,775 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,375 | 270,314 | -0.51 | 76.50 | -105,188 | 20,679,156 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -798 | 173,876 | -0.46 | 76.50 | -61,047 | 13,301,601 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -61 | 50,863 | -0.12 | 76.50 | -4,667 | 3,891,045 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -891 | 189,389 | -0.47 | 76.50 | -68,162 | 14,488,353 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -247 | 8,776,250 | 0.00 | 75.40 | -18,624 | 661,729,250 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39 | 1,388,872 | 0.00 | 75.40 | -2,941 | 104,720,949 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7 | 271,689 | 0.00 | 75.40 | -528 | 20,485,351 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 174,674 | 0.00 | 75.40 | -302 | 13,170,420 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 174,674 | 0.00 | 75.40 | -302 | 13,170,420 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 50,924 | 0.00 | 75.40 | -75 | 3,839,670 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63,047 | 8,776,497 | -0.71 | 75.92 | -4,786,390 | 666,292,344 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,679 | 1,388,911 | -0.69 | 75.92 | -734,808 | 105,443,068 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,668 | 271,696 | -0.61 | 75.92 | -126,631 | 20,626,563 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -967 | 174,678 | -0.55 | 75.92 | -73,413 | 13,261,169 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -73 | 50,925 | -0.14 | 75.92 | -5,542 | 3,866,114 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,080 | 190,284 | -0.56 | 75.92 | -81,991 | 14,445,943 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,832 | 8,839,544 | -0.03 | 76.05 | -215,369 | 672,232,294 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -435 | 1,398,590 | -0.03 | 76.05 | -33,081 | 106,360,392 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -75 | 273,364 | -0.03 | 76.05 | -5,704 | 20,788,867 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 175,645 | -0.02 | 76.05 | -3,270 | 13,357,504 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 | 50,998 | -0.01 | 76.05 | -228 | 3,878,311 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -49 | 191,364 | -0.03 | 76.05 | -3,726 | 14,552,907 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -61,122 | 8,842,376 | -0.69 | 75.63 | -4,622,669 | 668,750,665 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,384 | 1,399,025 | -0.67 | 75.63 | -709,714 | 105,808,541 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,618 | 273,439 | -0.59 | 75.63 | -122,370 | 20,680,246 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -938 | 175,688 | -0.53 | 75.63 | -70,941 | 13,287,319 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 51,001 | -0.14 | 75.63 | -5,370 | 3,857,216 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,047 | 191,413 | -0.54 | 75.63 | -79,185 | 14,476,603 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,296 | 8,903,498 | -0.04 | 74.03 | -244,007 | 659,137,531 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -506 | 1,408,409 | -0.04 | 74.03 | -37,460 | 104,266,349 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -87 | 275,057 | -0.03 | 74.03 | -6,441 | 20,362,827 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51 | 176,626 | -0.03 | 74.03 | -3,776 | 13,075,852 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 51,072 | -0.01 | 74.03 | -296 | 3,780,927 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 192,460 | -0.03 | 74.03 | -4,146 | 14,248,064 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37,107 | 8,906,794 | -0.41 | 75.08 | -2,786,101 | 668,747,923 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,697 | 1,408,915 | -0.40 | 75.08 | -427,747 | 105,785,424 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -982 | 275,144 | -0.36 | 75.08 | -73,731 | 20,658,609 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -569 | 176,677 | -0.32 | 75.08 | -42,722 | 13,265,422 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 51,076 | -0.08 | 75.08 | -3,229 | 3,834,934 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -637 | 192,516 | -0.33 | 75.08 | -47,828 | 14,454,660 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18,703 | 8,943,901 | -0.21 | 73.55 | -1,375,551 | 657,797,981 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,872 | 1,414,612 | -0.20 | 73.55 | -211,227 | 104,040,610 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -495 | 276,126 | -0.18 | 73.55 | -36,406 | 20,308,267 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -287 | 177,246 | -0.16 | 73.55 | -21,108 | 13,035,929 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22 | 51,119 | -0.04 | 73.55 | -1,618 | 3,759,654 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -321 | 193,153 | -0.17 | 73.55 | -23,609 | 14,205,843 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,647 | 8,962,604 | -0.02 | 73.72 | -121,421 | 660,745,573 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1,417,484 | -0.02 | 73.72 | -18,652 | 104,500,464 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 276,621 | -0.02 | 73.72 | -3,244 | 20,393,192 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 177,533 | -0.01 | 73.72 | -1,843 | 13,088,177 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 51,141 | 0.00 | 73.72 | -147 | 3,770,242 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29 | 193,474 | -0.01 | 73.72 | -2,138 | 14,263,387 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,486 | 8,964,251 | -0.09 | 77.04 | -653,755 | 690,598,726 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,303 | 1,417,737 | -0.09 | 77.04 | -100,382 | 109,221,324 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -225 | 276,665 | -0.08 | 77.04 | -17,334 | 21,314,050 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -130 | 177,558 | -0.07 | 77.04 | -10,015 | 13,678,926 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 51,143 | -0.02 | 77.04 | -770 | 3,940,016 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -146 | 193,503 | -0.08 | 77.04 | -11,248 | 14,907,316 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22,914 | 8,972,737 | -0.25 | 76.49 | -1,752,680 | 686,320,167 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,518 | 1,419,040 | -0.25 | 76.49 | -269,090 | 108,541,660 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -607 | 276,890 | -0.22 | 76.49 | -46,429 | 21,179,178 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -352 | 177,688 | -0.20 | 76.49 | -26,924 | 13,591,266 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 51,153 | -0.05 | 76.49 | -2,065 | 3,912,667 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -393 | 193,649 | -0.20 | 76.49 | -30,060 | 14,812,115 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -58,412 | 8,995,651 | -0.65 | 77.15 | -4,506,626 | 694,036,064 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,968 | 1,422,558 | -0.63 | 77.15 | -691,903 | 109,753,764 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,546 | 277,497 | -0.55 | 77.15 | -119,278 | 21,409,560 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -896 | 178,040 | -0.50 | 77.15 | -69,129 | 13,736,213 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -68 | 51,180 | -0.13 | 77.15 | -5,246 | 3,948,660 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,001 | 194,042 | -0.51 | 77.15 | -77,230 | 14,970,806 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,909 | 9,054,063 | -0.08 | 77.64 | -536,386 | 702,919,424 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,060 | 1,431,526 | -0.07 | 77.64 | -82,294 | 111,137,666 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -183 | 279,043 | -0.07 | 77.64 | -14,207 | 21,663,727 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -107 | 178,936 | -0.06 | 77.64 | -8,307 | 13,891,840 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 51,248 | -0.02 | 77.64 | -621 | 3,978,679 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -118 | 195,043 | -0.06 | 77.64 | -9,161 | 15,142,319 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -493 | 9,060,972 | -0.01 | 76.20 | -37,565 | 690,423,414 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 1,432,586 | -0.01 | 76.20 | -5,791 | 109,159,472 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 279,226 | 0.00 | 76.20 | -991 | 21,276,323 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 179,043 | 0.00 | 76.20 | -610 | 13,642,629 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,256 | 0.00 | 76.20 | -76 | 3,905,579 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 195,161 | 0.00 | 76.20 | -686 | 14,870,780 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -742 | 9,061,465 | -0.01 | 76.20 | -56,540 | 690,483,633 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -114 | 1,432,662 | -0.01 | 76.20 | -8,687 | 109,168,844 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -20 | 279,239 | -0.01 | 76.20 | -1,524 | 21,278,012 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 179,051 | -0.01 | 76.20 | -838 | 13,643,686 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,257 | 0.00 | 76.20 | -76 | 3,905,783 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 195,170 | -0.01 | 76.20 | -991 | 14,871,954 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -31,482 | 9,062,207 | -0.35 | 76.66 | -2,413,501 | 694,735,069 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,833 | 1,432,776 | -0.34 | 76.66 | -370,512 | 109,840,763 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -833 | 279,259 | -0.30 | 76.66 | -63,860 | 21,408,805 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -484 | 179,062 | -0.27 | 76.66 | -37,105 | 13,727,412 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37 | 51,258 | -0.07 | 76.66 | -2,837 | 3,929,587 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -539 | 195,183 | -0.28 | 76.66 | -41,321 | 14,963,295 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -620 | 9,093,689 | -0.01 | 77.81 | -48,239 | 707,539,019 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -95 | 1,437,609 | -0.01 | 77.81 | -7,392 | 111,853,887 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 280,092 | -0.01 | 77.81 | -1,245 | 21,792,698 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 179,546 | -0.01 | 77.81 | -778 | 13,969,666 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,295 | 0.00 | 77.81 | -78 | 3,991,033 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 195,722 | -0.01 | 77.81 | -856 | 15,228,248 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,506 | 9,094,309 | -0.07 | 78.13 | -508,342 | 710,577,468 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -999 | 1,437,704 | -0.07 | 78.13 | -78,056 | 112,333,996 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -172 | 280,108 | -0.06 | 78.13 | -13,439 | 21,886,043 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -100 | 179,556 | -0.06 | 78.13 | -7,813 | 14,029,482 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 51,296 | -0.02 | 78.13 | -625 | 4,007,977 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -112 | 195,733 | -0.06 | 78.13 | -8,751 | 15,293,461 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 9,100,815 | 0.09 | 17.59 | 145,118 | 160,083,336 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 9,100,815 | 0.09 | 17.59 | 145,118 | 160,083,336 | |
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 29,288,793 | 0.07 | 2.80 | 56,000 | 82,008,620 | |
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 29,288,793 | 0.07 | 2.80 | 56,000 | 82,008,620 | |
| 2019-02-06 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1,818,475 | 8,837,349 | 25.91 | ||||
| 2019-02-06 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 181,525 | 916,043 | 24.71 | ||||
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,634 | 9,092,565 | -0.15 | 70.55 | -961,887 | 641,485,916 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,093 | 1,430,453 | -0.15 | 70.55 | -147,662 | 100,919,317 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -361 | 280,280 | -0.13 | 70.55 | -25,469 | 19,773,922 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -210 | 179,656 | -0.12 | 70.55 | -14,816 | 12,674,839 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 51,304 | -0.03 | 70.55 | -1,129 | 3,619,528 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -234 | 195,845 | -0.12 | 70.55 | -16,509 | 13,816,982 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24,660 | 9,106,199 | -0.27 | 71.35 | -1,759,553 | 649,750,064 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,786 | 1,432,546 | -0.26 | 71.35 | -270,141 | 102,215,738 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -653 | 280,641 | -0.23 | 71.35 | -46,593 | 20,024,437 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -378 | 179,866 | -0.21 | 71.35 | -26,971 | 12,833,889 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29 | 51,320 | -0.06 | 71.35 | -2,069 | 3,661,810 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -423 | 196,079 | -0.22 | 71.35 | -30,182 | 13,990,727 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -75,736 | 9,130,859 | -0.82 | 72.20 | -5,468,397 | 659,279,065 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,627 | 1,436,332 | -0.80 | 72.20 | -839,509 | 103,708,054 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,004 | 281,294 | -0.71 | 72.20 | -144,696 | 20,310,383 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,162 | 180,244 | -0.64 | 72.20 | -83,900 | 13,014,230 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89 | 51,349 | -0.17 | 72.20 | -6,426 | 3,707,572 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,298 | 196,502 | -0.66 | 72.20 | -93,720 | 14,188,113 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -65,426 | 9,206,595 | -0.71 | 72.02 | -4,711,967 | 663,057,131 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10,044 | 1,447,959 | -0.69 | 72.02 | -723,367 | 104,281,718 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,732 | 283,298 | -0.61 | 72.02 | -124,738 | 20,403,065 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,004 | 181,406 | -0.55 | 72.02 | -72,308 | 13,064,824 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 51,438 | -0.15 | 72.02 | -5,474 | 3,704,554 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,121 | 197,800 | -0.56 | 72.02 | -80,734 | 14,245,516 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,648 | 9,272,021 | -0.02 | 73.46 | -121,054 | 681,076,303 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1,458,003 | -0.02 | 73.46 | -18,584 | 107,097,610 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 285,030 | -0.02 | 73.46 | -3,232 | 20,936,879 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 182,410 | -0.01 | 73.46 | -1,836 | 13,398,927 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 51,514 | 0.00 | 73.46 | -147 | 3,783,961 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 198,921 | -0.01 | 73.46 | -2,057 | 14,611,742 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29,260 | 9,273,669 | -0.31 | 70.52 | -2,063,313 | 653,946,680 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,492 | 1,458,256 | -0.31 | 70.52 | -316,760 | 102,831,109 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -774 | 285,074 | -0.27 | 70.52 | -54,580 | 20,102,421 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -450 | 182,435 | -0.25 | 70.52 | -31,732 | 12,864,678 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -34 | 51,516 | -0.07 | 70.52 | -2,398 | 3,632,728 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -502 | 198,949 | -0.25 | 70.52 | -35,399 | 14,029,187 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42,521 | 9,302,929 | -0.45 | 71.00 | -3,018,995 | 660,508,889 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,529 | 1,462,748 | -0.44 | 71.00 | -463,560 | 103,855,254 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,125 | 285,848 | -0.39 | 71.00 | -79,875 | 20,295,237 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -652 | 182,885 | -0.36 | 71.00 | -46,292 | 12,984,853 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -50 | 51,550 | -0.10 | 71.00 | -3,550 | 3,660,055 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -729 | 199,451 | -0.36 | 71.00 | -51,759 | 14,161,041 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10,547 | 9,345,450 | -0.11 | 71.61 | -755,298 | 669,251,973 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,619 | 1,469,277 | -0.11 | 71.61 | -115,941 | 105,218,746 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -279 | 286,973 | -0.10 | 71.61 | -19,980 | 20,550,883 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -162 | 183,537 | -0.09 | 71.61 | -11,601 | 13,143,562 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12 | 51,600 | -0.02 | 71.61 | -859 | 3,695,210 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -181 | 200,180 | -0.09 | 71.61 | -12,962 | 14,335,410 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,595 | 9,355,997 | -0.15 | 72.23 | -981,964 | 675,781,792 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,087 | 1,470,896 | -0.14 | 72.23 | -150,744 | 106,242,524 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 287,252 | -0.13 | 72.23 | -26,003 | 20,748,155 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -209 | 183,699 | -0.11 | 72.23 | -15,096 | 13,268,542 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 51,612 | -0.03 | 72.23 | -1,156 | 3,727,924 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -233 | 200,361 | -0.12 | 72.23 | -16,830 | 14,472,035 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -132,363 | 9,369,592 | -1.39 | 72.79 | -9,634,226 | 681,978,871 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -20,322 | 1,472,983 | -1.36 | 72.79 | -1,479,165 | 107,213,130 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,503 | 287,612 | -1.20 | 72.79 | -254,971 | 20,934,242 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,031 | 183,908 | -1.09 | 72.79 | -147,829 | 13,386,001 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -155 | 51,628 | -0.30 | 72.79 | -11,282 | 3,757,816 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,268 | 200,594 | -1.12 | 72.79 | -165,080 | 14,600,515 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -149,754 | 9,501,955 | -1.55 | 70.79 | -10,601,295 | 672,656,697 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22,991 | 1,493,305 | -1.52 | 70.79 | -1,627,565 | 105,713,152 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,963 | 291,115 | -1.34 | 70.79 | -280,546 | 20,608,438 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,298 | 185,939 | -1.22 | 70.79 | -162,679 | 13,162,882 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -175 | 51,783 | -0.34 | 70.79 | -12,388 | 3,665,791 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,566 | 202,862 | -1.25 | 70.79 | -181,651 | 14,360,885 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -493 | 9,651,709 | -0.01 | 70.07 | -34,545 | 676,311,658 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 1,516,296 | -0.01 | 70.07 | -5,325 | 106,249,438 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 295,078 | 0.00 | 70.07 | -911 | 20,676,617 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 188,237 | 0.00 | 70.07 | -561 | 13,190,087 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,958 | 0.00 | 70.07 | -70 | 3,640,785 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 205,428 | 0.00 | 70.07 | -631 | 14,394,689 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -23,462 | 9,652,202 | -0.24 | 70.22 | -1,647,574 | 677,807,546 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,602 | 1,516,372 | -0.24 | 70.22 | -252,944 | 106,484,343 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -621 | 295,091 | -0.21 | 70.22 | -43,609 | 20,722,205 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 188,245 | -0.19 | 70.22 | -25,280 | 13,219,147 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 51,959 | -0.05 | 70.22 | -1,896 | 3,648,722 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -402 | 205,437 | -0.20 | 70.22 | -28,230 | 14,426,423 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,392 | 9,675,664 | -0.09 | 70.28 | -589,772 | 679,985,347 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,288 | 1,519,974 | -0.08 | 70.28 | -90,518 | 106,820,581 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -222 | 295,712 | -0.08 | 70.28 | -15,602 | 20,782,018 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 188,605 | -0.07 | 70.28 | -9,066 | 13,254,763 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 51,986 | -0.02 | 70.28 | -703 | 3,653,467 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -144 | 205,839 | -0.07 | 70.28 | -10,120 | 14,465,933 | |
| 2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,658 | 85,072 | 4.49 | 3.52 | 12,876 | 299,453 | |
| 2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,658 | 85,072 | 4.49 | 3.52 | 12,876 | 299,453 | |
| 2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,658 | 85,072 | 4.49 | 3.52 | 12,876 | 299,453 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295,934 | 0.10 | 64.41 | 19,967 | 19,061,109 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295,934 | 0.10 | 64.41 | 19,967 | 19,061,109 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295,934 | 0.10 | 64.41 | 19,967 | 19,061,109 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 1,695,159 | 0.02 | 64.41 | 19,967 | 109,185,191 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 225,893 | 0.14 | 64.41 | 19,967 | 14,549,768 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 362,631 | 0.09 | 64.41 | 19,967 | 23,357,063 | |
| 2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 810,862 | 0.04 | 63.59 | 18,950 | 51,562,715 | |
| 2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 810,862 | 0.04 | 63.59 | 18,950 | 51,562,715 | |
| 2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 29,421,884 | 0.00 | 63.59 | 18,950 | 1,870,937,604 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,243 | 9,683,746 | -0.16 | 73.09 | -1,114,047 | 707,744,323 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,340 | 1,520,952 | -0.15 | 73.09 | -171,021 | 111,159,994 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -403 | 295,624 | -0.14 | 73.09 | -29,454 | 21,605,917 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -234 | 188,424 | -0.12 | 73.09 | -17,102 | 13,771,119 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 51,686 | -0.03 | 73.09 | -1,316 | 3,777,513 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -262 | 205,673 | -0.13 | 73.09 | -19,148 | 15,031,776 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12,627 | 9,698,989 | -0.13 | 71.81 | -906,797 | 696,524,166 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,939 | 1,523,292 | -0.13 | 71.81 | -139,248 | 109,393,844 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -334 | 296,027 | -0.11 | 71.81 | -23,986 | 21,258,913 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -194 | 188,658 | -0.10 | 71.81 | -13,932 | 13,548,304 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15 | 51,704 | -0.03 | 71.81 | -1,077 | 3,713,076 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -216 | 205,935 | -0.10 | 71.81 | -15,512 | 14,789,037 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -34,794 | 9,711,616 | -0.36 | 74.88 | -2,605,510 | 727,243,681 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,342 | 1,525,231 | -0.35 | 74.88 | -400,030 | 114,215,246 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -921 | 296,361 | -0.31 | 74.88 | -68,968 | 22,192,667 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -534 | 188,852 | -0.28 | 74.88 | -39,988 | 14,141,974 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41 | 51,719 | -0.08 | 74.88 | -3,070 | 3,872,920 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -597 | 206,151 | -0.29 | 74.88 | -44,706 | 15,437,391 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7,718 | 9,746,410 | -0.08 | 73.83 | -569,813 | 719,568,679 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,185 | 1,530,573 | -0.08 | 73.83 | -87,487 | 113,000,827 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -204 | 297,282 | -0.07 | 73.83 | -15,061 | 21,948,063 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -118 | 189,386 | -0.06 | 73.83 | -8,712 | 13,982,198 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 51,760 | -0.02 | 73.83 | -664 | 3,821,394 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -132 | 206,748 | -0.06 | 73.83 | -9,745 | 15,264,019 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -84,418 | 9,754,128 | -0.86 | 76.15 | -6,428,768 | 742,815,864 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12,961 | 1,531,758 | -0.84 | 76.15 | -987,032 | 116,649,499 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,234 | 297,486 | -0.75 | 76.15 | -170,128 | 22,654,749 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,296 | 189,504 | -0.68 | 76.15 | -98,696 | 14,431,488 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -99 | 51,769 | -0.19 | 76.15 | -7,539 | 3,942,416 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,447 | 206,880 | -0.69 | 76.15 | -110,195 | 15,754,740 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76,364 | 9,838,546 | -0.77 | 75.46 | -5,762,481 | 742,423,568 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,724 | 1,544,719 | -0.75 | 75.46 | -884,701 | 116,565,577 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,021 | 299,720 | -0.67 | 75.46 | -152,506 | 22,617,081 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,172 | 190,800 | -0.61 | 75.46 | -88,440 | 14,397,902 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89 | 51,868 | -0.17 | 75.46 | -6,716 | 3,913,996 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,309 | 208,327 | -0.62 | 75.46 | -98,778 | 15,720,501 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,538 | 9,914,910 | -0.03 | 77.75 | -197,318 | 770,839,635 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -390 | 1,556,443 | -0.03 | 77.75 | -30,321 | 121,006,439 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -67 | 301,741 | -0.02 | 77.75 | -5,209 | 23,459,005 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39 | 191,972 | -0.02 | 77.75 | -3,032 | 14,924,959 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 | 51,957 | -0.01 | 77.75 | -233 | 4,039,423 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 209,636 | -0.02 | 77.75 | -3,343 | 16,298,256 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,493 | 9,917,448 | -0.06 | 73.81 | -405,449 | 732,025,680 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -843 | 1,556,833 | -0.05 | 73.81 | -62,223 | 114,912,802 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -146 | 301,808 | -0.05 | 73.81 | -10,777 | 22,277,022 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -84 | 192,011 | -0.04 | 73.81 | -6,200 | 14,172,697 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 51,960 | -0.01 | 73.81 | -443 | 3,835,266 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -95 | 209,679 | -0.05 | 73.81 | -7,012 | 15,476,805 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18,604 | 9,922,941 | -0.19 | 75.83 | -1,410,758 | 752,465,547 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,856 | 1,557,676 | -0.18 | 75.83 | -216,573 | 118,119,973 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -492 | 301,954 | -0.16 | 75.83 | -37,309 | 22,897,444 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -286 | 192,095 | -0.15 | 75.83 | -21,688 | 14,566,737 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21 | 51,966 | -0.04 | 75.83 | -1,592 | 3,940,629 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -319 | 209,774 | -0.15 | 75.83 | -24,190 | 15,907,351 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -371 | 9,941,545 | 0.00 | 77.11 | -28,608 | 766,592,535 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -57 | 1,560,532 | 0.00 | 77.11 | -4,395 | 120,332,623 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 302,446 | 0.00 | 77.11 | -771 | 23,321,611 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 192,381 | 0.00 | 77.11 | -463 | 14,834,499 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 192,381 | 0.00 | 77.11 | -463 | 14,834,499 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,987 | 0.00 | 77.11 | -77 | 4,008,718 | |
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | 1,569 | 1,569 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | 1,569 | 1,569 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | -10,731 | 0 | -100.00 | ||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 71,647 | 71,647 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 71,647 | 71,647 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | -489,977 | 0 | -100.00 | ||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11,178,823 | 35,976,940 | 45.08 | 17.00 | 190,039,991 | 611,607,980 | |
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 585,882 | 3,736,902 | 18.59 | 17.00 | 9,959,994 | 63,527,334 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -247 | 9,941,916 | 0.00 | 76.62 | -18,925 | 761,724,749 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38 | 1,560,589 | 0.00 | 76.62 | -2,911 | 119,568,428 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 302,456 | 0.00 | 76.62 | -460 | 23,173,423 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 192,387 | 0.00 | 76.62 | -306 | 14,740,211 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 192,387 | 0.00 | 76.62 | -306 | 14,740,211 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51,988 | 0.00 | 76.62 | -77 | 3,983,191 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -32,598 | 9,942,163 | -0.33 | 77.52 | -2,527,147 | 770,762,210 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,005 | 1,560,627 | -0.32 | 77.52 | -388,011 | 120,986,984 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -863 | 302,462 | -0.28 | 77.52 | -66,904 | 23,448,246 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -500 | 192,391 | -0.26 | 77.52 | -38,762 | 14,915,035 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38 | 51,989 | -0.07 | 77.52 | -2,946 | 4,030,426 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -559 | 210,103 | -0.27 | 77.52 | -43,336 | 16,288,151 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89,047 | 9,974,761 | -0.88 | 78.05 | -6,950,074 | 778,525,109 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,671 | 1,565,632 | -0.87 | 78.05 | -1,067,015 | 122,196,795 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,357 | 303,325 | -0.77 | 78.05 | -183,963 | 23,674,365 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,367 | 192,891 | -0.70 | 78.05 | -106,694 | 15,055,046 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -104 | 52,027 | -0.20 | 78.05 | -8,117 | 4,060,681 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,526 | 210,662 | -0.72 | 78.05 | -119,104 | 16,442,064 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44,659 | 10,063,808 | -0.44 | 80.09 | -3,576,721 | 806,006,357 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,856 | 1,579,303 | -0.43 | 80.09 | -549,094 | 126,485,746 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,182 | 305,682 | -0.39 | 80.09 | -94,666 | 24,481,949 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -685 | 194,258 | -0.35 | 80.09 | -54,861 | 15,558,046 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -52 | 52,131 | -0.10 | 80.09 | -4,165 | 4,175,151 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -765 | 212,188 | -0.36 | 80.09 | -61,269 | 16,994,052 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129,121 | 10,108,467 | -1.26 | 79.07 | -10,209,675 | 799,282,551 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19,824 | 1,586,159 | -1.23 | 79.07 | -1,567,496 | 125,418,544 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,417 | 306,864 | -1.10 | 79.07 | -270,184 | 24,263,921 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,981 | 194,943 | -1.01 | 79.07 | -156,639 | 15,414,260 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -151 | 52,183 | -0.29 | 79.07 | -11,940 | 4,126,141 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,214 | 212,953 | -1.03 | 79.07 | -175,062 | 16,838,321 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39,591 | 10,237,588 | -0.39 | 79.63 | -3,152,536 | 815,194,562 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6,078 | 1,605,983 | -0.38 | 79.63 | -483,977 | 127,880,572 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,048 | 310,281 | -0.34 | 79.63 | -83,450 | 24,706,931 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -608 | 196,924 | -0.31 | 79.63 | -48,414 | 15,680,586 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46 | 52,334 | -0.09 | 79.63 | -3,663 | 4,167,231 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -678 | 215,167 | -0.31 | 79.63 | -53,988 | 17,133,232 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -30,257 | 10,277,179 | -0.29 | 77.61 | -2,348,376 | 797,656,054 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,646 | 1,612,061 | -0.29 | 77.61 | -360,596 | 125,118,986 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -801 | 311,329 | -0.26 | 77.61 | -62,169 | 24,163,582 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -465 | 197,532 | -0.23 | 77.61 | -36,091 | 15,331,308 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -35 | 52,380 | -0.07 | 77.61 | -2,717 | 4,065,437 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -518 | 215,845 | -0.24 | 77.61 | -40,204 | 16,752,659 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,994 | 10,307,436 | -0.12 | 78.80 | -945,149 | 812,244,510 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,841 | 1,616,707 | -0.11 | 78.80 | -145,074 | 127,399,422 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -317 | 312,130 | -0.10 | 78.80 | -24,980 | 24,596,406 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -184 | 197,997 | -0.09 | 78.80 | -14,500 | 15,602,520 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -14 | 52,415 | -0.03 | 78.80 | -1,103 | 4,130,396 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -206 | 216,363 | -0.10 | 78.80 | -16,233 | 17,049,794 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -77,976 | 10,319,430 | -0.75 | 76.81 | -5,989,017 | 792,593,109 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,972 | 1,618,548 | -0.73 | 76.81 | -919,520 | 124,314,036 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,064 | 312,447 | -0.66 | 76.81 | -158,527 | 23,997,773 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,197 | 198,181 | -0.60 | 76.81 | -91,937 | 15,221,470 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -91 | 52,429 | -0.17 | 76.81 | -6,989 | 4,026,857 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,335 | 216,569 | -0.61 | 76.81 | -102,536 | 16,633,777 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13,595 | 10,397,406 | -0.13 | 74.01 | -1,006,150 | 769,499,541 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,087 | 1,630,520 | -0.13 | 74.01 | -154,456 | 120,672,829 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 314,511 | -0.11 | 74.01 | -26,643 | 23,276,582 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -209 | 199,378 | -0.10 | 74.01 | -15,468 | 14,755,727 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 52,520 | -0.03 | 74.01 | -1,184 | 3,886,942 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -233 | 217,904 | -0.11 | 74.01 | -17,244 | 16,126,814 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -57,979 | 10,411,001 | -0.55 | 74.71 | -4,331,524 | 777,790,268 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,901 | 1,632,607 | -0.54 | 74.71 | -664,980 | 121,969,620 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,534 | 314,871 | -0.48 | 74.71 | -114,603 | 23,523,540 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -890 | 199,587 | -0.44 | 74.71 | -66,491 | 14,910,845 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -68 | 52,536 | -0.13 | 74.71 | -5,080 | 3,924,886 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -994 | 218,137 | -0.45 | 74.71 | -74,260 | 16,296,688 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56,764 | 10,468,980 | -0.54 | 75.27 | -4,272,831 | 788,037,813 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,715 | 1,641,508 | -0.53 | 75.27 | -656,009 | 123,562,217 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,502 | 316,405 | -0.47 | 75.27 | -113,061 | 23,816,943 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -871 | 200,477 | -0.43 | 75.27 | -65,563 | 15,090,626 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66 | 52,604 | -0.13 | 75.27 | -4,968 | 3,959,692 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -973 | 219,131 | -0.44 | 75.27 | -73,241 | 16,494,779 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -36,652 | 10,525,744 | -0.35 | 73.76 | -2,703,294 | 776,333,617 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,627 | 1,650,223 | -0.34 | 73.76 | -415,023 | 121,713,353 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -970 | 317,907 | -0.30 | 73.76 | -71,543 | 23,447,453 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -563 | 201,348 | -0.28 | 73.76 | -41,524 | 14,850,563 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 52,670 | -0.08 | 73.76 | -3,171 | 3,884,713 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -628 | 220,104 | -0.28 | 73.76 | -46,319 | 16,233,925 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -77,558 | 10,562,396 | -0.73 | 74.24 | -5,758,092 | 784,177,629 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,907 | 1,655,850 | -0.71 | 74.24 | -884,004 | 122,934,278 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,052 | 318,877 | -0.64 | 74.24 | -152,345 | 23,674,194 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,190 | 201,911 | -0.59 | 74.24 | -88,348 | 14,990,357 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -91 | 52,713 | -0.17 | 74.24 | -6,756 | 3,913,540 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,329 | 220,732 | -0.60 | 74.24 | -98,668 | 16,387,673 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,204 | 10,639,954 | -0.08 | 74.05 | -607,484 | 787,859,866 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,260 | 1,667,757 | -0.08 | 74.05 | -93,300 | 123,492,903 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -217 | 320,929 | -0.07 | 74.05 | -16,068 | 23,763,926 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -126 | 203,101 | -0.06 | 74.05 | -9,330 | 15,039,081 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 52,804 | -0.02 | 74.05 | -740 | 3,909,994 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -141 | 222,061 | -0.06 | 74.05 | -10,441 | 16,443,017 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24,487 | 10,648,158 | -0.23 | 74.36 | -1,820,848 | 791,794,899 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,759 | 1,669,017 | -0.22 | 74.36 | -279,518 | 124,107,770 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -648 | 321,146 | -0.20 | 74.36 | -48,185 | 23,880,352 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -376 | 203,227 | -0.18 | 74.36 | -27,959 | 15,111,919 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 52,814 | -0.05 | 74.36 | -2,082 | 3,927,238 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -419 | 222,202 | -0.19 | 74.36 | -31,157 | 16,522,896 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -55,365 | 10,672,645 | -0.52 | 76.35 | -4,227,024 | 814,838,302 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,499 | 1,672,776 | -0.51 | 76.35 | -648,884 | 127,713,604 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,466 | 321,794 | -0.45 | 76.35 | -111,927 | 24,568,425 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -850 | 203,603 | -0.42 | 76.35 | -64,896 | 15,544,743 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -65 | 52,842 | -0.12 | 76.35 | -4,963 | 4,034,397 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -949 | 222,621 | -0.42 | 76.35 | -72,455 | 16,996,735 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16,646 | 10,728,010 | -0.15 | 77.66 | -1,292,763 | 833,159,785 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,556 | 1,681,275 | -0.15 | 77.66 | -198,504 | 130,571,347 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -440 | 323,260 | -0.14 | 77.66 | -34,171 | 25,105,050 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -255 | 204,453 | -0.12 | 77.66 | -19,804 | 15,878,249 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19 | 52,907 | -0.04 | 77.66 | -1,476 | 4,108,869 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -285 | 223,570 | -0.13 | 77.66 | -22,134 | 17,362,916 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38,330 | 10,744,656 | -0.36 | 79.13 | -3,033,110 | 850,240,746 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,885 | 1,683,831 | -0.35 | 79.13 | -465,689 | 133,244,073 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,014 | 323,700 | -0.31 | 79.13 | -80,239 | 25,614,867 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -588 | 204,708 | -0.29 | 79.13 | -46,529 | 16,198,851 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -45 | 52,926 | -0.08 | 79.13 | -3,561 | 4,188,114 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -657 | 223,855 | -0.29 | 79.13 | -51,989 | 17,713,982 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,296 | 10,782,986 | -0.03 | 80.09 | -263,978 | 863,613,662 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -506 | 1,689,716 | -0.03 | 80.09 | -40,526 | 135,330,030 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -87 | 324,714 | -0.03 | 80.09 | -6,968 | 26,006,474 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51 | 205,296 | -0.02 | 80.09 | -4,085 | 16,442,239 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 52,971 | -0.01 | 80.09 | -320 | 4,242,469 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 224,512 | -0.02 | 80.09 | -4,485 | 17,981,256 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -53,013 | 10,786,282 | -0.49 | 80.07 | -4,244,714 | 863,650,049 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,139 | 1,690,222 | -0.48 | 80.07 | -651,684 | 135,334,892 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,403 | 324,801 | -0.43 | 80.07 | -112,337 | 26,006,589 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -814 | 205,347 | -0.39 | 80.07 | -65,176 | 16,441,991 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -62 | 52,975 | -0.12 | 80.07 | -4,964 | 4,241,671 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -908 | 224,568 | -0.40 | 80.07 | -72,703 | 17,981,003 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -99,280 | 10,839,295 | -0.91 | 78.09 | -7,752,428 | 846,402,609 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,242 | 1,698,361 | -0.89 | 78.09 | -1,190,194 | 132,619,066 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,628 | 326,204 | -0.80 | 78.09 | -205,211 | 25,472,129 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,524 | 206,161 | -0.73 | 78.09 | -119,004 | 16,098,391 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -115 | 53,037 | -0.22 | 78.09 | -8,980 | 4,141,474 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,702 | 225,476 | -0.75 | 78.09 | -132,903 | 17,606,632 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,014 | 10,938,575 | -0.14 | 81.26 | -1,220,038 | 888,868,604 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,305 | 1,713,603 | -0.13 | 81.26 | -187,304 | 139,247,380 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -397 | 328,832 | -0.12 | 81.26 | -32,260 | 26,720,888 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -230 | 207,685 | -0.11 | 81.26 | -18,690 | 16,876,483 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 53,152 | -0.03 | 81.26 | -1,463 | 4,319,132 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -257 | 227,178 | -0.11 | 81.26 | -20,884 | 18,460,484 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46,511 | 10,953,589 | -0.42 | 81.16 | -3,774,912 | 889,011,904 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7,140 | 1,715,908 | -0.41 | 81.16 | -579,495 | 139,266,010 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,231 | 329,229 | -0.37 | 81.16 | -99,910 | 26,720,785 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -714 | 207,915 | -0.34 | 81.16 | -57,949 | 16,874,735 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -54 | 53,170 | -0.10 | 81.16 | -4,383 | 4,315,368 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -796 | 227,435 | -0.35 | 81.16 | -64,605 | 18,459,011 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7,533 | 11,000,100 | -0.07 | 80.51 | -606,473 | 885,604,851 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,156 | 1,723,048 | -0.07 | 80.51 | -93,068 | 138,720,527 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -199 | 330,460 | -0.06 | 80.51 | -16,021 | 26,604,938 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -116 | 208,629 | -0.06 | 80.51 | -9,339 | 16,796,470 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 53,224 | -0.02 | 80.51 | -725 | 4,285,000 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 228,231 | -0.06 | 80.51 | -10,386 | 18,374,604 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11,877 | 11,007,633 | -0.11 | 80.38 | -954,711 | 884,828,765 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,824 | 1,724,204 | -0.11 | 80.38 | -146,619 | 138,597,035 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -314 | 330,659 | -0.09 | 80.38 | -25,240 | 26,579,429 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -182 | 208,745 | -0.09 | 80.38 | -14,630 | 16,779,591 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -14 | 53,233 | -0.03 | 80.38 | -1,125 | 4,279,039 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -204 | 228,360 | -0.09 | 80.38 | -16,398 | 18,356,308 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19,367 | 11,019,510 | -0.18 | 85.11 | -1,648,296 | 937,853,967 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,973 | 1,726,028 | -0.17 | 85.11 | -253,028 | 146,899,654 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -513 | 330,973 | -0.15 | 85.11 | -43,661 | 28,168,616 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -297 | 208,927 | -0.14 | 85.11 | -25,277 | 17,781,464 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -23 | 53,247 | -0.04 | 85.11 | -1,957 | 4,531,772 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -332 | 228,564 | -0.15 | 85.11 | -28,256 | 19,452,739 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -112,010 | 11,038,877 | -1.00 | 82.06 | -9,191,025 | 905,799,468 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -17,198 | 1,729,001 | -0.98 | 82.06 | -1,411,189 | 141,873,869 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,964 | 331,486 | -0.89 | 82.06 | -243,212 | 27,200,216 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,720 | 209,224 | -0.82 | 82.06 | -141,135 | 17,167,959 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 53,270 | -0.24 | 82.06 | -10,585 | 4,371,091 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,919 | 228,896 | -0.83 | 82.06 | -157,464 | 18,782,153 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8,157 | 11,150,887 | -0.07 | 82.55 | -673,321 | 920,452,198 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,252 | 1,746,199 | -0.07 | 82.55 | -103,347 | 144,140,346 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -216 | 334,450 | -0.06 | 82.55 | -17,830 | 27,607,242 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -125 | 210,944 | -0.06 | 82.55 | -10,318 | 17,412,415 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 53,399 | -0.02 | 82.55 | -743 | 4,407,831 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -140 | 230,815 | -0.06 | 82.55 | -11,556 | 19,052,670 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,120 | 11,159,044 | -0.04 | 83.90 | -345,678 | 936,271,689 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -633 | 1,747,451 | -0.04 | 83.90 | -53,110 | 146,615,508 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -109 | 334,666 | -0.03 | 83.90 | -9,145 | 28,079,314 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 211,069 | -0.03 | 83.90 | -5,286 | 17,709,217 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53,408 | -0.01 | 83.90 | -420 | 4,481,065 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 230,955 | -0.03 | 83.90 | -5,957 | 19,377,702 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -62,929 | 11,163,164 | -0.56 | 83.20 | -5,235,598 | 928,758,500 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,661 | 1,748,084 | -0.55 | 83.20 | -803,781 | 145,437,967 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,665 | 334,775 | -0.49 | 83.20 | -138,526 | 27,852,778 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -966 | 211,132 | -0.46 | 83.20 | -80,370 | 17,565,866 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 53,413 | -0.14 | 83.20 | -6,157 | 4,443,881 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,078 | 231,026 | -0.46 | 83.20 | -89,688 | 19,221,017 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -17,602 | 11,226,093 | -0.16 | 85.87 | -1,511,565 | 964,036,246 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,702 | 1,757,745 | -0.15 | 85.87 | -232,033 | 150,945,649 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -466 | 336,440 | -0.14 | 85.87 | -40,018 | 28,891,650 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -270 | 212,098 | -0.13 | 85.87 | -23,186 | 18,213,831 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21 | 53,487 | -0.04 | 85.87 | -1,803 | 4,593,175 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -302 | 232,104 | -0.13 | 85.87 | -25,934 | 19,931,838 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,120 | 11,243,695 | -0.04 | 82.00 | -337,840 | 921,982,990 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -633 | 1,760,447 | -0.04 | 82.00 | -51,906 | 144,356,654 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -109 | 336,906 | -0.03 | 82.00 | -8,938 | 27,626,292 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 212,368 | -0.03 | 82.00 | -5,166 | 17,414,176 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53,508 | -0.01 | 82.00 | -410 | 4,387,656 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 232,406 | -0.03 | 82.00 | -5,822 | 19,057,292 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,565 | 11,247,815 | -0.01 | 83.85 | -131,227 | 943,138,286 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -240 | 1,761,080 | -0.01 | 83.85 | -20,124 | 147,667,967 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42 | 337,015 | -0.01 | 83.85 | -3,522 | 28,258,977 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24 | 212,431 | -0.01 | 83.85 | -2,012 | 17,812,509 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 53,513 | 0.00 | 83.85 | -168 | 4,487,108 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 232,477 | -0.01 | 83.85 | -2,264 | 19,493,382 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9,301 | 11,249,380 | -0.08 | 84.84 | -789,121 | 954,426,648 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1,428 | 1,761,320 | -0.08 | 84.84 | -121,155 | 149,434,968 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -246 | 337,057 | -0.07 | 84.84 | -20,871 | 28,596,792 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -143 | 212,455 | -0.07 | 84.84 | -12,132 | 18,025,235 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 53,515 | -0.02 | 84.84 | -933 | 4,540,352 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -159 | 232,504 | -0.07 | 84.84 | -13,490 | 19,726,244 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21,423 | 11,258,681 | -0.19 | 89.34 | -1,913,901 | 1,005,834,798 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,289 | 1,762,748 | -0.19 | 89.34 | -293,835 | 157,481,438 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -567 | 337,303 | -0.17 | 89.34 | -50,655 | 30,134,178 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -329 | 212,598 | -0.15 | 89.34 | -29,392 | 18,993,208 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 53,526 | -0.05 | 89.34 | -2,233 | 4,781,938 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -367 | 232,663 | -0.16 | 89.34 | -32,787 | 20,785,787 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -30,555 | 11,280,104 | -0.27 | 85.15 | -2,601,670 | 960,468,143 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,692 | 1,766,037 | -0.26 | 85.15 | -399,510 | 150,372,929 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -809 | 337,870 | -0.24 | 85.15 | -68,884 | 28,768,651 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -470 | 212,927 | -0.22 | 85.15 | -40,019 | 18,130,117 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37 | 53,551 | -0.07 | 85.15 | -3,150 | 4,559,712 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -522 | 233,030 | -0.22 | 85.15 | -44,447 | 19,841,829 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -36,174 | 11,310,659 | -0.32 | 85.78 | -3,102,970 | 970,217,018 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5,554 | 1,770,729 | -0.31 | 85.78 | -476,417 | 151,891,363 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -957 | 338,679 | -0.28 | 85.78 | -82,091 | 29,051,546 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -555 | 213,397 | -0.26 | 85.78 | -47,607 | 18,304,981 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42 | 53,588 | -0.08 | 85.78 | -3,603 | 4,596,725 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -620 | 233,552 | -0.26 | 85.78 | -53,183 | 20,033,857 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3,663 | 11,346,833 | -0.03 | 87.30 | -319,780 | 990,579,656 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -562 | 1,776,283 | -0.03 | 87.30 | -49,063 | 155,069,684 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -97 | 339,636 | -0.03 | 87.30 | -8,468 | 29,650,257 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 213,952 | -0.03 | 87.30 | -4,889 | 18,678,031 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 53,630 | -0.01 | 87.30 | -349 | 4,681,904 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 234,172 | -0.03 | 87.30 | -5,500 | 20,443,239 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4,306 | 11,350,496 | -0.04 | 88.38 | -380,544 | 1,003,104,624 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -661 | 1,776,845 | -0.04 | 88.38 | -58,416 | 157,029,388 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -114 | 339,733 | -0.03 | 88.38 | -10,075 | 30,024,040 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66 | 214,008 | -0.03 | 88.38 | -5,833 | 18,913,043 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53,634 | -0.01 | 88.38 | -442 | 4,739,926 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 234,235 | -0.03 | 88.38 | -6,540 | 20,700,612 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15,798 | 11,354,802 | -0.14 | 83.94 | -1,326,160 | 953,176,583 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2,425 | 1,777,506 | -0.14 | 83.94 | -203,566 | 149,212,386 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -418 | 339,847 | -0.12 | 83.94 | -35,089 | 28,528,388 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -242 | 214,074 | -0.11 | 83.94 | -20,315 | 17,970,399 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 53,639 | -0.03 | 83.94 | -1,511 | 4,502,715 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -271 | 234,309 | -0.12 | 83.94 | -22,749 | 19,669,022 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Secured Bridge Notes 30% 12/1/2020 |
C - Conversion | -3,660,993 | 0 | -100.00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Secured Bridge Notes 30% 12/1/2020 |
C - Conversion | -294,948 | 0 | -100.00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Series B Redeemable Convertible Preferred Shares |
C - Conversion | -4,627,208 | 0 | -100.00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Series B Redeemable Convertible Preferred Shares |
C - Conversion | -372,792 | 0 | -100.00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2,248,102 | 8,374,935 | 36.69 | 10.00 | 22,481,020 | 83,749,350 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 251,898 | 770,180 | 48.60 | 10.00 | 2,518,980 | 7,701,800 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
J - Other | 767,427 | 6,126,833 | 14.32 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
J - Other | 86,501 | 518,282 | 20.03 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 732,198 | 5,359,406 | 15.82 | 5.00 | 3,660,990 | 26,797,030 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 58,989 | 431,781 | 15.82 | 5.00 | 294,945 | 2,158,905 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 4,627,208 | 4,627,208 | |||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 372,792 | 372,792 | |||||
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 340,265 | 0.08 | 70.18 | 19,931 | 23,879,798 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 340,265 | 0.08 | 70.18 | 19,931 | 23,879,798 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 11,544,497 | 0.00 | 70.18 | 19,931 | 810,192,799 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 1,953,828 | 0.01 | 70.18 | 19,931 | 137,119,649 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 227,554 | 0.12 | 70.18 | 19,931 | 15,969,740 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 388,213 | 0.07 | 70.18 | 19,931 | 27,244,788 | |
| 2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,340 | 81,414 | 2.96 | 8.71 | 20,381 | 709,116 | |
| 2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,340 | 81,414 | 2.96 | 8.71 | 20,381 | 709,116 | |
| 2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2,340 | 4,280,212 | 0.05 | 8.71 | 20,381 | 37,280,647 | |
| 2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 810,564 | 0.03 | 69.08 | 18,997 | 55,993,761 | |
| 2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 810,564 | 0.03 | 69.08 | 18,997 | 55,993,761 | |
| 2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 1,269,837 | 0.02 | 69.08 | 18,997 | 87,720,340 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 131,007 | 24,798,117 | 0.53 | 19.09 | 2,501,238 | 473,455,569 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 14,555 | 3,151,020 | 0.46 | 19.09 | 277,890 | 60,160,534 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 38,207 | 24,667,110 | 0.16 | 19.01 | 726,353 | 468,946,428 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4,245 | 3,136,465 | 0.14 | 19.01 | 80,702 | 59,627,336 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 920,495 | 24,628,903 | 3.88 | 18.64 | 17,154,897 | 458,999,014 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 102,267 | 3,132,220 | 3.38 | 18.64 | 1,905,909 | 58,373,931 | |
| 2018-08-06 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
P - Purchase | 5,231,900 | 5,250,491 | 28,142.11 | 108.00 | 565,045,200 | 567,053,028 | |
| 2018-08-06 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
P - Purchase | 582,200 | 600,791 | 3,131.62 | 108.00 | 62,877,600 | 64,885,428 | |
| 2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16,383 | 632,599 | 2.66 | 1.32 | 21,626 | 835,031 | |
| 2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16,383 | 632,599 | 2.66 | 1.32 | 21,626 | 835,031 | |
| 2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16,383 | 34,222,983 | 0.05 | 1.32 | 21,626 | 45,174,338 | |
| 2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810,289 | 0.03 | 67.00 | 18,961 | 54,289,363 | |
| 2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810,289 | 0.03 | 67.00 | 18,961 | 54,289,363 | |
| 2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810,289 | 0.03 | 67.00 | 18,961 | 54,289,363 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339,981 | 0.12 | 50.40 | 19,958 | 17,135,042 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339,981 | 0.12 | 50.40 | 19,958 | 17,135,042 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339,981 | 0.12 | 50.40 | 19,958 | 17,135,042 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 1,953,544 | 0.02 | 50.40 | 19,958 | 98,458,618 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 227,270 | 0.17 | 50.40 | 19,958 | 11,454,408 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 387,929 | 0.10 | 50.40 | 19,958 | 19,551,622 | |
| 2018-06-21 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100,000 | 100,000 | |||||
| 2018-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20,000 | 20,000 | |||||
| 2018-06-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30,000 | 30,000 | |||||
| 2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 34,884 | 34,884 | |||||
| 2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
A - Award | 18,580 | 73,180,602 | 0.03 | ||||
| 2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
A - Award | 18,580 | 73,180,602 | 0.03 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class B1 Common Shares |
C - Conversion | 14,658,102 | 14,658,102 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series A Preferred |
C - Conversion | -14,658,102 | 0 | -100.00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class B1 Common Shares |
C - Conversion | 1,399,516 | 1,399,516 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series A Preferred |
C - Conversion | -1,399,516 | 0 | -100.00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 3,284,771 | 7,018,874 | 87.97 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series B Preferred |
C - Conversion | -3,284,771 | 0 | -100.00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 313,621 | 734,518 | 74.51 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series B Preferred |
C - Conversion | -313,621 | 0 | -100.00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 3,734,103 | 3,734,103 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
C - Conversion | -3,734,103 | 0 | -100.00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 420,897 | 420,897 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
C - Conversion | -420,897 | 0 | -100.00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
P - Purchase | 2,700,597 | 2,700,597 | 18.00 | 48,610,746 | 48,610,746 | ||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
P - Purchase | 299,403 | 299,403 | 18.00 | 5,389,254 | 5,389,254 | ||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
P - Purchase | 3,734,103 | 3,734,103 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
P - Purchase | 420,897 | 420,897 | |||||
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 45,829,686 | 0.01 | 56.77 | 210,049 | 2,601,751,274 | |
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 45,829,686 | 0.01 | 56.77 | 210,049 | 2,601,751,274 | |
| 2018-05-11 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2,174 | 7,648,080 | 0.03 | ||||
| 2018-05-11 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2,174 | 7,648,080 | 0.03 | ||||
| 2018-05-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30,000 | 30,000 | |||||
| 2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 126,399 | 45,825,986 | 0.28 | 54.02 | 6,828,339 | 2,475,615,998 | |
| 2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 129,715 | 45,699,587 | 0.28 | 53.70 | 6,966,305 | 2,454,282,610 | |
| 2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 204,537 | 45,569,872 | 0.45 | 52.68 | 10,775,582 | 2,400,748,453 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 810,006 | 2.53 | 9.92 | 198,400 | 8,035,260 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 810,006 | 2.53 | 9.92 | 198,400 | 8,035,260 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 810,006 | 2.53 | 9.92 | 198,400 | 8,035,260 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,105 | 45,365,335 | 0.02 | 54.42 | 495,488 | 2,468,749,775 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,442 | 45,356,230 | 0.05 | 52.26 | 1,120,576 | 2,370,352,865 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37,400 | 45,334,788 | 0.08 | 52.33 | 1,957,022 | 2,372,224,385 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,000 | 45,297,388 | 0.00 | 51.88 | 103,750 | 2,349,802,002 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,951 | 45,295,388 | 0.01 | 52.33 | 311,418 | 2,370,321,243 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37,963 | 45,289,437 | 0.08 | 52.06 | 1,976,213 | 2,357,600,519 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57,270 | 45,251,474 | 0.13 | 51.37 | 2,941,708 | 2,324,369,113 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,500 | 45,194,204 | 0.02 | 51.36 | 539,280 | 2,321,174,317 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22,700 | 45,183,704 | 0.05 | 51.30 | 1,164,424 | 2,317,752,317 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72,533 | 45,161,004 | 0.16 | 51.26 | 3,717,693 | 2,314,736,292 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100,000 | 45,088,471 | 0.22 | 51.14 | 5,114,000 | 2,305,824,407 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 44,988,471 | 0.02 | 10.08 | 100,800 | 453,483,788 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 44,988,471 | 0.02 | 10.08 | 100,800 | 453,483,788 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 168,097 | 44,978,471 | 0.38 | 51.25 | 8,614,786 | 2,305,097,162 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 52,700 | 44,810,374 | 0.12 | 51.07 | 2,691,173 | 2,288,282,078 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 248,121 | 44,757,674 | 0.56 | 51.03 | 12,661,069 | 2,283,885,637 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 154,218 | 44,509,553 | 0.35 | 50.90 | 7,849,897 | 2,265,594,110 | |
| 2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,349 | 616,216 | 2.21 | 1.62 | 21,625 | 998,270 | |
| 2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,349 | 616,216 | 2.21 | 1.62 | 21,625 | 998,270 | |
| 2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,349 | 616,216 | 2.21 | 1.62 | 21,625 | 998,270 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 339,585 | 0.19 | 31.29 | 19,963 | 10,625,615 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1,382,967 | 0.05 | 31.29 | 19,963 | 43,273,037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1,382,967 | 0.05 | 31.29 | 19,963 | 43,273,037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1,382,967 | 0.05 | 31.29 | 19,963 | 43,273,037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1,382,967 | 0.05 | 31.29 | 19,963 | 43,273,037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 339,585 | 0.19 | 31.29 | 19,963 | 10,625,615 | |
| 2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 790,006 | 0.03 | 83.33 | 18,999 | 65,831,200 | |
| 2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 1,249,279 | 0.02 | 83.33 | 18,999 | 104,102,419 | |
| 2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 790,006 | 0.03 | 83.33 | 18,999 | 65,831,200 | |
| 2018-03-29 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 999,514 | 7,480,182 | 15.42 | 4.50 | 4,497,813 | 33,660,819 | |
| 2018-03-29 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 111,597 | 845,858 | 15.20 | 4.50 | 502,186 | 3,806,361 | |
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -439,036 | 0 | -100.00 | ||||
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -17,626,445 | 0 | -100.00 | ||||
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -2,250,846 | 0 | -100.00 | ||||
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 439,036 | 602,867 | 267.98 | 0.47 | 206,347 | 283,347 | |
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 17,626,445 | 34,193,251 | 106.40 | 0.47 | 8,284,429 | 16,070,828 | |
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 2,250,846 | 4,102,796 | 121.54 | 0.47 | 1,057,898 | 1,928,314 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 338,947 | 2.49 | 18.50 | 152,625 | 6,270,520 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 338,947 | 2.49 | 18.50 | 152,625 | 6,270,520 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,382,329 | 0.60 | 18.50 | 152,625 | 25,573,086 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,382,329 | 0.60 | 18.50 | 152,625 | 25,573,086 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,382,329 | 0.60 | 18.50 | 152,625 | 25,573,086 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 338,947 | 2.49 | 18.50 | 152,625 | 6,270,520 | |
| 2018-02-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,456,543 | 44,355,335 | 8.45 | 52.00 | 179,740,236 | 2,306,477,420 | |
| 2018-02-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 389,610 | 5,278,174 | 7.97 | 52.00 | 20,259,720 | 274,465,048 | |
| 2018-01-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1,645,148 | 5,121,404 | 47.33 | 101.00 | 166,159,948 | 517,261,804 | |
| 2018-01-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 335,050 | 708,025 | 89.83 | 101.00 | 33,840,050 | 71,510,525 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -4,136 | 58,131 | -6.64 | 7.91 | -32,715 | 459,799 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -265,708 | 3,734,776 | -6.64 | 7.91 | -2,101,671 | 29,540,958 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -25,517 | 358,671 | -6.64 | 7.91 | -201,832 | 2,836,980 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -4,548 | 62,267 | -6.81 | 8.12 | -36,910 | 505,340 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -292,168 | 4,000,484 | -6.81 | 8.12 | -2,371,148 | 32,466,728 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -28,058 | 384,188 | -6.81 | 8.12 | -227,710 | 3,117,955 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -3,649 | 66,815 | -5.18 | 8.63 | -31,476 | 576,340 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -234,437 | 4,292,652 | -5.18 | 8.63 | -2,022,230 | 37,027,987 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -22,514 | 412,246 | -5.18 | 8.63 | -194,204 | 3,555,993 | |
| 2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,333 | 163,831 | 6.04 | 2.21 | 20,626 | 362,067 | |
| 2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,333 | 163,831 | 6.04 | 2.21 | 20,626 | 362,067 | |
| 2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,333 | 163,831 | 6.04 | 2.21 | 20,626 | 362,067 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330,697 | 0.18 | 34.20 | 19,973 | 11,309,837 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330,697 | 0.18 | 34.20 | 19,973 | 11,309,837 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1,374,079 | 0.04 | 34.20 | 19,973 | 46,993,502 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1,374,079 | 0.04 | 34.20 | 19,973 | 46,993,502 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1,374,079 | 0.04 | 34.20 | 19,973 | 46,993,502 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330,697 | 0.18 | 34.20 | 19,973 | 11,309,837 | |
| 2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789,778 | 0.03 | 94.71 | 18,942 | 74,799,874 | |
| 2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789,778 | 0.03 | 94.71 | 18,942 | 74,799,874 | |
| 2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789,778 | 0.03 | 94.71 | 18,942 | 74,799,874 | |
| 2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
M - Exercise | -39,378 | 0 | -100.00 | ||||
| 2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
F - Taxes | -1,941 | 489,977 | -0.39 | 28.00 | -54,348 | 13,719,356 | |
| 2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 39,378 | 491,918 | 8.70 | 1.38 | 54,342 | 678,847 | |
| 2017-11-20 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
P - Purchase | 1,618,684 | 1,618,684 | 13.00 | 21,041,273 | 21,041,273 | ||
| 2017-11-20 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
P - Purchase | 304,392 | 304,392 | 13.00 | 3,956,792 | 3,956,792 | ||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -5,996 | 0 | -100.00 | ||||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -249,801 | 0 | -100.00 | ||||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -24,466 | 0 | -100.00 | ||||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 5,996 | 35,999 | 19.98 | 7.86 | 47,129 | 282,952 | |
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 249,801 | 2,372,218 | 11.77 | 7.86 | 1,963,436 | 18,645,633 | |
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 24,466 | 141,244 | 20.95 | 7.86 | 192,303 | 1,110,178 | |
| 2017-10-30 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7,204,652 | 16,557,473 | 77.03 | 1.50 | 10,806,978 | 24,836,210 | |
| 2017-10-30 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 795,348 | 1,842,617 | 75.94 | 1.50 | 1,193,022 | 2,763,926 | |
| 2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
M - Exercise | -1,426,590 | 0 | -100.00 | ||||
| 2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
F - Taxes | -55,457 | 23,708,408 | -0.23 | 35.40 | -1,963,178 | 839,277,643 | |
| 2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1,426,590 | 23,763,865 | 6.39 | 1.38 | 1,968,694 | 32,794,134 | |
| 2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 7,102 | 7,102 | |||||
| 2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 7,102 | 7,102 | |||||
| 2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | -49,200 | 0 | -100.00 | ||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Series A Convertible Prefered |
C - Conversion | -9,913,242 | 0 | -100.00 | ||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Series A Convertible Prefered |
C - Conversion | -760,829 | 0 | -100.00 | ||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 797,191 | 1,878,242 | 73.74 | 17.00 | 13,552,247 | 31,930,114 | |
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 87,809 | 170,778 | 105.83 | 17.00 | 1,492,753 | 2,903,226 | |
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
C - Conversion | 1,081,051 | 1,081,051 | |||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
C - Conversion | 82,969 | 82,969 | |||||
| 2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,045 | 154,498 | 6.22 | 2.28 | 20,623 | 352,255 | |
| 2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,045 | 154,498 | 6.22 | 2.28 | 20,623 | 352,255 | |
| 2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9,045 | 154,498 | 6.22 | 2.28 | 20,623 | 352,255 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330,113 | 0.19 | 32.09 | 19,960 | 10,593,326 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330,113 | 0.19 | 32.09 | 19,960 | 10,593,326 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1,373,495 | 0.05 | 32.09 | 19,960 | 44,075,455 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1,373,495 | 0.05 | 32.09 | 19,960 | 44,075,455 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1,373,495 | 0.05 | 32.09 | 19,960 | 44,075,455 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330,113 | 0.19 | 32.09 | 19,960 | 10,593,326 | |
| 2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789,578 | 0.02 | 116.74 | 18,912 | 92,175,336 | |
| 2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789,578 | 0.02 | 116.74 | 18,912 | 92,175,336 | |
| 2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789,578 | 0.02 | 116.74 | 18,912 | 92,175,336 | |
| 2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,029 | 789,416 | 0.26 | 132.00 | 267,828 | 104,202,912 | |
| 2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 85,402 | 29,247,347 | 0.29 | 132.00 | 11,273,064 | 3,860,649,804 | |
| 2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12,569 | 4,386,818 | 0.29 | 132.00 | 1,659,108 | 579,059,976 | |
| 2017-08-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 158,279 | 3,476,256 | 4.77 | 71.00 | 11,237,809 | 246,814,176 | |
| 2017-08-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 17,777 | 372,975 | 5.00 | 71.00 | 1,262,167 | 26,481,225 | |
| 2017-08-02 |
|
4 | NVTA |
Invitae Corp
Series A Convertible Preferred |
P - Purchase | 3,109,063 | 3,109,063 | 8.50 | 26,427,036 | 26,427,036 | ||
| 2017-08-02 |
|
4 | NVTA |
Invitae Corp
Series A Convertible Preferred |
P - Purchase | 349,760 | 349,760 | 8.50 | 2,972,960 | 2,972,960 | ||
| 2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11,787 | 145,453 | 8.82 | 1.75 | 20,627 | 254,543 | |
| 2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11,787 | 145,453 | 8.82 | 1.75 | 20,627 | 254,543 | |
| 2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11,787 | 145,453 | 8.82 | 1.75 | 20,627 | 254,543 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1,372,873 | 0.04 | 32.55 | 19,986 | 44,687,016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1,372,873 | 0.04 | 32.55 | 19,986 | 44,687,016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1,372,873 | 0.04 | 32.55 | 19,986 | 44,687,016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1,372,873 | 0.04 | 32.55 | 19,986 | 44,687,016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1,372,873 | 0.04 | 32.55 | 19,986 | 44,687,016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 329,491 | 0.19 | 32.55 | 19,986 | 10,724,932 | |
| 2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 1,246,660 | 0.01 | 125.91 | 18,886 | 156,966,961 | |
| 2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 1,246,660 | 0.01 | 125.91 | 18,886 | 156,966,961 | |
| 2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 787,387 | 0.02 | 125.91 | 18,886 | 99,139,897 | |
| 2017-06-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20,000 | 20,000 | |||||
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 22,560 | 7,317,906 | 0.31 | 117.95 | 2,660,914 | 863,134,572 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,564 | 647,367 | 0.40 | 117.95 | 302,419 | 76,355,837 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 197,126 | 7,295,346 | 2.78 | 117.51 | 23,163,488 | 857,246,927 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 22,399 | 644,803 | 3.60 | 117.51 | 2,632,017 | 75,768,221 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 32,172 | 7,098,220 | 0.46 | 117.22 | 3,771,228 | 832,059,027 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,656 | 622,404 | 0.59 | 117.22 | 428,559 | 72,958,695 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 65,264 | 7,066,048 | 0.93 | 117.01 | 7,636,802 | 826,826,541 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7,416 | 618,748 | 1.21 | 117.01 | 867,776 | 72,402,178 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 898 | 7,000,784 | 0.01 | 116.96 | 105,030 | 818,811,697 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 102 | 611,332 | 0.02 | 116.96 | 11,930 | 71,501,391 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 31,974 | 6,999,886 | 0.46 | 116.71 | 3,731,542 | 816,925,196 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,634 | 611,230 | 0.60 | 116.71 | 424,108 | 71,333,903 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 12,726 | 6,967,912 | 0.18 | 116.37 | 1,480,897 | 810,840,590 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,446 | 607,596 | 0.24 | 116.37 | 168,268 | 70,704,610 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 385,774 | 6,955,186 | 5.87 | 116.37 | 44,891,517 | 809,356,911 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43,835 | 606,150 | 7.80 | 116.37 | 5,100,965 | 70,536,100 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,976 | 6,569,412 | 0.03 | 116.18 | 229,562 | 763,202,753 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 224 | 562,315 | 0.04 | 116.18 | 26,023 | 65,327,058 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 169,897 | 6,567,436 | 2.66 | 115.77 | 19,668,568 | 760,296,304 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 19,305 | 562,091 | 3.56 | 115.77 | 2,234,894 | 65,071,926 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 207,814 | 6,397,539 | 3.36 | 115.71 | 24,046,636 | 740,273,952 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 23,614 | 542,786 | 4.55 | 115.71 | 2,732,430 | 62,807,016 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 18,678 | 6,189,725 | 0.30 | 115.06 | 2,149,048 | 712,175,522 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,122 | 519,172 | 0.41 | 115.06 | 244,152 | 59,734,736 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 64,455 | 6,171,047 | 1.06 | 114.33 | 7,369,301 | 705,551,231 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7,324 | 517,050 | 1.44 | 114.33 | 837,371 | 59,115,619 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 160,000 | 980,146 | 19.51 | 117.71 | 18,832,960 | 115,369,065 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 103,200 | 820,146 | 14.39 | 117.63 | 12,139,416 | 96,473,774 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 32,008 | 716,946 | 4.67 | 117.60 | 3,764,067 | 84,311,201 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 300 | 684,938 | 0.04 | 116.75 | 35,025 | 79,966,512 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,747 | 7,645,906 | 0.05 | 116.75 | 437,462 | 892,659,526 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 426 | 684,638 | 0.06 | 116.75 | 49,736 | 79,931,486 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 44,898 | 7,642,159 | 0.59 | 117.50 | 5,275,484 | 897,948,333 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5,102 | 684,212 | 0.75 | 117.50 | 599,481 | 80,394,431 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5,373 | 7,597,261 | 0.07 | 117.21 | 629,790 | 890,504,591 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 611 | 679,110 | 0.09 | 117.21 | 71,618 | 79,601,132 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 217,305 | 7,591,888 | 2.95 | 117.05 | 25,434,638 | 888,598,604 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24,692 | 678,499 | 3.78 | 117.05 | 2,890,095 | 79,415,458 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 8,950 | 7,374,583 | 0.12 | 116.95 | 1,046,720 | 862,471,494 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,017 | 653,807 | 0.16 | 116.95 | 118,940 | 76,463,971 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 39,473 | 7,365,633 | 0.54 | 116.65 | 4,604,506 | 859,197,407 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4,485 | 652,790 | 0.69 | 116.65 | 523,173 | 76,147,627 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4,310 | 7,326,160 | 0.06 | 116.54 | 502,277 | 853,773,836 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 490 | 648,305 | 0.08 | 116.54 | 57,103 | 75,551,974 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,944 | 7,321,850 | 0.05 | 118.00 | 465,392 | 863,978,300 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 448 | 647,815 | 0.07 | 118.00 | 52,864 | 76,442,170 | |
| 2017-06-14 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30,000 | 30,000 | |||||
| 2017-06-09 |
|
4/A | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100,000 | 100,000 | |||||
| 2017-06-08 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100,000 | 100,000 | |||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 328,877 | 2.57 | 18.13 | 149,572 | 5,962,540 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,372,259 | 0.60 | 18.13 | 149,572 | 24,879,056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,372,259 | 0.60 | 18.13 | 149,572 | 24,879,056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,372,259 | 0.60 | 18.13 | 149,572 | 24,879,056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 1,372,259 | 0.60 | 18.13 | 149,572 | 24,879,056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 328,877 | 2.57 | 18.13 | 149,572 | 5,962,540 | |
| 2017-05-31 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 40,898,792 | 0.01 | 66.60 | 246,420 | 2,723,859,547 | |
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 40,898,792 | 0.01 | 66.60 | 246,420 | 2,723,859,547 | |
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 40,895,092 | 0.02 | 10.20 | 102,000 | 417,129,938 | |
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 40,895,092 | 0.02 | 10.20 | 102,000 | 417,129,938 | |
| 2017-05-12 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2,030 | 6,559,338 | 0.03 | ||||
| 2017-05-12 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2,030 | 6,106,592 | 0.03 | ||||
| 2017-05-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Non-Qualified Stock Option (right to buy) |
A - Award | 36,000 | 36,000 | |||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 787,237 | 2.61 | 7.26 | 145,200 | 5,715,341 | |
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 787,237 | 2.61 | 7.26 | 145,200 | 5,715,341 | |
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 787,237 | 2.61 | 7.26 | 145,200 | 5,715,341 | |
| 2017-04-21 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (right to buy) |
A - Award | 399,984 | 399,984 | |||||
| 2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,487 | 133,666 | 6.78 | 2.43 | 20,623 | 324,808 | |
| 2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,487 | 133,666 | 6.78 | 2.43 | 20,623 | 324,808 | |
| 2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,487 | 133,666 | 6.78 | 2.43 | 20,623 | 324,808 | |
| 2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 767,237 | 0.02 | 133.67 | 18,981 | 102,556,570 | |
| 2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 1,226,510 | 0.01 | 133.67 | 18,981 | 163,947,592 | |
| 2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 767,237 | 0.02 | 133.67 | 18,981 | 102,556,570 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 320,627 | 0.20 | 31.49 | 19,965 | 10,096,544 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1,364,009 | 0.05 | 31.49 | 19,965 | 42,952,643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1,364,009 | 0.05 | 31.49 | 19,965 | 42,952,643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1,364,009 | 0.05 | 31.49 | 19,965 | 42,952,643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1,364,009 | 0.05 | 31.49 | 19,965 | 42,952,643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 320,627 | 0.20 | 31.49 | 19,965 | 10,096,544 | |
| 2017-03-28 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 151,177 | 4,527,089 | 3.45 | 12.00 | 1,814,124 | 54,325,068 | |
| 2017-03-28 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 15,489 | 434,760 | 3.69 | 12.00 | 185,868 | 5,217,120 | |
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -6,050,000 | 0 | -100.00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -5,674,000 | 0 | -100.00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -243,450,000 | 0 | -100.00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -228,326,000 | 0 | -100.00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -25,000,000 | 0 | -100.00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -25,000,000 | 0 | -100.00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 121,672 | 767,095 | 18.85 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 111,514 | 645,423 | 20.89 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 4,896,067 | 29,141,653 | 20.19 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 4,487,412 | 24,245,586 | 22.71 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 502,779 | 4,353,957 | 13.06 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 491,338 | 3,851,178 | 14.62 | ||||
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 32,051 | 9,764,459 | 0.33 | 17.76 | 569,226 | 173,416,792 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,389 | 1,169,695 | 0.29 | 17.76 | 60,189 | 20,773,783 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 235,169 | 9,732,408 | 2.48 | 17.60 | 4,138,880 | 171,286,488 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 24,871 | 1,166,306 | 2.18 | 17.60 | 437,720 | 20,526,519 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 35,360 | 9,497,239 | 0.37 | 16.31 | 576,555 | 154,855,331 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,739 | 1,141,435 | 0.33 | 16.31 | 60,966 | 18,611,440 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,006 | 9,461,879 | 0.05 | 15.62 | 78,207 | 147,819,151 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 529 | 1,137,696 | 0.05 | 15.62 | 8,264 | 17,773,770 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 15,148 | 9,456,873 | 0.16 | 15.13 | 229,189 | 143,082,488 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,602 | 1,137,167 | 0.14 | 15.13 | 24,238 | 17,205,337 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9,143 | 9,441,725 | 0.10 | 16.20 | 148,089 | 152,927,620 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 967 | 1,135,565 | 0.09 | 16.20 | 15,662 | 18,392,746 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 8,671 | 9,432,582 | 0.09 | 15.35 | 133,078 | 144,766,552 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 917 | 1,134,598 | 0.08 | 15.35 | 14,074 | 17,413,243 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,442 | 9,423,911 | 0.03 | 16.85 | 41,156 | 158,823,999 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 258 | 1,133,681 | 0.02 | 16.85 | 4,348 | 19,106,266 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 11,305 | 9,421,469 | 0.12 | 15.32 | 173,204 | 144,346,327 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,195 | 1,133,423 | 0.11 | 15.32 | 18,309 | 17,365,174 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,697 | 9,410,164 | 0.06 | 16.74 | 95,365 | 157,521,440 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 603 | 1,132,228 | 0.05 | 16.74 | 10,094 | 18,952,931 | |
| 2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14,169 | 125,179 | 12.76 | 1.50 | 21,254 | 187,768 | |
| 2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14,169 | 125,179 | 12.76 | 1.50 | 21,254 | 187,768 | |
| 2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14,169 | 125,179 | 12.76 | 1.50 | 21,254 | 187,768 | |
| 2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 993,182 | 0.02 | 100.27 | 18,951 | 99,586,359 | |
| 2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 993,182 | 0.02 | 100.27 | 18,951 | 99,586,359 | |
| 2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 533,909 | 0.04 | 100.27 | 18,951 | 53,535,055 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14,045,614 | 0.00 | 29.39 | 19,985 | 412,800,595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14,045,614 | 0.00 | 29.39 | 19,985 | 412,800,595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14,045,614 | 0.00 | 29.39 | 19,985 | 412,800,595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14,045,614 | 0.00 | 29.39 | 19,985 | 412,800,595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 1,363,375 | 0.05 | 29.39 | 19,985 | 40,069,591 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 319,993 | 0.21 | 29.39 | 19,985 | 9,404,594 | |
| 2016-11-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1,594,671 | 3,317,977 | 92.54 | 32.00 | 51,029,472 | 106,175,264 | |
| 2016-11-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 165,824 | 355,198 | 87.56 | 32.00 | 5,306,368 | 11,366,336 | |
| 2016-11-18 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 664,259 | 6,480,668 | 11.42 | 6.00 | 3,985,554 | 38,884,008 | |
| 2016-11-18 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 69,074 | 734,261 | 10.38 | 6.00 | 414,444 | 4,405,566 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 294,178 | 40,885,092 | 0.72 | 59.46 | 17,493,177 | 2,431,215,642 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32,122 | 4,874,864 | 0.66 | 59.46 | 1,910,122 | 289,881,838 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50,667 | 40,590,914 | 0.12 | 58.74 | 2,976,321 | 2,384,423,943 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,533 | 4,842,742 | 0.11 | 58.74 | 325,024 | 284,476,225 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18,616 | 40,540,247 | 0.05 | 55.99 | 1,042,351 | 2,269,937,618 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,039 | 4,837,209 | 0.04 | 55.99 | 114,168 | 270,845,974 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16,854 | 40,521,631 | 0.04 | 56.42 | 950,861 | 2,286,129,117 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,846 | 4,835,170 | 0.04 | 56.42 | 104,147 | 272,788,203 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 143,016 | 40,504,777 | 0.35 | 56.48 | 8,078,001 | 2,287,839,420 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15,662 | 4,833,324 | 0.33 | 56.48 | 884,640 | 273,001,606 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 361 | 40,361,761 | 0.00 | 56.49 | 20,393 | 2,280,035,879 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39 | 4,817,662 | 0.00 | 56.49 | 2,203 | 272,149,726 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 456 | 40,361,400 | 0.00 | 56.55 | 25,788 | 2,282,558,254 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50 | 4,817,623 | 0.00 | 56.55 | 2,828 | 272,451,034 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 341,438 | 40,360,944 | 0.85 | 56.91 | 19,430,383 | 2,296,840,421 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37,392 | 4,817,573 | 0.78 | 56.91 | 2,127,885 | 274,156,035 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 95,280 | 40,019,506 | 0.24 | 55.84 | 5,320,673 | 2,234,789,264 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,434 | 4,780,181 | 0.22 | 55.84 | 582,661 | 266,937,257 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,335 | 39,924,226 | 0.01 | 55.87 | 186,336 | 2,230,686,279 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 365 | 4,769,747 | 0.01 | 55.87 | 20,394 | 266,500,074 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,289 | 39,920,891 | 0.02 | 56.12 | 352,915 | 2,240,208,704 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 689 | 4,769,382 | 0.01 | 56.12 | 38,664 | 267,639,594 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 26,381 | 39,914,602 | 0.07 | 56.13 | 1,480,758 | 2,240,394,636 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,889 | 4,768,693 | 0.06 | 56.13 | 162,159 | 267,665,307 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 289,278 | 39,888,221 | 0.73 | 56.26 | 16,274,202 | 2,244,031,537 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31,679 | 4,765,804 | 0.67 | 56.26 | 1,782,197 | 268,114,601 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,884 | 39,598,943 | 0.01 | 51.83 | 149,479 | 2,052,425,095 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 316 | 4,734,125 | 0.01 | 51.83 | 16,378 | 245,371,119 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,434 | 39,596,059 | 0.01 | 53.33 | 129,815 | 2,111,812,251 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 266 | 4,733,809 | 0.01 | 53.33 | 14,187 | 252,472,496 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32,717 | 39,593,625 | 0.08 | 53.66 | 1,755,578 | 2,124,574,121 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,583 | 4,733,543 | 0.08 | 53.66 | 192,262 | 253,999,551 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40,332 | 39,560,908 | 0.10 | 54.37 | 2,192,976 | 2,151,049,207 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,417 | 4,729,960 | 0.09 | 54.37 | 240,166 | 257,182,588 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 924 | 39,520,576 | 0.00 | 54.51 | 50,365 | 2,154,183,605 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4,725,543 | 0.00 | 54.51 | 5,505 | 257,579,425 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,803 | 39,519,652 | 0.00 | 54.61 | 98,455 | 2,158,021,973 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 197 | 4,725,442 | 0.00 | 54.61 | 10,757 | 258,038,903 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 85,353 | 39,517,849 | 0.22 | 54.93 | 4,688,039 | 2,170,529,712 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,347 | 4,725,245 | 0.20 | 54.93 | 513,387 | 259,535,499 | |
| 2016-10-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2,928,596 | 9,309,333 | 45.90 | 2.00 | 5,857,192 | 18,618,666 | |
| 2016-10-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 321,404 | 1,003,781 | 47.10 | 2.00 | 642,808 | 2,007,562 | |
| 2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,299 | 111,010 | 8.08 | 2.56 | 21,245 | 284,186 | |
| 2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,299 | 111,010 | 8.08 | 2.56 | 21,245 | 284,186 | |
| 2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,299 | 111,010 | 8.08 | 2.56 | 21,245 | 284,186 | |
| 2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 992,993 | 0.02 | 94.29 | 18,952 | 93,629,310 | |
| 2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 992,993 | 0.02 | 94.29 | 18,952 | 93,629,310 | |
| 2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 533,720 | 0.04 | 94.29 | 18,952 | 50,324,459 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1,362,695 | 0.05 | 28.92 | 19,955 | 39,409,139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1,362,695 | 0.05 | 28.92 | 19,955 | 39,409,139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1,362,695 | 0.05 | 28.92 | 19,955 | 39,409,139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1,362,695 | 0.05 | 28.92 | 19,955 | 39,409,139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1,362,695 | 0.05 | 28.92 | 19,955 | 39,409,139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 319,313 | 0.22 | 28.92 | 19,955 | 9,234,532 | |
| 2016-09-21 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 12,550 | 1,131,625 | 1.12 | 13.15 | 165,029 | 14,880,529 | |
| 2016-09-21 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,476,348 | 9,404,467 | 35.74 | 12.25 | 30,335,263 | 115,204,721 | |
| 2016-09-21 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 294,707 | 1,119,075 | 35.75 | 12.25 | 3,610,161 | 13,708,669 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24,339 | 39,432,496 | 0.06 | 51.55 | 1,254,571 | 2,032,575,609 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,730 | 4,715,898 | 0.06 | 51.55 | 140,720 | 243,084,264 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 58,541 | 39,408,157 | 0.15 | 51.41 | 3,009,341 | 2,025,803,896 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,565 | 4,713,168 | 0.14 | 51.41 | 337,478 | 242,283,700 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 899 | 39,349,616 | 0.00 | 50.64 | 45,523 | 1,992,546,505 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4,706,603 | 0.00 | 50.64 | 5,114 | 238,328,256 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,804 | 39,348,717 | 0.06 | 50.42 | 1,099,388 | 1,984,017,399 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,445 | 4,706,502 | 0.05 | 50.42 | 123,280 | 237,308,420 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,290 | 39,326,913 | 0.05 | 50.41 | 1,073,191 | 1,982,398,896 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,388 | 4,704,057 | 0.05 | 50.41 | 120,375 | 237,123,046 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90 | 39,305,623 | 0.00 | 50.00 | 4,500 | 1,965,281,150 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10 | 4,701,669 | 0.00 | 50.00 | 500 | 235,083,450 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 899 | 39,305,533 | 0.00 | 49.84 | 44,802 | 1,958,791,237 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4,701,659 | 0.00 | 49.84 | 5,033 | 234,307,176 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,380 | 39,304,634 | 0.02 | 50.99 | 427,266 | 2,004,001,791 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 940 | 4,701,558 | 0.02 | 50.99 | 47,927 | 239,715,517 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,338 | 39,296,254 | 0.01 | 50.48 | 118,029 | 1,983,788,861 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 262 | 4,700,618 | 0.01 | 50.48 | 13,227 | 237,300,828 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33,241 | 39,293,916 | 0.08 | 51.25 | 1,703,751 | 2,013,990,018 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,728 | 4,700,356 | 0.08 | 51.25 | 191,077 | 240,914,397 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23,440 | 39,260,675 | 0.06 | 50.33 | 1,179,656 | 1,975,856,286 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,637 | 4,696,628 | 0.06 | 50.33 | 132,711 | 236,365,319 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 170,652 | 39,237,235 | 0.44 | 50.38 | 8,597,226 | 1,976,720,891 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19,201 | 4,693,991 | 0.41 | 50.38 | 967,321 | 236,477,164 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7,944 | 39,066,583 | 0.02 | 51.05 | 405,541 | 1,994,349,062 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 894 | 4,674,790 | 0.02 | 51.05 | 45,639 | 238,648,030 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 28,271 | 39,058,639 | 0.07 | 50.55 | 1,428,963 | 1,974,226,720 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,181 | 4,673,896 | 0.07 | 50.55 | 160,784 | 236,243,008 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33,893 | 39,030,368 | 0.09 | 50.48 | 1,710,844 | 1,970,167,110 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,813 | 4,670,715 | 0.08 | 50.48 | 192,472 | 235,767,418 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 48,036 | 38,996,475 | 0.12 | 50.10 | 2,406,829 | 1,953,906,681 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,405 | 4,666,902 | 0.12 | 50.10 | 270,816 | 233,833,725 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101,290 | 38,948,439 | 0.26 | 50.05 | 5,069,433 | 1,949,318,739 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,397 | 4,661,497 | 0.25 | 50.05 | 570,405 | 233,301,865 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,581 | 38,847,149 | 0.01 | 49.46 | 276,030 | 1,921,337,258 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 628 | 4,650,100 | 0.01 | 49.46 | 31,060 | 229,988,831 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 944 | 38,841,568 | 0.00 | 49.18 | 46,427 | 1,910,267,156 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 106 | 4,649,472 | 0.00 | 49.18 | 5,213 | 228,665,682 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,825 | 38,840,624 | 0.04 | 48.61 | 672,033 | 1,888,042,733 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,556 | 4,649,366 | 0.03 | 48.61 | 75,637 | 226,005,681 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 12,955 | 38,826,799 | 0.03 | 48.95 | 634,191 | 1,900,703,822 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,457 | 4,647,810 | 0.03 | 48.95 | 71,325 | 227,526,102 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 548 | 38,813,844 | 0.00 | 47.27 | 25,904 | 1,834,718,762 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 62 | 4,646,353 | 0.00 | 47.27 | 2,931 | 219,631,712 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,681 | 38,813,296 | 0.03 | 48.16 | 562,550 | 1,869,225,047 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,314 | 4,646,291 | 0.03 | 48.16 | 63,281 | 223,762,587 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,598 | 38,801,615 | 0.02 | 48.44 | 416,460 | 1,879,426,065 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 967 | 4,644,977 | 0.02 | 48.44 | 46,838 | 224,987,822 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,930 | 38,793,017 | 0.02 | 48.29 | 286,332 | 1,873,132,464 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 667 | 4,644,010 | 0.01 | 48.29 | 32,206 | 224,237,416 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 84,331 | 4,643,343 | 1.85 | 46.17 | 3,893,638 | 214,387,325 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,600 | 4,559,012 | 0.08 | 45.10 | 162,369 | 205,623,295 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 35,263 | 4,555,412 | 0.78 | 45.39 | 1,600,457 | 206,753,296 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,360 | 4,520,149 | 0.19 | 46.10 | 385,414 | 208,388,813 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,735 | 4,511,789 | 0.06 | 44.98 | 123,025 | 202,948,842 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,074 | 4,509,054 | 0.20 | 45.80 | 415,623 | 206,531,357 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -850 | 9,418,390 | -0.01 | 4.29 | -3,645 | 40,392,649 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -140 | 1,551,387 | -0.01 | 4.29 | -600 | 6,653,433 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -343,583 | 9,419,240 | -3.52 | 4.83 | -1,658,681 | 45,472,323 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -56,417 | 1,551,527 | -3.51 | 4.83 | -272,359 | 7,490,152 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -296,856 | 9,762,823 | -2.95 | 5.25 | -1,559,711 | 51,294,848 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -48,744 | 1,607,944 | -2.94 | 5.25 | -256,106 | 8,448,299 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -2,834,561 | 10,059,679 | -21.98 | 5.00 | -14,172,805 | 50,298,395 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -465,439 | 1,656,688 | -21.93 | 5.00 | -2,327,195 | 8,283,440 | |
| 2016-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 89,896 | 11,348,958 | 0.80 | 27.02 | 2,428,621 | 306,602,314 | |
| 2016-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10,104 | 1,758,289 | 0.58 | 27.02 | 272,969 | 47,501,760 | |
| 2016-08-12 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,169,877 | 22,337,275 | 5.53 | 33.00 | 38,605,941 | 737,130,075 | |
| 2016-08-12 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 133,153 | 3,029,953 | 4.60 | 33.00 | 4,394,049 | 99,988,449 | |
| 2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,038 | 102,711 | 14.54 | 1.63 | 21,252 | 167,419 | |
| 2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,038 | 102,711 | 14.54 | 1.63 | 21,252 | 167,419 | |
| 2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13,038 | 102,711 | 14.54 | 1.63 | 21,252 | 167,419 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 13,937,394 | 0.01 | 26.74 | 19,948 | 372,685,916 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 13,937,394 | 0.01 | 26.74 | 19,948 | 372,685,916 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 1,362,005 | 0.05 | 26.74 | 19,948 | 36,420,014 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 1,362,005 | 0.05 | 26.74 | 19,948 | 36,420,014 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 318,623 | 0.23 | 26.74 | 19,948 | 8,519,979 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 318,623 | 0.23 | 26.74 | 19,948 | 8,519,979 | |
| 2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 23,803,844 | 0.00 | 79.98 | 18,955 | 1,903,831,443 | |
| 2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 533,519 | 0.04 | 79.98 | 18,955 | 42,670,850 | |
| 2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 533,519 | 0.04 | 79.98 | 18,955 | 42,670,850 | |
| 2016-06-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70,000 | 70,000 | |||||
| 2016-06-13 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 26,500 | 26,500 | |||||
| 2016-06-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20,000 | 20,000 | |||||
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -2,318 | 30,003 | -7.17 | 9.56 | -22,157 | 286,787 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -158,684 | 2,122,417 | -6.96 | 9.56 | -1,516,797 | 20,287,335 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -9,056 | 116,778 | -7.20 | 9.56 | -86,563 | 1,116,234 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -5,111 | 32,321 | -13.65 | 9.40 | -48,043 | 303,817 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -349,919 | 2,281,101 | -13.30 | 9.40 | -3,289,239 | 21,442,349 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -19,970 | 125,834 | -13.70 | 9.40 | -187,718 | 1,182,840 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -2,154 | 37,432 | -5.44 | 9.21 | -19,844 | 344,839 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -147,529 | 2,631,020 | -5.31 | 9.21 | -1,359,096 | 24,238,009 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -8,417 | 145,804 | -5.46 | 9.21 | -77,541 | 1,343,205 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -4,201 | 39,586 | -9.59 | 9.44 | -39,648 | 373,605 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -275,506 | 2,778,549 | -9.02 | 9.44 | -2,600,171 | 26,223,390 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -16,493 | 154,221 | -9.66 | 9.44 | -155,658 | 1,455,507 | |
| 2016-05-31 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 38,787,087 | 0.01 | 38.82 | 143,634 | 1,505,714,717 | |
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 38,787,087 | 0.01 | 38.82 | 143,634 | 1,505,714,717 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 13,932,918 | 0.06 | 10.73 | 88,522 | 149,500,210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 13,932,918 | 0.06 | 10.73 | 88,522 | 149,500,210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 13,932,918 | 0.06 | 10.73 | 88,522 | 149,500,210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 13,932,918 | 0.06 | 10.73 | 88,522 | 149,500,210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 13,932,918 | 0.06 | 10.73 | 88,522 | 149,500,210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8,250 | 0 | -100.00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8,250 | 317,877 | 2.66 | 10.73 | 88,522 | 3,410,820 | |
| 2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 2,294 | 2,294 | |||||
| 2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 835 | 6,104,562 | 0.01 | ||||
| 2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 835 | 6,104,562 | 0.01 | ||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Series B Preferred Stock |
C - Conversion | -1,232,130 | 0 | -100.00 | ||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Series B Preferred Stock |
C - Conversion | -101,204 | 0 | -100.00 | ||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
P - Purchase | 179,531 | 976,214 | 22.53 | 18.00 | 3,231,558 | 17,571,852 | |
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
P - Purchase | 20,469 | 85,906 | 31.28 | 18.00 | 368,442 | 1,546,308 | |
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
C - Conversion | 796,683 | 796,683 | |||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
C - Conversion | 65,437 | 65,437 | |||||
| 2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10,788 | 7,110,113 | 0.15 | 1.97 | 21,252 | 14,006,923 | |
| 2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10,788 | 89,673 | 13.68 | 1.97 | 21,252 | 176,656 | |
| 2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10,788 | 89,673 | 13.68 | 1.97 | 21,252 | 176,656 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13,883,418 | 0.01 | 25.48 | 19,976 | 353,749,491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13,883,418 | 0.01 | 25.48 | 19,976 | 353,749,491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13,883,418 | 0.01 | 25.48 | 19,976 | 353,749,491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13,883,418 | 0.01 | 25.48 | 19,976 | 353,749,491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 309,627 | 0.25 | 25.48 | 19,976 | 7,889,296 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 309,627 | 0.25 | 25.48 | 19,976 | 7,889,296 | |
| 2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533,282 | 0.05 | 72.47 | 18,987 | 38,646,947 | |
| 2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533,282 | 0.05 | 72.47 | 18,987 | 38,646,947 | |
| 2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533,282 | 0.05 | 72.47 | 18,987 | 38,646,947 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 137 | 3,268,830 | 0.00 | 6.74 | 923 | 22,031,914 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -3,479 | 0 | -100.00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -310,003 | 0 | -100.00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -137 | 0 | -100.00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -137 | 0 | -100.00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 3,479 | 43,787 | 8.63 | 6.74 | 23,448 | 295,124 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 310,003 | 3,054,055 | 11.30 | 6.74 | 2,089,420 | 20,584,331 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 137 | 137 | 6.74 | 923 | 923 | ||
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 262,253 | 21,167,398 | 1.25 | 28.55 | 7,486,904 | 604,295,345 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28,647 | 2,896,800 | 1.00 | 28.55 | 817,826 | 82,699,005 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 10,818 | 20,905,145 | 0.05 | 27.82 | 300,959 | 581,585,315 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,182 | 2,868,153 | 0.04 | 27.82 | 32,883 | 79,792,590 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 318,969 | 20,894,327 | 1.55 | 27.72 | 8,840,959 | 579,134,330 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 34,844 | 2,866,971 | 1.23 | 27.72 | 965,782 | 79,464,695 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 60,587 | 20,575,358 | 0.30 | 27.56 | 1,669,705 | 567,032,176 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 6,618 | 2,832,127 | 0.23 | 27.56 | 182,384 | 78,050,022 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28,433 | 20,514,771 | 0.14 | 26.55 | 755,024 | 544,759,487 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,106 | 2,825,509 | 0.11 | 26.55 | 82,478 | 75,029,979 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 180,122 | 20,486,338 | 0.89 | 26.49 | 4,772,224 | 542,773,234 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 19,676 | 2,822,403 | 0.70 | 26.49 | 521,304 | 74,777,874 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 13,433 | 20,306,216 | 0.07 | 26.28 | 353,086 | 533,748,888 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,467 | 2,802,727 | 0.05 | 26.28 | 38,560 | 73,669,679 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 14,775 | 20,292,783 | 0.07 | 25.61 | 378,343 | 519,637,294 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,614 | 2,801,260 | 0.06 | 25.61 | 41,330 | 71,731,865 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 16,057 | 2,799,646 | 0.58 | 26.35 | 423,057 | 73,762,833 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 37,882 | 2,783,589 | 1.38 | 25.98 | 983,985 | 72,303,724 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 408,607 | 2,745,707 | 17.48 | 25.92 | 10,593,014 | 71,181,630 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 92,140 | 38,783,387 | 0.24 | 31.73 | 2,923,547 | 1,230,573,599 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,034 | 4,496,280 | 0.22 | 31.73 | 318,373 | 142,664,267 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19,741 | 38,691,247 | 0.05 | 32.41 | 639,713 | 1,253,801,466 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,150 | 4,486,246 | 0.05 | 32.41 | 69,671 | 145,378,148 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 206,421,153 | 0.01 | 3.86 | 77,200 | 796,785,651 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 90,179 | 19,757,285 | 0.46 | 62.59 | 5,644,024 | 1,236,547,221 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9,821 | 3,358,951 | 0.29 | 62.59 | 614,666 | 210,226,330 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 127,964 | 19,667,106 | 0.65 | 61.38 | 7,854,149 | 1,207,123,699 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 13,936 | 3,349,130 | 0.42 | 61.38 | 855,361 | 205,562,231 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 24,431 | 19,539,142 | 0.13 | 61.03 | 1,490,975 | 1,192,434,758 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,660 | 3,335,194 | 0.08 | 61.03 | 162,334 | 203,540,219 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 20,659 | 19,514,711 | 0.11 | 60.95 | 1,259,178 | 1,189,433,344 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,250 | 3,332,534 | 0.07 | 60.95 | 137,139 | 203,119,947 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 97,484 | 19,494,052 | 0.50 | 60.85 | 5,931,960 | 1,186,224,761 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 10,616 | 3,330,284 | 0.32 | 60.85 | 645,990 | 202,649,780 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 533,020 | 3.90 | 3.86 | 77,200 | 2,057,457 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 533,020 | 3.90 | 3.86 | 77,200 | 2,057,457 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1,182 | 19,376,568 | 0.01 | 65.29 | 77,176 | 1,265,142,628 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 129 | 3,299,668 | 0.00 | 65.29 | 8,423 | 215,443,243 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 179,176 | 19,375,386 | 0.93 | 65.80 | 11,789,387 | 1,274,857,773 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19,513 | 3,299,539 | 0.59 | 65.80 | 1,283,912 | 217,102,407 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 180,358 | 19,196,210 | 0.95 | 67.15 | 12,110,607 | 1,288,979,431 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19,642 | 3,280,026 | 0.60 | 67.15 | 1,318,913 | 220,245,874 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 198,484 | 38,671,506 | 0.52 | 31.60 | 6,272,531 | 1,222,104,667 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,616 | 4,484,096 | 0.48 | 31.60 | 683,113 | 141,707,299 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32,810 | 38,473,022 | 0.09 | 31.86 | 1,045,205 | 1,225,608,131 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,573 | 4,462,480 | 0.08 | 31.86 | 113,823 | 142,158,102 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,627 | 38,440,212 | 0.02 | 31.50 | 271,712 | 1,210,693,697 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 940 | 4,458,907 | 0.02 | 31.50 | 29,606 | 140,435,505 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 273,381 | 38,431,585 | 0.72 | 31.89 | 8,719,077 | 1,225,717,756 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29,772 | 4,457,967 | 0.67 | 31.89 | 949,533 | 142,180,171 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 145,272 | 38,158,204 | 0.38 | 31.74 | 4,611,296 | 1,211,236,790 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15,821 | 4,428,195 | 0.36 | 31.74 | 502,198 | 140,561,980 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 63,560 | 38,012,932 | 0.17 | 31.50 | 2,002,401 | 1,197,563,211 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,922 | 4,412,374 | 0.16 | 31.50 | 218,071 | 139,007,872 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 387,336 | 37,949,372 | 1.03 | 32.31 | 12,514,051 | 1,226,068,311 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42,182 | 4,405,452 | 0.97 | 32.31 | 1,362,816 | 142,331,343 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 107,260 | 37,562,036 | 0.29 | 33.77 | 3,622,063 | 1,268,432,394 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,681 | 4,363,270 | 0.27 | 33.77 | 394,456 | 147,343,265 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 128,975 | 6,928,119 | 1.90 | 8.16 | 1,051,920 | 56,505,739 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 14,046 | 824,368 | 1.73 | 8.16 | 114,559 | 6,723,545 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 185,413 | 6,799,144 | 2.80 | 7.91 | 1,466,320 | 53,770,350 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 20,192 | 810,322 | 2.56 | 7.91 | 159,686 | 6,408,351 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 11,840 | 6,613,731 | 0.18 | 7.70 | 91,160 | 50,921,099 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,289 | 790,130 | 0.16 | 7.70 | 9,924 | 6,083,448 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 68,132 | 6,601,891 | 1.04 | 8.03 | 546,807 | 52,984,797 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 7,420 | 788,841 | 0.95 | 8.03 | 59,551 | 6,331,001 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 30,986 | 6,533,759 | 0.48 | 7.88 | 244,126 | 51,476,874 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,374 | 781,421 | 0.43 | 7.88 | 26,582 | 6,156,503 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,874 | 37,454,776 | 0.01 | 32.34 | 157,646 | 1,211,448,511 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 547 | 4,351,589 | 0.01 | 32.34 | 17,692 | 140,749,100 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 147,831 | 37,449,902 | 0.40 | 33.15 | 4,900,997 | 1,241,565,366 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16,608 | 4,351,042 | 0.38 | 33.15 | 550,600 | 144,248,790 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23,289 | 37,302,071 | 0.06 | 32.96 | 767,582 | 1,229,438,958 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,616 | 4,334,434 | 0.06 | 32.96 | 86,221 | 142,858,610 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 95,682 | 37,278,782 | 0.26 | 32.41 | 3,100,652 | 1,208,048,754 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,749 | 4,331,818 | 0.25 | 32.41 | 348,330 | 140,376,028 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 165,237 | 37,183,100 | 0.45 | 32.30 | 5,337,915 | 1,201,185,172 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18,563 | 4,321,069 | 0.43 | 32.30 | 599,670 | 139,590,406 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 36,589 | 37,017,863 | 0.10 | 31.15 | 1,139,842 | 1,153,202,679 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,111 | 4,302,506 | 0.10 | 31.15 | 128,068 | 134,034,248 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 97,272 | 36,981,274 | 0.26 | 32.12 | 3,124,484 | 1,187,879,200 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,927 | 4,298,395 | 0.25 | 32.12 | 350,987 | 138,069,176 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 53,734 | 36,884,002 | 0.15 | 32.47 | 1,744,598 | 1,197,523,958 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,037 | 4,287,468 | 0.14 | 32.47 | 196,005 | 139,202,510 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 286,671,473 | 0.00 | 4.18 | 41,800 | 1,198,286,757 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 88,732 | 36,830,268 | 0.24 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,968 | 4,281,431 | 0.23 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 48,996 | 36,741,536 | 0.13 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,504 | 4,271,463 | 0.13 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 36,692,540 | 0.03 | 4.18 | 41,800 | 153,374,817 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14,157 | 36,682,540 | 0.04 | 33.72 | 477,445 | 1,237,118,662 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,590 | 4,255,959 | 0.04 | 33.72 | 53,623 | 143,532,217 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40,921 | 36,668,383 | 0.11 | 33.68 | 1,378,043 | 1,234,833,465 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,597 | 4,254,369 | 0.11 | 33.68 | 154,807 | 143,268,854 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 218,550 | 36,627,462 | 0.60 | 32.49 | 7,101,280 | 1,190,125,135 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23,908 | 4,249,772 | 0.57 | 32.49 | 776,835 | 138,086,567 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 41,104 | 36,408,912 | 0.11 | 31.68 | 1,302,257 | 1,153,507,150 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,496 | 4,225,864 | 0.11 | 31.68 | 142,442 | 133,883,823 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59,492 | 36,367,808 | 0.16 | 32.24 | 1,918,022 | 1,172,498,130 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,508 | 4,221,368 | 0.15 | 32.24 | 209,818 | 136,096,904 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 301,066 | 36,308,316 | 0.84 | 32.76 | 9,862,139 | 1,189,366,031 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32,934 | 4,214,860 | 0.79 | 32.76 | 1,078,832 | 138,067,855 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,814 | 36,007,250 | 0.06 | 31.24 | 681,563 | 1,125,021,321 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,386 | 4,181,926 | 0.06 | 31.24 | 74,549 | 130,661,351 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 172,462 | 35,985,436 | 0.48 | 30.34 | 5,232,928 | 1,091,888,092 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18,866 | 4,179,540 | 0.45 | 30.34 | 572,442 | 126,817,692 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 54,439 | 35,812,974 | 0.15 | 30.55 | 1,663,024 | 1,094,029,055 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,955 | 4,160,674 | 0.14 | 30.55 | 181,916 | 127,101,934 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6,022 | 19,015,852 | 0.03 | 74.00 | 445,628 | 1,407,173,048 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 678 | 3,260,384 | 0.02 | 74.00 | 50,172 | 241,268,416 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 20,492 | 19,009,830 | 0.11 | 69.70 | 1,428,282 | 1,324,975,646 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,308 | 3,259,706 | 0.07 | 69.70 | 160,866 | 227,199,878 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 23,157 | 18,989,338 | 0.12 | 70.50 | 1,632,684 | 1,338,843,276 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2,608 | 3,257,398 | 0.08 | 70.50 | 183,877 | 229,662,846 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8,111 | 18,966,181 | 0.04 | 71.96 | 583,702 | 1,364,886,043 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 914 | 3,254,790 | 0.03 | 71.96 | 65,775 | 234,228,359 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39,815 | 35,758,535 | 0.11 | 30.13 | 1,199,793 | 1,077,554,845 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,485 | 4,154,719 | 0.11 | 30.13 | 135,152 | 125,199,133 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 128,255 | 35,718,720 | 0.36 | 29.86 | 3,830,118 | 1,066,678,851 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14,447 | 4,150,234 | 0.35 | 29.86 | 431,435 | 123,939,683 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 67,407 | 35,590,465 | 0.19 | 28.52 | 1,922,670 | 1,015,157,510 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7,593 | 4,135,787 | 0.18 | 28.52 | 216,577 | 117,966,293 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,134 | 35,523,058 | 0.01 | 28.46 | 117,674 | 1,011,163,846 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 466 | 4,128,194 | 0.01 | 28.46 | 13,265 | 117,509,042 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43,056 | 35,518,924 | 0.12 | 29.77 | 1,281,975 | 1,057,561,755 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,850 | 4,127,728 | 0.12 | 29.77 | 144,407 | 122,901,450 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 218,768 | 35,475,868 | 0.62 | 30.21 | 6,610,053 | 1,071,899,804 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24,643 | 4,122,878 | 0.60 | 30.21 | 744,586 | 124,572,346 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 456,849 | 35,257,100 | 1.31 | 29.20 | 13,339,991 | 1,029,507,320 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49,677 | 4,098,235 | 1.23 | 29.20 | 1,450,568 | 119,668,462 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 226,865 | 34,800,251 | 0.66 | 29.94 | 6,791,816 | 1,041,839,474 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24,669 | 4,048,558 | 0.61 | 29.94 | 738,533 | 121,204,515 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 726,291 | 34,573,386 | 2.15 | 31.25 | 22,694,197 | 1,080,304,220 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 78,976 | 4,023,889 | 2.00 | 31.25 | 2,467,739 | 125,733,252 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 902 | 33,847,095 | 0.00 | 29.50 | 26,609 | 998,489,302 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98 | 3,944,913 | 0.00 | 29.50 | 2,891 | 116,374,934 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 106,444 | 33,846,193 | 0.32 | 29.19 | 3,107,590 | 988,126,066 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,575 | 3,944,815 | 0.29 | 29.19 | 337,927 | 115,167,296 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 151,144 | 33,739,749 | 0.45 | 30.27 | 4,574,645 | 1,021,194,235 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16,435 | 3,933,240 | 0.42 | 30.27 | 497,435 | 119,046,588 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 631 | 33,588,605 | 0.00 | 27.93 | 17,626 | 938,227,145 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 69 | 3,916,805 | 0.00 | 27.93 | 1,927 | 109,407,722 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72,073 | 33,587,974 | 0.22 | 27.28 | 1,966,043 | 916,229,549 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7,909 | 3,916,736 | 0.20 | 27.28 | 215,746 | 106,842,683 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 87,049 | 33,515,901 | 0.26 | 28.07 | 2,443,831 | 940,932,108 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,551 | 3,908,827 | 0.24 | 28.07 | 268,137 | 109,737,191 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 15,187 | 18,958,070 | 0.08 | 69.45 | 1,054,742 | 1,316,643,649 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1,651 | 3,253,876 | 0.05 | 69.45 | 114,662 | 225,982,664 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8,250 | 18,942,883 | 0.04 | 70.86 | 584,597 | 1,342,296,478 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 897 | 3,252,225 | 0.03 | 70.86 | 63,562 | 230,453,314 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 67,373 | 18,934,633 | 0.36 | 69.54 | 4,684,923 | 1,316,659,468 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,326 | 3,251,328 | 0.23 | 69.54 | 509,429 | 226,087,920 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 124,057 | 18,867,260 | 0.66 | 70.21 | 8,710,228 | 1,324,698,625 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 13,490 | 3,244,002 | 0.42 | 70.21 | 947,153 | 227,766,246 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 397,079 | 18,743,203 | 2.16 | 71.10 | 28,233,945 | 1,332,718,580 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 43,178 | 3,230,512 | 1.35 | 71.10 | 3,070,133 | 229,702,648 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 149,927 | 18,346,124 | 0.82 | 67.94 | 10,186,595 | 1,246,503,545 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 16,450 | 3,187,334 | 0.52 | 67.94 | 1,117,674 | 216,559,265 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 38,117 | 18,196,197 | 0.21 | 63.98 | 2,438,547 | 1,164,107,162 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 4,183 | 3,170,884 | 0.13 | 63.98 | 267,609 | 202,858,255 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 168,055 | 18,158,080 | 0.93 | 64.87 | 10,902,350 | 1,177,981,834 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 18,441 | 3,166,701 | 0.59 | 64.87 | 1,196,336 | 205,435,611 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 541,340 | 17,990,025 | 3.10 | 65.80 | 35,621,958 | 1,183,803,012 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 59,401 | 3,148,260 | 1.92 | 65.80 | 3,908,782 | 207,165,897 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 49,021 | 17,448,685 | 0.28 | 66.68 | 3,268,823 | 1,163,514,958 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5,379 | 3,088,859 | 0.17 | 66.68 | 358,683 | 205,971,605 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 72,894 | 17,399,664 | 0.42 | 67.68 | 4,933,706 | 1,177,666,678 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,999 | 3,083,480 | 0.26 | 67.68 | 541,399 | 208,700,102 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6,939 | 17,326,770 | 0.04 | 60.85 | 422,220 | 1,054,288,905 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 761 | 3,075,481 | 0.02 | 60.85 | 46,305 | 187,135,023 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 57,865 | 17,319,831 | 0.34 | 61.73 | 3,572,047 | 1,069,165,292 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6,349 | 3,074,720 | 0.21 | 61.73 | 391,928 | 189,804,618 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 136,793 | 17,261,966 | 0.80 | 58.13 | 7,952,133 | 1,003,482,965 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 15,010 | 3,068,371 | 0.49 | 58.13 | 872,570 | 178,372,384 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 114,908 | 17,125,173 | 0.68 | 59.01 | 6,780,526 | 1,010,527,346 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12,609 | 3,053,361 | 0.41 | 59.01 | 744,036 | 180,173,642 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 65,309 | 17,010,265 | 0.39 | 60.40 | 3,944,513 | 1,027,380,882 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7,166 | 3,040,752 | 0.24 | 60.40 | 432,810 | 183,654,427 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 113,546 | 16,944,956 | 0.67 | 61.40 | 6,971,475 | 1,040,383,019 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12,459 | 3,033,586 | 0.41 | 61.40 | 764,955 | 186,255,507 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 289,755 | 16,831,410 | 1.75 | 62.56 | 18,126,986 | 1,052,967,960 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 31,795 | 3,021,127 | 1.06 | 62.56 | 1,989,086 | 189,000,799 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 176,647 | 16,541,655 | 1.08 | 63.37 | 11,194,368 | 1,048,267,836 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19,383 | 2,989,332 | 0.65 | 63.37 | 1,228,328 | 189,438,154 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 235,734 | 16,365,008 | 1.46 | 64.46 | 15,195,814 | 1,054,916,236 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 25,869 | 2,969,949 | 0.88 | 64.46 | 1,667,560 | 191,447,961 | |
| 2016-02-09 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 45,000 | 12,894,240 | 0.35 | 6.33 | 284,656 | 81,565,094 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -56,853 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -2,296,890 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -238,850 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A-2 Preferred shares |
C - Conversion | -26,292,961 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A-2 Preferred shares |
C - Conversion | -1,912,167 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -582,747 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -44,572,171 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -4,382,118 | 0 | -100.00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1,723,306 | 1,723,306 | 24.00 | 41,359,344 | 41,359,344 | ||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 189,374 | 189,374 | 24.00 | 4,544,976 | 4,544,976 | ||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 56,853 | 639,600 | 9.76 | 0.68 | 38,376 | 431,730 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 2,296,890 | 73,162,022 | 3.24 | 0.68 | 1,550,401 | 49,384,365 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 238,850 | 6,533,135 | 3.79 | 0.68 | 161,224 | 4,409,866 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 26,292,961 | 70,865,132 | 58.99 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 1,912,167 | 6,294,285 | 43.64 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 582,747 | 582,747 | |||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 44,572,171 | 44,572,171 | |||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 4,382,118 | 4,382,118 | |||||
| 2016-02-04 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24,800 | 12,849,240 | 0.19 | 6.65 | 164,915 | 85,444,876 | |
| 2016-02-04 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 91,187 | 12,824,440 | 0.72 | 6.29 | 573,311 | 80,629,819 | |
| 2016-02-04 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 91,728 | 12,733,253 | 0.73 | 6.52 | 598,360 | 83,061,556 | |
| 2016-01-29 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25,000 | 12,641,525 | 0.20 | 6.88 | 172,015 | 86,981,277 | |
| 2016-01-29 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 63,345 | 12,616,525 | 0.50 | 6.98 | 441,971 | 88,028,018 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,581 | 6,502,773 | 0.06 | 11.00 | 39,377 | 71,504,492 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 395 | 778,047 | 0.05 | 11.00 | 4,343 | 8,555,405 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 66,345 | 6,499,192 | 1.03 | 10.80 | 716,745 | 70,212,721 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 7,318 | 777,652 | 0.95 | 10.80 | 79,059 | 8,401,208 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,522 | 6,432,847 | 0.04 | 11.20 | 28,257 | 72,075,548 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 278 | 770,334 | 0.04 | 11.20 | 3,115 | 8,631,053 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4,503 | 6,430,325 | 0.07 | 10.98 | 49,423 | 70,576,032 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 497 | 770,056 | 0.06 | 10.98 | 5,455 | 8,451,750 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,833 | 6,425,822 | 0.04 | 11.23 | 31,822 | 72,178,688 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 312 | 769,559 | 0.04 | 11.23 | 3,505 | 8,644,148 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 25,650 | 6,422,989 | 0.40 | 10.69 | 274,219 | 68,666,891 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,810 | 769,247 | 0.37 | 10.69 | 30,041 | 8,223,866 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 156 | 6,397,339 | 0.00 | 10.60 | 1,654 | 67,811,793 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 17 | 766,437 | 0.00 | 10.60 | 180 | 8,124,232 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4,021 | 6,397,183 | 0.06 | 10.69 | 42,999 | 68,409,556 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 440 | 766,420 | 0.06 | 10.69 | 4,705 | 8,195,866 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 17,221 | 6,393,162 | 0.27 | 10.78 | 185,666 | 68,927,237 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,887 | 765,980 | 0.25 | 10.78 | 20,345 | 8,258,337 | |
| 2016-01-25 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3,200 | 12,553,180 | 0.03 | 7.00 | 22,389 | 87,829,579 | |
| 2016-01-25 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 103,600 | 12,549,980 | 0.83 | 7.29 | 755,368 | 91,504,414 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,734 | 6,375,941 | 0.03 | 8.90 | 15,433 | 56,745,875 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 190 | 764,093 | 0.02 | 8.90 | 1,691 | 6,800,428 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 27,996 | 6,374,207 | 0.44 | 8.96 | 250,766 | 57,095,047 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,067 | 763,903 | 0.40 | 8.96 | 27,472 | 6,842,432 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 13,789 | 6,346,211 | 0.22 | 8.96 | 123,493 | 56,836,031 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,511 | 760,836 | 0.20 | 8.96 | 13,532 | 6,813,971 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 57,453 | 6,332,422 | 0.92 | 9.89 | 567,934 | 62,597,258 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 6,294 | 759,325 | 0.84 | 9.89 | 62,217 | 7,506,079 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 14,313 | 6,274,969 | 0.23 | 9.15 | 131,017 | 57,439,184 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,568 | 753,031 | 0.21 | 9.15 | 14,353 | 6,893,020 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 10,123 | 6,260,656 | 0.16 | 9.21 | 93,282 | 57,691,319 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,109 | 751,463 | 0.15 | 9.21 | 10,219 | 6,924,656 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 45,903 | 6,250,533 | 0.74 | 9.08 | 416,602 | 56,727,962 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,029 | 750,354 | 0.67 | 9.08 | 45,642 | 6,809,988 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Comon Stock |
P - Purchase | 1,325 | 12,446,380 | 0.01 | 6.94 | 9,197 | 86,396,547 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Comon Stock |
P - Purchase | 51,370 | 12,445,055 | 0.41 | 6.87 | 352,974 | 85,512,462 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 92,200 | 12,393,685 | 0.75 | 7.12 | 656,750 | 88,281,458 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25,000 | 12,301,485 | 0.20 | 7.49 | 187,332 | 92,178,718 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 175,000 | 12,276,485 | 1.45 | 7.45 | 1,303,890 | 91,469,634 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 47,193 | 6,204,630 | 0.77 | 8.56 | 403,930 | 53,106,049 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,196 | 745,325 | 0.70 | 8.56 | 44,473 | 6,379,311 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4,949 | 6,157,437 | 0.08 | 8.95 | 44,308 | 55,126,918 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 545 | 740,129 | 0.07 | 8.95 | 4,879 | 6,626,301 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,279 | 6,152,488 | 0.05 | 8.82 | 28,937 | 54,295,091 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 361 | 739,584 | 0.05 | 8.82 | 3,186 | 6,526,755 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 20,851 | 6,149,209 | 0.34 | 8.10 | 168,891 | 49,807,978 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,296 | 739,223 | 0.31 | 8.10 | 18,597 | 5,987,632 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,998 | 6,128,358 | 0.05 | 8.08 | 24,213 | 49,495,071 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 330 | 736,927 | 0.04 | 8.08 | 2,665 | 5,951,717 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 12,706 | 6,125,360 | 0.21 | 7.91 | 100,517 | 48,457,723 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,399 | 736,597 | 0.19 | 7.91 | 11,067 | 5,827,219 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 90,550 | 6,112,654 | 1.50 | 8.17 | 739,947 | 49,950,775 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9,970 | 735,198 | 1.37 | 8.17 | 81,472 | 6,007,817 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 47,193 | 6,204,630 | 0.77 | 8.56 | 403,930 | 53,106,049 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5,196 | 745,325 | 0.70 | 8.56 | 44,473 | 6,379,311 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4,949 | 6,157,437 | 0.08 | 8.95 | 44,308 | 55,126,918 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 545 | 740,129 | 0.07 | 8.95 | 4,879 | 6,626,301 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3,279 | 6,152,488 | 0.05 | 8.82 | 28,937 | 54,295,091 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 361 | 739,584 | 0.05 | 8.82 | 3,186 | 6,526,755 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 20,851 | 6,149,209 | 0.34 | 8.10 | 168,891 | 49,807,978 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,296 | 739,223 | 0.31 | 8.10 | 18,597 | 5,987,632 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,998 | 6,128,358 | 0.05 | 8.08 | 24,213 | 49,495,071 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 330 | 736,927 | 0.04 | 8.08 | 2,665 | 5,951,717 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 12,706 | 6,125,360 | 0.21 | 7.91 | 100,517 | 48,457,723 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1,399 | 736,597 | 0.19 | 7.91 | 11,067 | 5,827,219 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 90,550 | 6,112,654 | 1.50 | 8.17 | 739,947 | 49,950,775 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9,970 | 735,198 | 1.37 | 8.17 | 81,472 | 6,007,817 | |
| 2016-01-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,801,161 | 20,278,008 | 9.75 | 29.00 | 52,233,669 | 588,062,232 | |
| 2016-01-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 785,045 | 2,337,100 | 50.58 | 29.00 | 22,766,305 | 67,775,900 | |
| 2016-01-08 |
|
4/A | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,801,161 | 20,278,008 | 9.75 | 29.00 | 52,233,669 | 588,062,232 | |
| 2016-01-08 |
|
4/A | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 785,045 | 2,337,100 | 50.58 | 29.00 | 22,766,305 | 67,775,900 | |
| 2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7,082 | 78,885 | 9.86 | 3.00 | 21,246 | 236,655 | |
| 2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7,082 | 78,885 | 9.86 | 3.00 | 21,246 | 236,655 | |
| 2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7,082 | 6,348,612 | 0.11 | 3.00 | 21,246 | 19,045,836 | |
| 2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 513,020 | 0.03 | 108.45 | 18,979 | 55,637,019 | |
| 2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 513,020 | 0.03 | 108.45 | 18,979 | 55,637,019 | |
| 2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 666,111 | 0.03 | 108.45 | 18,979 | 72,239,738 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 308,843 | 0.18 | 35.20 | 19,994 | 10,871,274 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 308,843 | 0.18 | 35.20 | 19,994 | 10,871,274 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 482,740 | 0.12 | 35.20 | 19,994 | 16,992,448 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 11,423,179 | 0.00 | 35.20 | 19,994 | 402,095,901 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 196,132 | 0.29 | 35.20 | 19,994 | 6,903,846 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 356,791 | 0.16 | 35.20 | 19,994 | 12,559,043 | |
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5,284,918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9,241,559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4,936,111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5,284,918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9,241,559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4,936,111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5,284,918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9,241,559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4,936,111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5,284,918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9,241,559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4,936,111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5,284,918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9,241,559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4,936,111 | ||||||||
| 2015-12-15 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 150,000 | 33,428,852 | 0.45 | 44.00 | 6,600,000 | 1,470,869,488 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31,647 | 33,278,852 | 0.10 | 43.87 | 1,388,259 | 1,459,843,401 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57,461 | 33,247,205 | 0.17 | 43.93 | 2,524,015 | 1,460,406,753 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 75,612 | 33,189,744 | 0.23 | 43.93 | 3,321,363 | 1,457,905,971 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,000 | 33,114,132 | 0.01 | 43.00 | 172,000 | 1,423,907,676 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,638 | 33,110,132 | 0.03 | 43.84 | 466,321 | 1,451,395,880 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,400 | 33,099,494 | 0.03 | 44.00 | 413,600 | 1,456,377,736 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 800 | 33,090,094 | 0.00 | 43.00 | 34,400 | 1,422,874,042 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 407,800 | 33,089,294 | 1.25 | 43.71 | 17,823,388 | 1,446,207,301 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98,700 | 32,681,494 | 0.30 | 44.00 | 4,342,800 | 1,437,985,736 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 196,490 | 32,582,794 | 0.61 | 41.31 | 8,117,179 | 1,346,024,545 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 221,434 | 32,386,304 | 0.69 | 42.51 | 9,412,318 | 1,376,618,715 | |
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16,392,657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26,372,015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16,392,657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26,372,015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16,392,657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26,372,015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16,392,657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26,372,015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14,293,989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16,392,657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26,372,015 | ||||||||
| 2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,945 | 71,803 | 10.71 | 3.06 | 21,252 | 219,717 | |
| 2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,945 | 71,803 | 10.71 | 3.06 | 21,252 | 219,717 | |
| 2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,945 | 71,803 | 10.71 | 3.06 | 21,252 | 219,717 | |
| 2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 512,845 | 0.03 | 110.33 | 18,977 | 56,582,189 | |
| 2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 972,118 | 0.02 | 110.33 | 18,977 | 107,253,779 | |
| 2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 16,282,190 | 0.00 | 110.33 | 18,977 | 1,796,414,023 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 308,275 | 0.30 | 21.34 | 19,974 | 6,578,588 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 308,275 | 0.30 | 21.34 | 19,974 | 6,578,588 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 11,422,611 | 0.01 | 21.34 | 19,974 | 243,758,519 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 1,911,734 | 0.05 | 21.34 | 19,974 | 40,796,404 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 195,564 | 0.48 | 21.34 | 19,974 | 4,173,336 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 356,223 | 0.26 | 21.34 | 19,974 | 7,601,799 | |
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -892,000 | 0 | -100.00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -31,967,000 | 0 | -100.00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -7,587,000 | 0 | -100.00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -65,000 | 0 | -100.00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -64,000 | 0 | -100.00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 101,652 | 512,673 | 24.73 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 3,642,962 | 16,128,927 | 29.18 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 864,614 | 2,943,733 | 41.59 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 7,406 | 61,049 | 13.81 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 7,292 | 58,632 | 14.20 | ||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
J - Other | 137 | 137 | |||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
J - Other | 137 | 137 | |||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
J - Other | -274 | 0 | -100.00 | ||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 139,220 | 2,744,052 | 5.34 | 45.00 | 6,264,900 | 123,482,340 | |
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 10,780 | 170,714 | 6.74 | 45.00 | 485,100 | 7,682,130 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 346,000 | 32,164,870 | 1.09 | 48.44 | 16,761,728 | 1,558,204,612 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50,000 | 31,818,870 | 0.16 | 47.40 | 2,370,000 | 1,508,214,438 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 160,453 | 31,768,870 | 0.51 | 48.60 | 7,798,690 | 1,544,100,511 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33,320 | 31,608,417 | 0.11 | 47.98 | 1,598,614 | 1,516,495,987 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14,386 | 31,575,097 | 0.05 | 47.54 | 683,847 | 1,500,941,181 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,600 | 31,560,711 | 0.01 | 47.24 | 75,577 | 1,490,798,589 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20,500 | 31,559,111 | 0.06 | 46.31 | 949,351 | 1,461,496,119 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,950 | 31,538,611 | 0.01 | 44.68 | 87,130 | 1,409,201,909 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 89,843 | 31,536,661 | 0.29 | 45.28 | 4,067,696 | 1,427,841,249 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 212,983 | 31,446,818 | 0.68 | 46.81 | 9,969,500 | 1,471,990,959 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,818 | 31,233,835 | 0.03 | 46.74 | 458,905 | 1,459,906,929 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,331 | 31,224,017 | 0.01 | 45.63 | 106,368 | 1,424,814,344 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,513 | 31,221,686 | 0.01 | 45.43 | 159,601 | 1,418,448,028 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,897 | 31,218,173 | 0.04 | 45.00 | 625,359 | 1,404,805,298 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40,649 | 31,204,276 | 0.13 | 42.14 | 1,713,148 | 1,315,101,092 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,063 | 31,163,627 | 0.03 | 44.40 | 357,971 | 1,383,565,315 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15,391 | 31,155,564 | 0.05 | 40.67 | 625,950 | 1,267,093,672 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 191,321 | 31,140,173 | 0.62 | 41.06 | 7,856,214 | 1,278,708,924 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 88,640 | 30,948,852 | 0.29 | 42.44 | 3,761,802 | 1,313,441,425 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 183,073 | 30,860,212 | 0.60 | 43.28 | 7,923,253 | 1,335,605,287 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 274,814 | 30,677,139 | 0.90 | 44.63 | 12,265,553 | 1,369,188,203 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,100 | 30,402,325 | 0.01 | 40.55 | 125,706 | 1,232,823,399 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,300 | 30,399,225 | 0.04 | 41.13 | 464,823 | 1,250,466,041 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43,612 | 30,387,925 | 0.14 | 43.60 | 1,901,322 | 1,324,801,095 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,338,927 | 30,344,313 | 12.36 | 41.00 | 136,896,007 | 1,244,116,833 | |
| 2015-09-11 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2,213,469 | 6,022,104 | 58.12 | 15.50 | 34,308,770 | 93,342,612 | |
| 2015-09-11 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 266,563 | 725,228 | 58.12 | 15.50 | 4,131,726 | 11,241,034 | |
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7,220,154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12,371,376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6,628,338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7,220,154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12,371,376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6,628,338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7,220,154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12,371,376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6,628,338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7,220,154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12,371,376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6,628,338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7,220,154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12,371,376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6,628,338 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4,725,965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8,075,935 | ||||||||
| 2015-08-10 | 3/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
2,260 | ||||||||
| 2015-08-10 | 3/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
2,260 | ||||||||
| 2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 2,329 | 2,329 | |||||
| 2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 696 | 6,103,727 | 0.01 | ||||
| 2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 696 | 6,103,727 | 0.01 | ||||
| 2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -229,436 | 90,538 | -71.70 | 1.09 | -250,659 | 98,913 | |
| 2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -9,411,311 | 3,153,539 | -74.90 | 1.09 | -10,281,857 | 3,445,241 | |
| 2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -1,359,253 | 467,436 | -74.41 | 1.09 | -1,484,984 | 510,674 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 307,339 | 0.24 | 27.34 | 19,958 | 8,402,648 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 1,350,721 | 0.05 | 27.34 | 19,958 | 36,928,712 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 481,236 | 0.15 | 27.34 | 19,958 | 13,156,992 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 11,421,675 | 0.01 | 27.34 | 19,958 | 312,268,594 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 194,628 | 0.38 | 27.34 | 19,958 | 5,321,130 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 355,287 | 0.21 | 27.34 | 19,958 | 9,713,547 | |
| 2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 826,200 | 0.02 | 104.21 | 18,966 | 86,098,302 | |
| 2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 411,021 | 0.04 | 104.21 | 18,966 | 42,832,498 | |
| 2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 549,414 | 0.03 | 104.21 | 18,966 | 57,254,433 | |
| 2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,260 | 64,858 | 8.83 | 3.66 | 19,252 | 237,380 | |
| 2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,260 | 64,858 | 8.83 | 3.66 | 19,252 | 237,380 | |
| 2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,260 | 64,858 | 8.83 | 3.66 | 19,252 | 237,380 | |
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 6,103,033 | 6,103,033 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 506,166 | 506,166 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 94,412 | 94,412 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 66,154 | 66,154 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 65,811 | 65,811 | |||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -3,000 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -3,000 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -15,000 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,750 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,750 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2,750 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -9,184,771 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12,250 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -680,187 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -143,462 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -200,526 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7,500 | 0 | -100.00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -15,000 | 0 | -100.00 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 21,196 | 100,523 | 26.72 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -211,614 | 12,250 | -94.53 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 497 | 79,327 | 0.63 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -100,490 | 12,250 | -89.13 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 40,449 | 78,830 | 105.39 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -1,068,128 | 680,187 | -61.09 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 5,543 | 38,381 | 16.88 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -55,479 | 12,250 | -81.91 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 12,500 | 32,838 | 61.46 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -165,213 | 12,250 | -93.10 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 19,318 | 20,338 | 1,893.92 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -206,800 | 12,250 | -94.41 | ||||
| 2015-06-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12,500 | 12,500 | |||||
| 2015-06-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20,000 | 20,000 | |||||
| 2015-06-10 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70,000 | 70,000 | |||||
| 2015-05-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 198,802 | 27,005,386 | 0.74 | 43.27 | 8,602,242 | 1,168,533,854 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57,202 | 26,816,266 | 0.21 | 43.29 | 2,476,343 | 1,160,908,335 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16,300 | 26,759,064 | 0.06 | 43.67 | 711,775 | 1,168,493,400 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90,155 | 26,742,764 | 0.34 | 43.62 | 3,932,723 | 1,166,567,503 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 150,000 | 26,652,609 | 0.57 | 42.93 | 6,439,500 | 1,144,196,504 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9,200 | 26,492,927 | 0.03 | 40.95 | 376,718 | 1,084,821,778 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 52,381 | 26,483,727 | 0.20 | 41.54 | 2,176,038 | 1,100,200,229 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 139,683 | 26,431,346 | 0.53 | 42.68 | 5,961,908 | 1,128,134,781 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 13,352 | 26,291,663 | 0.05 | 42.97 | 573,749 | 1,129,779,051 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 2,300 | 26,278,311 | 0.01 | 42.15 | 96,949 | 1,107,675,482 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7,382 | 26,276,011 | 0.03 | 41.24 | 304,410 | 1,083,538,610 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,500 | 26,268,629 | 0.02 | 41.07 | 184,815 | 1,078,852,593 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 89,100 | 26,264,129 | 0.34 | 40.57 | 3,614,475 | 1,065,443,789 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 120,529 | 26,175,029 | 0.46 | 41.09 | 4,951,958 | 1,075,406,301 | |
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9,260 | 9,260 | |||||
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 26,054,500 | 0.01 | 39.94 | 147,778 | 1,040,616,730 | |
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,700 | 26,054,500 | 0.01 | 39.94 | 147,778 | 1,040,616,730 | |
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20,000 | 0 | -100.00 | ||||
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 410,839 | 5.12 | 7.68 | 153,600 | 3,155,244 | |
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 410,839 | 5.12 | 7.68 | 153,600 | 3,155,244 | |
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20,000 | 410,839 | 5.12 | 7.68 | 153,600 | 3,155,244 | |
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 26,050,800 | 0.04 | 5.11 | 51,100 | 133,119,588 | |
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 26,050,800 | 0.04 | 5.11 | 51,100 | 133,119,588 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,100 | 26,040,800 | 0.00 | 37.07 | 40,777 | 965,332,456 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46,617 | 26,039,700 | 0.18 | 37.15 | 1,732,013 | 967,481,618 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8,334 | 25,993,083 | 0.03 | 35.85 | 298,745 | 931,761,050 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 129,118 | 25,984,749 | 0.50 | 36.40 | 4,700,515 | 945,969,590 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 137,800 | 25,855,631 | 0.54 | 36.25 | 4,995,250 | 937,266,624 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 155,731 | 25,717,831 | 0.61 | 36.67 | 5,710,048 | 942,972,563 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 23,012 | 25,562,100 | 0.09 | 35.91 | 826,437 | 918,019,366 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 354,300 | 25,539,088 | 1.41 | 34.76 | 12,315,078 | 887,710,606 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59,973 | 25,184,788 | 0.24 | 34.61 | 2,075,833 | 871,716,030 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,330 | 25,124,815 | 0.02 | 33.99 | 147,177 | 853,992,462 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90,397 | 25,120,485 | 0.36 | 34.56 | 3,123,949 | 868,116,233 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,952 | 25,030,088 | 0.09 | 34.52 | 757,888 | 864,158,782 | |
| 2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,470 | 59,598 | 10.11 | 3.52 | 19,254 | 209,785 | |
| 2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,470 | 59,598 | 10.11 | 3.52 | 19,254 | 209,785 | |
| 2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5,470 | 59,598 | 10.11 | 3.52 | 19,254 | 209,785 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 306,609 | 0.21 | 30.43 | 19,962 | 9,330,112 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1,349,991 | 0.05 | 30.43 | 19,962 | 41,080,226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1,349,991 | 0.05 | 30.43 | 19,962 | 41,080,226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1,349,991 | 0.05 | 30.43 | 19,962 | 41,080,226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1,349,991 | 0.05 | 30.43 | 19,962 | 41,080,226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 306,609 | 0.21 | 30.43 | 19,962 | 9,330,112 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,880 | 25,008,136 | 0.01 | 34.72 | 99,986 | 868,217,461 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,439 | 25,005,256 | 0.03 | 34.47 | 221,935 | 861,863,660 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 158,771 | 24,998,817 | 0.64 | 34.69 | 5,507,401 | 867,151,464 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 116,946 | 24,840,046 | 0.47 | 34.62 | 4,049,208 | 860,076,657 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19,600 | 24,723,100 | 0.08 | 34.82 | 682,537 | 860,939,928 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,021 | 24,703,500 | 0.02 | 34.79 | 139,882 | 859,380,417 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 213,820 | 24,699,479 | 0.87 | 34.76 | 7,432,169 | 858,529,191 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 211,400 | 24,485,659 | 0.87 | 34.92 | 7,382,532 | 855,090,632 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,000 | 24,274,259 | 0.00 | 35.60 | 35,595 | 864,042,249 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 62,650 | 24,273,259 | 0.26 | 34.46 | 2,159,163 | 836,551,171 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 163,054 | 24,210,609 | 0.68 | 33.80 | 5,510,818 | 818,258,058 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,995 | 24,047,555 | 0.02 | 33.60 | 167,830 | 807,985,824 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49,416 | 24,042,560 | 0.21 | 33.65 | 1,662,843 | 809,029,740 | |
| 2015-02-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4,898,409 | 6,323,855 | 343.64 | 3.75 | 18,369,034 | 23,714,456 | |
| 2015-02-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 434,924 | 625,495 | 228.22 | 3.75 | 1,630,965 | 2,345,606 | |
| 2015-02-02 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 390,935 | 2,604,832 | 17.66 | 20.00 | 7,818,700 | 52,096,640 | |
| 2015-02-02 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 34,065 | 159,934 | 27.06 | 20.00 | 681,300 | 3,198,680 | |
| 2015-01-09 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 1,000,000 | 9,184,771 | 12.22 | 94.19 | 94,190,000 | 865,113,580 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -21,441 | 345,074 | -5.85 | 3.86 | -82,762 | 1,331,986 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -859,988 | 12,589,950 | -6.39 | 3.86 | -3,319,554 | 48,597,207 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -118,571 | 1,851,789 | -6.02 | 3.86 | -457,684 | 7,147,906 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -21,548 | 366,515 | -5.55 | 3.81 | -82,130 | 1,396,972 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -863,100 | 13,449,938 | -6.03 | 3.81 | -3,289,706 | 51,264,439 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -118,652 | 1,970,360 | -5.68 | 3.81 | -452,242 | 7,510,027 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -4,554 | 388,063 | -1.16 | 3.55 | -16,184 | 1,379,059 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -182,454 | 14,313,038 | -1.26 | 3.55 | -648,387 | 50,864,243 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -25,092 | 2,089,012 | -1.19 | 3.55 | -89,169 | 7,423,722 | |
| 2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,927 | 54,128 | 7.82 | 4.90 | 19,242 | 265,227 | |
| 2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,927 | 54,128 | 7.82 | 4.90 | 19,242 | 265,227 | |
| 2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3,927 | 1,425,446 | 0.28 | 4.90 | 19,242 | 6,984,685 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 305,953 | 0.20 | 31.97 | 19,949 | 9,781,317 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 1,349,335 | 0.05 | 31.97 | 19,949 | 43,138,240 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 11,420,289 | 0.01 | 31.97 | 19,949 | 365,106,639 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 1,909,412 | 0.03 | 31.97 | 19,949 | 61,043,902 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 193,242 | 0.32 | 31.97 | 19,949 | 6,177,947 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 353,901 | 0.18 | 31.97 | 19,949 | 11,314,215 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -8,415 | 392,617 | -2.10 | 3.65 | -30,711 | 1,432,856 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -337,123 | 14,495,492 | -2.27 | 3.65 | -1,230,330 | 52,901,298 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -46,362 | 2,114,104 | -2.15 | 3.65 | -169,198 | 7,715,423 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -4,746 | 401,032 | -1.17 | 3.68 | -17,447 | 1,474,274 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -190,117 | 14,832,615 | -1.27 | 3.68 | -698,908 | 54,527,659 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -26,137 | 2,160,466 | -1.20 | 3.68 | -96,085 | 7,942,305 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -2,825 | 405,778 | -0.69 | 3.71 | -10,482 | 1,505,680 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -112,855 | 15,022,732 | -0.75 | 3.71 | -418,760 | 55,743,349 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -15,420 | 2,186,603 | -0.70 | 3.71 | -57,217 | 8,113,609 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -16,182 | 408,603 | -3.81 | 4.21 | -68,102 | 1,719,606 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -647,781 | 15,135,587 | -4.10 | 4.21 | -2,726,186 | 63,698,118 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -88,937 | 2,202,023 | -3.88 | 4.21 | -374,291 | 9,267,214 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -3,558 | 424,785 | -0.83 | 4.29 | -15,260 | 1,821,903 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -142,543 | 15,783,368 | -0.90 | 4.29 | -611,367 | 67,694,865 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -19,599 | 2,290,960 | -0.85 | 4.29 | -84,060 | 9,825,927 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -14,753 | 428,343 | -3.33 | 4.31 | -63,571 | 1,845,730 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -590,638 | 15,925,911 | -3.58 | 4.31 | -2,545,059 | 68,624,750 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -81,109 | 2,310,559 | -3.39 | 4.31 | -349,499 | 9,956,199 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,900 | 23,993,144 | 0.02 | 31.97 | 124,679 | 767,036,821 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 500 | 23,989,244 | 0.00 | 30.80 | 15,400 | 738,868,715 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49,685 | 23,988,744 | 0.21 | 31.82 | 1,581,096 | 763,379,407 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,855,894 | 23,939,059 | 8.40 | 31.94 | 59,276,698 | 764,606,363 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 597,000 | 22,083,165 | 2.78 | 31.75 | 18,954,631 | 701,136,072 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 305,532 | 21,486,165 | 1.44 | 31.68 | 9,680,415 | 680,763,355 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 70,867 | 21,180,633 | 0.34 | 31.41 | 2,226,244 | 665,376,877 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -6,874 | 443,096 | -1.53 | 4.27 | -29,358 | 1,892,419 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -274,734 | 16,516,549 | -1.64 | 4.27 | -1,173,361 | 70,540,529 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -37,592 | 2,391,668 | -1.55 | 4.27 | -160,552 | 10,214,575 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -9,908 | 449,970 | -2.15 | 4.45 | -44,093 | 2,002,456 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -396,496 | 16,791,283 | -2.31 | 4.45 | -1,764,486 | 74,724,568 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -54,396 | 2,429,260 | -2.19 | 4.45 | -242,073 | 10,810,693 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -5,457 | 459,878 | -1.17 | 4.71 | -25,724 | 2,167,865 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -218,383 | 17,187,779 | -1.25 | 4.71 | -1,029,457 | 81,023,190 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -29,960 | 2,483,656 | -1.19 | 4.71 | -141,231 | 11,707,954 | |
| 2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -8,429 | 465,335 | -1.78 | 4.62 | -38,907 | 2,147,940 | |
| 2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -337,541 | 17,406,162 | -1.90 | 4.62 | -1,558,056 | 80,345,103 | |
| 2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -46,383 | 2,513,616 | -1.81 | 4.62 | -214,099 | 11,602,600 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100,000 | 21,109,766 | 0.48 | 34.95 | 3,495,000 | 737,786,322 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 354,000 | 21,009,766 | 1.71 | 34.27 | 12,131,651 | 720,008,883 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14,772 | 20,655,766 | 0.07 | 34.53 | 510,114 | 713,295,239 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 185,378 | 20,640,994 | 0.91 | 34.33 | 6,364,935 | 708,706,465 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 30,507 | 107,504 | 39.62 | ||||
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 30,507 | 3,993,087 | 0.77 | ||||
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -399,208 | 0 | -100.00 | ||||
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,500 | 20,455,616 | 0.03 | 33.90 | 186,438 | 693,400,380 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 80,430 | 20,450,116 | 0.39 | 34.64 | 2,786,393 | 708,467,684 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42,500 | 20,369,686 | 0.21 | 33.28 | 1,414,515 | 677,958,148 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 185,528 | 20,327,186 | 0.92 | 33.31 | 6,180,420 | 677,151,416 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 216,284 | 20,141,658 | 1.09 | 32.56 | 7,043,267 | 655,911,079 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 38,614 | 19,925,374 | 0.19 | 33.00 | 1,274,254 | 657,533,357 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24,890 | 19,886,760 | 0.13 | 33.06 | 822,744 | 657,360,829 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -28,086 | 473,764 | -5.60 | 4.55 | -127,671 | 2,153,589 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -1,122,584 | 17,743,703 | -5.95 | 4.55 | -5,102,930 | 80,657,551 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -153,618 | 2,559,999 | -5.66 | 4.55 | -698,301 | 11,636,987 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -11,965 | 501,850 | -2.33 | 4.84 | -57,913 | 2,429,054 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -486,800 | 18,866,287 | -2.52 | 4.84 | -2,356,209 | 91,316,602 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -69,153 | 2,713,617 | -2.49 | 4.84 | -334,714 | 13,134,449 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -10,534 | 513,815 | -2.01 | 5.36 | -56,453 | 2,753,586 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -428,583 | 19,353,087 | -2.17 | 5.36 | -2,296,819 | 103,715,129 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -60,883 | 2,782,770 | -2.14 | 5.36 | -326,278 | 14,913,143 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98,076 | 19,861,870 | 0.50 | 36.57 | 3,586,737 | 726,368,448 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,639 | 19,763,794 | 0.05 | 36.75 | 390,999 | 726,349,075 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 69,397 | 19,753,155 | 0.35 | 35.88 | 2,490,291 | 708,836,041 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 63,137 | 19,683,758 | 0.32 | 36.74 | 2,319,502 | 723,134,028 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25,505 | 19,620,621 | 0.13 | 35.91 | 915,851 | 704,550,993 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22,839 | 19,595,116 | 0.12 | 35.55 | 811,963 | 696,637,726 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,116 | 19,572,277 | 0.07 | 35.56 | 466,413 | 696,001,913 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 17,098 | 19,559,161 | 0.09 | 34.91 | 596,816 | 682,724,250 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 104,140 | 19,542,063 | 0.54 | 35.98 | 3,746,947 | 703,121,473 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29,006 | 19,437,923 | 0.15 | 35.28 | 1,023,471 | 685,863,225 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,500 | 19,408,917 | 0.07 | 34.26 | 462,530 | 664,978,610 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25,769 | 19,395,417 | 0.13 | 34.58 | 890,989 | 670,615,938 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 866,669 | 19,369,648 | 4.68 | 33.79 | 29,287,172 | 654,554,641 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4,394 | 18,502,979 | 0.02 | 33.71 | 148,139 | 623,807,584 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 38,166 | 18,498,585 | 0.21 | 34.83 | 1,329,390 | 644,339,013 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 252,474 | 18,460,419 | 1.39 | 34.41 | 8,686,949 | 635,173,175 | |
| 2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,914 | 50,201 | 21.59 | 2.16 | 19,254 | 108,434 | |
| 2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,914 | 50,201 | 21.59 | 2.16 | 19,254 | 108,434 | |
| 2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8,914 | 1,421,519 | 0.63 | 2.16 | 19,254 | 3,070,481 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 305,329 | 0.23 | 28.54 | 19,978 | 8,714,090 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 305,329 | 0.23 | 28.54 | 19,978 | 8,714,090 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 1,348,711 | 0.05 | 28.54 | 19,978 | 38,492,212 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 11,419,665 | 0.01 | 28.54 | 19,978 | 325,917,239 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 192,618 | 0.36 | 28.54 | 19,978 | 5,497,318 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 353,277 | 0.20 | 28.54 | 19,978 | 10,082,526 | |
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 7,000 | 7,000 | |||||
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5,500 | 524,349 | 1.06 | ||||
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5,500 | 524,349 | 1.06 | ||||
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5,500 | 524,349 | 1.06 | ||||
| 2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,182 | 41,287 | 17.61 | 2.83 | 17,495 | 116,842 | |
| 2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,182 | 41,287 | 17.61 | 2.83 | 17,495 | 116,842 | |
| 2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6,182 | 1,412,605 | 0.44 | 2.83 | 17,495 | 3,997,672 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 304,629 | 0.24 | 27.86 | 19,948 | 8,486,964 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 1,348,011 | 0.05 | 27.86 | 19,948 | 37,555,586 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 11,418,965 | 0.01 | 27.86 | 19,948 | 318,132,365 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 1,908,088 | 0.04 | 27.86 | 19,948 | 53,159,332 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 191,918 | 0.37 | 27.86 | 19,948 | 5,346,835 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 352,577 | 0.20 | 27.86 | 19,948 | 9,822,795 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4,250 | 0 | -100.00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4,250 | 0 | -100.00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4,250 | 0 | -100.00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4,250 | 0 | -100.00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4,250 | 0 | -100.00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4,250 | 0 | -100.00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4,250 | 0 | -100.00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4,250 | 223,864 | 1.94 | 60.45 | 256,912 | 13,532,579 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4,250 | 223,864 | 1.94 | 60.45 | 256,912 | 13,532,579 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4,250 | 223,864 | 1.94 | 60.45 | 256,912 | 13,532,579 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4,250 | 257,722 | 1.68 | 60.45 | 256,912 | 15,579,295 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4,250 | 1,893,297 | 0.22 | 60.45 | 256,912 | 114,449,804 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4,250 | 212,711 | 2.04 | 60.45 | 256,912 | 12,858,380 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4,250 | 322,445 | 1.34 | 60.45 | 256,912 | 19,491,800 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 670 | 416,208 | 0.16 | 39.80 | 26,668 | 16,566,494 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 27,046 | 18,207,945 | 0.15 | 39.80 | 1,076,523 | 724,738,118 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,471 | 415,538 | 0.36 | 39.93 | 58,731 | 16,590,770 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59,400 | 18,180,899 | 0.33 | 39.93 | 2,371,604 | 725,890,573 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,938 | 414,067 | 0.47 | 39.99 | 77,503 | 16,559,036 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 78,262 | 18,121,499 | 0.43 | 39.99 | 3,129,791 | 724,700,491 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,155 | 412,129 | 0.28 | 39.84 | 46,021 | 16,421,239 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46,653 | 18,043,237 | 0.26 | 39.84 | 1,858,884 | 718,930,974 | |
| 2014-06-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70,000 | 70,000 | |||||
| 2014-06-10 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12,500 | 12,500 | |||||
| 2014-06-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20,000 | 20,000 | |||||
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,534 | 410,974 | 1.36 | 38.96 | 215,578 | 16,009,574 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 223,466 | 17,996,584 | 1.26 | 38.96 | 8,705,163 | 701,060,529 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 534 | 405,440 | 0.13 | 38.56 | 20,591 | 15,633,847 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21,559 | 17,773,118 | 0.12 | 38.56 | 831,319 | 685,334,985 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 477 | 404,906 | 0.12 | 37.52 | 17,895 | 15,190,413 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19,223 | 17,751,559 | 0.11 | 37.52 | 721,168 | 665,965,712 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,757 | 404,429 | 0.94 | 37.40 | 140,504 | 15,124,795 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 151,530 | 17,732,336 | 0.86 | 37.40 | 5,666,904 | 663,152,128 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,411 | 400,672 | 0.61 | 37.67 | 90,826 | 15,093,995 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 97,254 | 17,580,806 | 0.56 | 37.67 | 3,663,724 | 662,298,849 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 496 | 398,261 | 0.12 | 37.63 | 18,667 | 14,988,274 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20,011 | 17,483,552 | 0.11 | 37.63 | 753,100 | 657,981,241 | |
| 2014-06-06 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,534 | 397,765 | 0.39 | 36.04 | 55,281 | 14,334,377 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61,878 | 17,463,541 | 0.36 | 36.04 | 2,229,916 | 629,338,866 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 572 | 396,231 | 0.14 | 36.39 | 20,817 | 14,419,995 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23,058 | 17,401,663 | 0.13 | 36.39 | 839,147 | 633,296,981 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19 | 395,659 | 0.00 | 35.27 | 670 | 13,956,001 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 781 | 17,378,605 | 0.00 | 35.27 | 27,548 | 612,992,058 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,137 | 395,640 | 0.54 | 34.38 | 73,479 | 13,603,725 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 86,201 | 17,377,824 | 0.50 | 34.38 | 2,963,944 | 597,520,838 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 270 | 393,503 | 0.07 | 35.11 | 9,481 | 13,817,386 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10,896 | 17,291,623 | 0.06 | 35.11 | 382,600 | 607,174,592 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,809 | 393,233 | 0.46 | 34.05 | 61,604 | 13,391,196 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72,980 | 17,280,727 | 0.42 | 34.05 | 2,485,268 | 588,479,605 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 480 | 391,424 | 0.12 | 34.21 | 16,421 | 13,391,046 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19,348 | 17,207,747 | 0.11 | 34.21 | 661,916 | 588,695,953 | |
| 2014-05-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11,600 | 11,600 | |||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8,400 | 518,849 | 1.65 | ||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8,400 | 518,849 | 1.65 | ||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8,400 | 518,849 | 1.65 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10,000 | 390,839 | 2.63 | 7.02 | 70,200 | 2,743,690 | |
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10,000 | 390,839 | 2.63 | 7.02 | 70,200 | 2,743,690 | |
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10,000 | 390,839 | 2.63 | 7.02 | 70,200 | 2,743,690 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8,750 | 8,750 | |||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8,750 | 8,750 | |||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8,750 | 8,750 | |||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,151 | 390,944 | 0.30 | 34.08 | 39,232 | 13,325,287 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46,460 | 17,188,399 | 0.27 | 34.08 | 1,583,584 | 585,864,861 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,921 | 389,793 | 0.76 | 34.03 | 99,415 | 13,266,449 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 117,879 | 17,141,939 | 0.69 | 34.03 | 4,011,965 | 583,419,037 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,500 | 386,872 | 0.91 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,500 | 386,872 | 0.91 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,500 | 17,178,061 | 0.02 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 505 | 383,372 | 0.13 | 34.26 | 17,304 | 13,136,012 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20,395 | 17,020,560 | 0.12 | 34.26 | 698,822 | 583,199,276 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7 | 382,867 | 0.00 | 34.10 | 239 | 13,055,765 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 293 | 17,000,165 | 0.00 | 34.10 | 9,991 | 579,705,626 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 0 | -100.00 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 382,860 | 2.68 | 7.26 | 72,600 | 2,779,564 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 382,860 | 2.68 | 7.26 | 72,600 | 2,779,564 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10,000 | 382,860 | 2.68 | 7.26 | 72,600 | 2,779,564 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 746 | 372,860 | 0.20 | 34.60 | 25,815 | 12,902,522 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 30,122 | 16,989,872 | 0.18 | 34.60 | 1,042,348 | 587,920,929 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 740 | 372,114 | 0.20 | 33.73 | 24,964 | 12,553,191 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29,865 | 16,959,750 | 0.18 | 33.73 | 1,007,490 | 572,133,774 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,069 | 371,374 | 0.29 | 34.31 | 36,673 | 12,740,319 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43,131 | 16,929,885 | 0.26 | 34.31 | 1,479,648 | 580,794,942 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 783 | 370,305 | 0.21 | 33.92 | 26,559 | 12,560,486 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31,617 | 16,886,754 | 0.19 | 33.92 | 1,072,427 | 572,786,875 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 329 | 369,522 | 0.09 | 34.74 | 11,430 | 12,837,564 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,271 | 16,855,137 | 0.08 | 34.74 | 461,048 | 585,564,315 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,933 | 369,193 | 0.80 | 33.77 | 99,060 | 12,469,235 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 118,389 | 16,841,866 | 0.71 | 33.77 | 3,998,506 | 568,822,235 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 839 | 366,260 | 0.23 | 33.72 | 28,295 | 12,352,009 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33,868 | 16,723,477 | 0.20 | 34.72 | 1,176,056 | 580,717,722 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,534 | 365,421 | 0.42 | 33.98 | 52,118 | 12,415,252 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61,892 | 16,689,609 | 0.37 | 33.98 | 2,102,793 | 567,032,804 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 623 | 363,887 | 0.17 | 34.01 | 21,190 | 12,376,779 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25,156 | 16,627,717 | 0.15 | 34.01 | 855,623 | 565,553,550 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,228 | 363,264 | 0.34 | 33.40 | 41,020 | 12,134,580 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49,553 | 16,602,561 | 0.30 | 33.40 | 1,655,283 | 554,596,928 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 984 | 362,036 | 0.27 | 33.54 | 33,007 | 12,143,991 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39,710 | 16,553,008 | 0.24 | 33.54 | 1,332,016 | 555,247,479 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 746 | 372,860 | 0.20 | 34.60 | 25,815 | 12,902,522 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 30,122 | 16,989,872 | 0.18 | 34.60 | 1,042,348 | 587,920,929 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 740 | 372,114 | 0.20 | 33.73 | 24,964 | 12,553,191 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29,865 | 16,959,750 | 0.18 | 33.73 | 1,007,490 | 572,133,774 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,069 | 371,374 | 0.29 | 34.31 | 36,673 | 12,740,319 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43,131 | 16,929,885 | 0.26 | 34.31 | 1,479,648 | 580,794,942 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 783 | 370,305 | 0.21 | 33.92 | 26,559 | 12,560,486 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31,617 | 16,886,754 | 0.19 | 33.92 | 1,072,427 | 572,786,875 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 329 | 369,522 | 0.09 | 34.74 | 11,430 | 12,837,564 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,271 | 16,855,137 | 0.08 | 34.74 | 461,048 | 585,564,315 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,933 | 369,193 | 0.80 | 33.77 | 99,060 | 12,469,235 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 118,389 | 16,841,866 | 0.71 | 33.77 | 3,998,506 | 568,822,235 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 839 | 366,260 | 0.23 | 33.72 | 28,295 | 12,352,009 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33,868 | 16,723,477 | 0.20 | 34.72 | 1,176,056 | 580,717,722 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,534 | 365,421 | 0.42 | 33.98 | 52,118 | 12,415,252 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61,892 | 16,689,609 | 0.37 | 33.98 | 2,102,793 | 567,032,804 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 623 | 363,887 | 0.17 | 34.01 | 21,190 | 12,376,779 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25,156 | 16,627,717 | 0.15 | 34.01 | 855,623 | 565,553,550 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,228 | 363,264 | 0.34 | 33.40 | 41,020 | 12,134,580 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49,553 | 16,602,561 | 0.30 | 33.40 | 1,655,283 | 554,596,928 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 984 | 362,036 | 0.27 | 33.54 | 33,007 | 12,143,991 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39,710 | 16,553,008 | 0.24 | 33.54 | 1,332,016 | 555,247,479 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8,000 | 0 | -100.00 | 65.10 | 520,800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8,000 | 0 | -100.00 | 65.10 | 520,800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8,000 | 0 | -100.00 | 65.10 | 520,800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8,000 | 0 | -100.00 | 65.10 | 520,800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8,000 | 0 | -100.00 | 65.10 | 520,800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8,000 | 0 | -100.00 | 65.10 | 520,800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8,000 | 0 | -100.00 | 65.10 | 520,800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8,000 | 219,614 | 3.78 | 65.10 | 520,800 | 14,296,871 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8,000 | 219,614 | 3.78 | 65.10 | 520,800 | 14,296,871 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8,000 | 219,614 | 3.78 | 65.10 | 520,800 | 14,296,871 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8,000 | 253,472 | 3.26 | 65.10 | 520,800 | 16,501,027 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8,000 | 1,889,047 | 0.43 | 65.10 | 520,800 | 122,976,960 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8,000 | 208,461 | 3.99 | 65.10 | 520,800 | 13,570,811 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8,000 | 318,195 | 2.58 | 65.10 | 520,800 | 20,714,494 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 303,913 | 0.25 | 26.57 | 19,981 | 8,074,968 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 303,913 | 0.25 | 26.57 | 19,981 | 8,074,968 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 1,347,295 | 0.06 | 26.57 | 19,981 | 35,797,628 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 11,418,249 | 0.01 | 26.57 | 19,981 | 303,382,876 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 1,907,372 | 0.04 | 26.57 | 19,981 | 50,678,874 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 191,202 | 0.39 | 26.57 | 19,981 | 5,080,237 | |
| 2014-03-19 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 80,000 | 80,000 | |||||
| 2014-03-12 |
|
4 | IDP |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 60,000 | 60,000 | |||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,784,624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3,019,499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1,648,181 | ||||||||
| 2014-03-07 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 9,031 | 211,614 | 4.46 | 105.75 | 955,028 | 22,378,180 | |
| 2014-03-07 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 365,969 | 8,172,521 | 4.69 | 105.75 | 38,701,222 | 864,244,096 | |
| 2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11,738 | 452,540 | 2.66 | 28.50 | 334,533 | 12,897,390 | |
| 2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 475,644 | 18,476,847 | 2.64 | 28.50 | 13,555,854 | 526,590,140 | |
| 2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 38,934 | 1,552,055 | 2.57 | 28.50 | 1,109,619 | 44,233,568 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 303,161 | 0.23 | 29.27 | 19,962 | 8,873,522 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 303,161 | 0.23 | 29.27 | 19,962 | 8,873,522 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 11,243,600 | 0.01 | 29.27 | 19,962 | 329,100,172 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 1,732,723 | 0.04 | 29.27 | 19,962 | 50,716,802 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 16,553 | 4.30 | 29.27 | 19,962 | 484,506 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 177,212 | 0.39 | 29.27 | 19,962 | 5,186,995 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 639 | 361,052 | 0.18 | 39.91 | 25,504 | 14,410,344 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25,596 | 16,513,298 | 0.16 | 39.91 | 1,021,590 | 659,080,401 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,280 | 360,413 | 0.36 | 39.92 | 51,100 | 14,388,372 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 51,244 | 16,487,702 | 0.31 | 39.92 | 2,045,758 | 658,220,390 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,063 | 359,133 | 0.30 | 39.65 | 42,153 | 14,241,383 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42,646 | 16,436,458 | 0.26 | 39.65 | 1,691,123 | 651,786,098 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,486 | 358,070 | 0.70 | 39.70 | 98,694 | 14,215,379 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 99,775 | 16,393,812 | 0.61 | 39.70 | 3,961,068 | 650,834,336 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,377 | 355,584 | 0.39 | 39.54 | 54,442 | 14,058,725 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 55,256 | 16,294,037 | 0.34 | 39.54 | 2,184,656 | 644,217,341 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,056 | 354,207 | 0.87 | 39.53 | 120,798 | 14,001,201 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 122,660 | 16,238,781 | 0.76 | 39.53 | 4,848,541 | 641,891,407 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5,492 | 351,151 | 1.59 | 43.98 | 241,512 | 15,441,935 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 219,958 | 16,116,121 | 1.38 | 43.98 | 9,672,697 | 708,709,644 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 553 | 345,659 | 0.16 | 44.00 | 24,332 | 15,208,823 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22,147 | 15,896,163 | 0.14 | 44.00 | 974,457 | 699,423,224 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,863 | 345,106 | 0.84 | 44.05 | 126,102 | 15,200,366 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 114,663 | 15,874,016 | 0.73 | 44.05 | 5,050,389 | 699,178,972 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 170 | 342,243 | 0.05 | 43.42 | 7,382 | 14,861,800 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6,814 | 15,759,353 | 0.04 | 43.42 | 295,896 | 684,345,176 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,512 | 342,073 | 0.74 | 42.95 | 107,883 | 14,691,043 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100,626 | 15,752,539 | 0.64 | 42.95 | 4,321,595 | 676,525,868 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 340 | 339,561 | 0.10 | 43.72 | 14,864 | 14,845,233 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13,632 | 15,651,913 | 0.09 | 43.72 | 595,976 | 684,284,419 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,011 | 339,221 | 0.30 | 43.01 | 43,479 | 14,588,403 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40,471 | 15,638,281 | 0.26 | 43.01 | 1,740,480 | 672,533,657 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1,818 | 338,210 | 0.54 | 43.20 | 78,547 | 14,612,329 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72,807 | 15,597,810 | 0.47 | 43.20 | 3,145,619 | 673,901,821 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 455 | 336,392 | 0.14 | 43.64 | 19,858 | 14,681,829 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18,232 | 15,525,003 | 0.12 | 43.64 | 795,736 | 677,588,756 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 290 | 335,937 | 0.09 | 42.65 | 12,369 | 14,328,721 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11,617 | 15,506,771 | 0.07 | 42.65 | 495,500 | 661,410,303 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3,551 | 335,647 | 1.07 | 42.56 | 151,129 | 14,284,968 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 142,220 | 15,495,154 | 0.93 | 42.56 | 6,052,812 | 659,466,007 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,632 | 332,096 | 0.80 | 42.41 | 111,631 | 14,085,188 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 105,414 | 15,352,934 | 0.69 | 42.41 | 4,470,924 | 651,163,990 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2,816 | 329,464 | 0.86 | 42.31 | 119,144 | 13,939,556 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 112,797 | 15,247,520 | 0.75 | 42.31 | 4,772,419 | 645,119,522 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -127,000 | 892,000 | -12.46 | 432.60 | -54,940,390 | 385,880,538 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -4,567,000 | 31,967,000 | -12.50 | 432.60 | -1,975,691,050 | 13,828,972,150 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -1,084,000 | 7,587,000 | -12.50 | 432.60 | -468,940,026 | 3,282,147,580 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -2,459,000 | 1,019,000 | -70.70 | 425.88 | -1,047,233,756 | 433,969,580 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -88,153,000 | 36,534,000 | -70.70 | 425.88 | -37,542,414,519 | 15,559,023,199 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -20,922,000 | 8,671,000 | -70.70 | 425.88 | -8,910,217,424 | 3,692,787,271 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 170,000 | 6,050,000 | 2.89 | 104.52 | 17,768,043 | 632,333,295 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 6,830,000 | 243,450,000 | 2.89 | 104.52 | 713,857,257 | 25,444,882,755 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 242,000 | 5,880,000 | 4.29 | 104.25 | 25,228,500 | 612,990,000 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 9,758,000 | 236,620,000 | 4.30 | 104.25 | 1,017,271,500 | 24,667,635,000 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 61,000 | 5,638,000 | 1.09 | 103.75 | 6,328,750 | 584,942,500 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 2,439,000 | 226,862,000 | 1.09 | 103.75 | 253,046,250 | 23,536,932,500 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 121,000 | 5,577,000 | 2.22 | 104.75 | 12,674,750 | 584,190,750 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 4,879,000 | 224,423,000 | 2.22 | 104.75 | 511,075,250 | 23,508,309,250 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 5,456,000 | 5,456,000 | 100.00 | 545,600,000 | 545,600,000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 5,456,000 | 5,456,000 | 100.00 | 545,600,000 | 545,600,000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 219,544,000 | 219,544,000 | 100.00 | 21,954,400,000 | 21,954,400,000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 219,544,000 | 219,544,000 | 100.00 | 21,954,400,000 | 21,954,400,000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 25,000,000 | 25,000,000 | 100.00 | 2,500,000,000 | 2,500,000,000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 25,000,000 | 25,000,000 | 100.00 | 2,500,000,000 | 2,500,000,000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 133,000 | 5,674,000 | 2.40 | 104.09 | 13,844,090 | 590,611,767 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 5,367,000 | 228,326,000 | 2.41 | 104.09 | 558,655,860 | 23,766,658,833 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 85,000 | 5,541,000 | 1.56 | 104.12 | 8,850,625 | 576,956,625 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 3,415,000 | 222,959,000 | 1.56 | 104.12 | 355,586,875 | 23,215,605,875 | |
| 2013-10-28 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 8,721 | 40,308 | 27.61 | 17.50 | 152,618 | 705,390 | |
| 2013-10-28 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 346,965 | 2,213,897 | 18.58 | 17.50 | 6,071,888 | 38,743,198 | |
| 2013-10-28 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 44,314 | 125,869 | 54.34 | 17.50 | 775,495 | 2,202,708 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 302,479 | 0.22 | 30.33 | 19,957 | 9,174,188 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 11,242,918 | 0.01 | 30.33 | 19,957 | 340,997,703 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 1,732,041 | 0.04 | 30.33 | 19,957 | 52,532,804 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 15,871 | 4.33 | 30.33 | 19,957 | 481,367 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 176,530 | 0.37 | 30.33 | 19,957 | 5,354,155 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 196,794 | 0.34 | 30.33 | 19,957 | 5,968,762 | |
| 2013-09-27 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 25,663 | 202,583 | 14.51 | 56.63 | 1,453,296 | 11,472,275 | |
| 2013-09-27 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 1,024,337 | 7,806,552 | 15.10 | 56.63 | 58,008,204 | 442,085,040 | |
| 2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 21,410 | 510,449 | 4.38 | 3.62 | 77,504 | 1,847,825 | |
| 2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 1,854,058 | 19,767,770 | 10.35 | 3.62 | 6,711,690 | 71,559,327 | |
| 2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 882,323 | 2,829,753 | 45.31 | 3.62 | 3,194,009 | 10,243,706 | |
| 2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 21,410 | 510,449 | 4.38 | 3.62 | 77,504 | 1,847,825 | |
| 2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 1,854,058 | 19,767,770 | 10.35 | 3.62 | 6,711,690 | 71,559,327 | |
| 2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 882,323 | 2,829,753 | 45.31 | 3.62 | 3,194,009 | 10,243,706 | |
| 2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24,705 | 145,533 | 20.45 | 4.40 | 108,702 | 640,345 | |
| 2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 991,161 | 4,832,285 | 25.80 | 4.40 | 4,361,108 | 21,262,054 | |
| 2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 120,498 | 1,642,513 | 7.92 | 4.40 | 530,191 | 7,227,057 | |
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,030 | 3,030 | |||||
| 2013-07-11 | 3 | MYG |
Mirati Therapeutics, Inc.
Common Stock |
81,555 | ||||||||
| 2013-07-11 | 3 | MYG |
Mirati Therapeutics, Inc.
Common Stock |
1,866,932 | ||||||||
| 2013-07-11 | 3 | MYG |
Mirati Therapeutics, Inc.
Common Stock |
31,587 | ||||||||
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301,821 | 0.20 | 32.85 | 19,907 | 9,914,820 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301,821 | 0.20 | 32.85 | 19,907 | 9,914,820 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301,821 | 0.20 | 32.85 | 19,907 | 9,914,820 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 1,731,383 | 0.04 | 32.85 | 19,907 | 56,875,932 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 15,213 | 4.15 | 32.85 | 19,907 | 499,747 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 175,872 | 0.35 | 32.85 | 19,907 | 5,777,395 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 10,000 | -50.00 | 4.44 | -44,400 | 44,400 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 10,000 | -50.00 | 4.44 | -44,400 | 44,400 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10,000 | 10,000 | -50.00 | 4.44 | -44,400 | 44,400 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10,000 | 380,839 | 2.70 | 4.44 | 44,400 | 1,690,925 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10,000 | 380,839 | 2.70 | 4.44 | 44,400 | 1,690,925 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10,000 | 12,455,783 | 0.08 | 4.44 | 44,400 | 55,303,677 | |
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16,500 | 16,500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16,500 | 16,500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16,500 | 16,500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16,500 | 16,500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16,500 | 16,500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16,500 | 16,500 | |||||
| 2013-06-11 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12,500 | 12,500 | |||||
| 2013-06-11 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12,500 | 12,500 | |||||
| 2013-06-11 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12,500 | 12,500 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 5,437 | 440,802 | 1.25 | 14.46 | 78,641 | 6,375,804 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 217,986 | 18,001,203 | 1.23 | 14.46 | 3,152,971 | 260,371,200 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 26,577 | 1,513,121 | 1.79 | 14.46 | 384,412 | 21,885,933 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 3,790 | 435,365 | 0.88 | 14.55 | 55,145 | 6,334,648 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 151,980 | 17,783,217 | 0.86 | 14.55 | 2,211,339 | 258,749,364 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 18,530 | 1,486,544 | 1.26 | 14.55 | 269,615 | 21,629,513 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 4,312 | 431,575 | 1.01 | 14.58 | 62,885 | 6,294,003 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 172,893 | 17,631,237 | 0.99 | 14.58 | 2,521,437 | 257,130,434 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 21,080 | 1,468,014 | 1.46 | 14.58 | 307,427 | 21,409,223 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 5,437 | 427,263 | 1.29 | 14.46 | 78,600 | 6,176,728 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 217,986 | 17,458,344 | 1.26 | 14.46 | 3,151,315 | 252,386,550 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 26,577 | 1,446,934 | 1.87 | 14.46 | 384,210 | 20,917,601 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2,775 | 421,826 | 0.66 | 14.42 | 40,004 | 6,081,001 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 111,266 | 17,240,358 | 0.65 | 14.42 | 1,604,000 | 248,535,277 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 13,566 | 1,420,357 | 0.96 | 14.42 | 195,566 | 20,475,724 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11,552 | 419,051 | 2.83 | 14.45 | 166,955 | 6,056,335 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 463,197 | 17,129,092 | 2.78 | 14.45 | 6,694,355 | 247,558,202 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 56,475 | 1,406,791 | 4.18 | 14.45 | 816,205 | 20,331,647 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 890 | 407,499 | 0.22 | 14.50 | 12,903 | 5,907,798 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 35,702 | 16,665,895 | 0.21 | 14.50 | 517,597 | 241,617,146 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4,353 | 1,350,316 | 0.32 | 14.50 | 63,108 | 19,576,476 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5,189 | 406,609 | 1.29 | 14.00 | 72,641 | 5,692,119 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 208,063 | 16,630,193 | 1.27 | 14.00 | 2,912,674 | 232,806,072 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25,368 | 1,345,963 | 1.92 | 14.00 | 355,127 | 18,842,136 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11,511 | 401,420 | 2.95 | 14.08 | 162,100 | 5,652,877 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 461,548 | 16,422,130 | 2.89 | 14.08 | 6,499,611 | 231,259,719 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 56,274 | 1,320,595 | 4.45 | 14.08 | 792,462 | 18,596,883 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4,735 | 301,215 | 1.60 | 35.82 | 169,584 | 10,788,015 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 189,886 | 11,241,654 | 1.72 | 35.82 | 6,800,767 | 402,619,838 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 23,152 | 1,730,777 | 1.36 | 35.82 | 829,189 | 61,987,778 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,558 | 296,480 | 1.21 | 36.62 | 130,294 | 10,857,098 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 142,702 | 11,051,768 | 1.31 | 36.62 | 5,225,747 | 404,715,744 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17,399 | 1,707,625 | 1.03 | 36.62 | 637,151 | 62,533,228 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,790 | 292,922 | 0.96 | 36.69 | 102,356 | 10,746,400 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 111,907 | 10,909,066 | 1.04 | 36.69 | 4,105,521 | 400,219,813 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 13,644 | 1,690,226 | 0.81 | 36.69 | 500,556 | 62,009,152 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,114 | 290,132 | 0.39 | 36.75 | 40,942 | 10,662,989 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 44,627 | 10,797,159 | 0.42 | 36.75 | 1,640,140 | 396,819,347 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5,501 | 1,676,582 | 0.33 | 36.75 | 202,174 | 61,618,077 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,021 | 289,018 | 0.35 | 36.82 | 37,595 | 10,642,105 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 40,933 | 10,752,532 | 0.38 | 36.82 | 1,507,219 | 395,925,432 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5,046 | 1,671,081 | 0.30 | 36.82 | 185,802 | 61,531,876 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,613 | 287,997 | 0.56 | 36.93 | 59,574 | 10,636,852 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 64,679 | 10,711,599 | 0.61 | 36.93 | 2,388,848 | 395,621,126 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7,974 | 1,666,035 | 0.48 | 36.93 | 294,511 | 61,533,170 | |
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11,600 | 11,600 | |||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11,600 | 11,600 | |||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11,600 | 11,600 | |||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8,400 | 489,039 | 1.75 | ||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8,400 | 489,039 | 1.75 | ||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8,400 | 1,947,430 | 0.43 | ||||
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,358 | 286,384 | 0.48 | 36.93 | 50,154 | 10,576,877 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 54,399 | 10,646,920 | 0.51 | 36.93 | 2,009,091 | 393,217,373 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 6,760 | 1,658,061 | 0.41 | 36.93 | 249,664 | 61,236,338 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 332 | 285,026 | 0.12 | 36.99 | 12,280 | 10,542,371 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 13,313 | 10,592,521 | 0.13 | 36.99 | 492,413 | 391,789,811 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,655 | 1,651,301 | 0.10 | 36.99 | 61,214 | 61,077,331 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 35 | 284,694 | 0.01 | 36.18 | 1,266 | 10,300,969 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,392 | 10,579,208 | 0.01 | 36.18 | 50,366 | 382,783,251 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 173 | 1,649,646 | 0.01 | 36.18 | 6,260 | 59,688,481 | |
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 8,750 | 8,750 | |||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 8,750 | 8,750 | |||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 8,750 | 8,750 | |||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,500 | 326,648 | 1.08 | ||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,500 | 326,648 | 1.08 | ||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3,500 | 326,648 | 1.08 | ||||
| 2013-05-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43,184 | 389,909 | 12.45 | 12.50 | 539,800 | 4,873,862 | |
| 2013-05-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1,730,970 | 15,960,582 | 12.16 | 12.50 | 21,637,125 | 199,507,275 | |
| 2013-05-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 218,846 | 1,264,321 | 20.93 | 12.50 | 2,735,575 | 15,804,012 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 418 | 284,659 | 0.15 | 36.54 | 15,273 | 10,401,212 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 16,768 | 10,577,816 | 0.16 | 36.54 | 612,689 | 386,504,934 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,120 | 1,649,473 | 0.13 | 36.54 | 77,463 | 60,270,424 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,129 | 284,241 | 0.40 | 36.41 | 41,111 | 10,350,295 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 45,279 | 10,561,048 | 0.43 | 36.41 | 1,648,780 | 384,567,890 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5,725 | 1,647,353 | 0.35 | 36.41 | 208,469 | 59,986,383 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 589 | 283,112 | 0.21 | 35.53 | 20,928 | 10,059,507 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 23,610 | 10,515,769 | 0.23 | 35.53 | 838,908 | 373,645,253 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,985 | 1,641,628 | 0.18 | 35.53 | 106,063 | 58,330,162 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,516 | 282,523 | 1.26 | 34.02 | 119,609 | 9,610,980 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 140,962 | 10,492,159 | 1.36 | 34.02 | 4,795,302 | 356,926,462 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17,822 | 1,638,643 | 1.10 | 34.02 | 606,276 | 55,744,013 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,104 | 279,007 | 0.40 | 34.74 | 38,358 | 9,694,098 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 44,244 | 10,351,197 | 0.43 | 34.74 | 1,537,258 | 359,652,340 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5,594 | 1,620,821 | 0.35 | 34.74 | 194,364 | 56,315,426 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 277,903 | 0.26 | 27.99 | 19,985 | 7,778,505 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 277,903 | 0.26 | 27.99 | 19,985 | 7,778,505 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 10,306,953 | 0.01 | 27.99 | 19,985 | 288,491,614 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 1,615,227 | 0.04 | 27.99 | 19,985 | 45,210,204 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 14,607 | 5.14 | 27.99 | 19,985 | 408,850 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 175,266 | 0.41 | 27.99 | 19,985 | 4,905,695 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 612 | 277,189 | 0.22 | 27.63 | 16,912 | 7,659,813 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24,508 | 10,306,239 | 0.24 | 27.64 | 677,325 | 284,832,497 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,080 | 1,614,513 | 0.19 | 27.64 | 85,122 | 44,620,134 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 453 | 276,577 | 0.16 | 27.97 | 12,672 | 7,736,744 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 18,151 | 10,281,731 | 0.18 | 27.97 | 507,742 | 287,612,918 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,281 | 1,611,433 | 0.14 | 27.97 | 63,807 | 45,076,938 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 758 | 276,124 | 0.28 | 28.43 | 21,551 | 7,850,509 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 30,102 | 10,263,580 | 0.29 | 28.43 | 855,833 | 291,804,869 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,940 | 1,609,152 | 0.25 | 28.43 | 112,019 | 45,749,961 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 375 | 275,366 | 0.14 | 28.58 | 10,718 | 7,870,098 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 14,878 | 10,233,478 | 0.15 | 28.58 | 425,221 | 292,477,918 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,947 | 1,605,212 | 0.12 | 28.58 | 55,646 | 45,877,762 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,742 | 274,991 | 0.64 | 28.23 | 49,180 | 7,763,463 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 69,187 | 10,218,600 | 0.68 | 28.23 | 1,953,267 | 288,488,450 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 9,055 | 1,603,265 | 0.57 | 28.23 | 255,638 | 45,262,897 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 788 | 273,249 | 0.29 | 27.96 | 22,033 | 7,640,288 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 31,584 | 10,149,413 | 0.31 | 27.96 | 883,117 | 283,786,722 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4,004 | 1,594,210 | 0.25 | 27.96 | 111,955 | 44,575,546 | |
| 2013-01-23 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Stock Options (right to buy) |
A - Award | 15,000 | 15,000 | |||||
| 2013-01-08 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 20,099 | 176,920 | 12.82 | 47.53 | 955,305 | 8,409,008 | |
| 2013-01-08 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 839,621 | 6,782,215 | 14.13 | 47.53 | 39,907,186 | 322,358,679 | |
| 2012-12-21 | 3 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
1,045,475 | ||||||||
| 2012-12-21 | 3 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
14,229,612 | ||||||||
| 2012-12-21 | 3 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
346,725 | ||||||||
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 6 | 271,806 | 0.00 | 27.54 | 165 | 7,485,537 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 268 | 10,117,174 | 0.00 | 27.54 | 7,381 | 278,626,972 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 26 | 1,589,551 | 0.00 | 27.54 | 716 | 43,776,235 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4,859 | 271,800 | 1.82 | 26.83 | 130,352 | 7,291,551 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 202,311 | 10,116,906 | 2.04 | 26.83 | 5,427,377 | 271,405,226 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 21,830 | 1,589,525 | 1.39 | 26.83 | 585,631 | 42,642,028 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,223 | 266,941 | 0.84 | 27.32 | 60,725 | 7,291,894 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 92,592 | 9,914,595 | 0.94 | 27.32 | 2,529,289 | 270,832,034 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8,352 | 1,567,695 | 0.54 | 27.32 | 228,147 | 42,823,940 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,231 | 264,718 | 0.85 | 27.99 | 62,450 | 7,409,960 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 92,917 | 9,822,003 | 0.96 | 27.99 | 2,600,923 | 274,936,526 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8,691 | 1,559,343 | 0.56 | 27.99 | 243,278 | 43,648,973 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4,298 | 262,487 | 1.66 | 27.94 | 120,075 | 7,333,204 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 178,978 | 9,729,086 | 1.87 | 27.94 | 5,000,180 | 271,805,367 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 16,724 | 1,550,652 | 1.09 | 27.94 | 467,225 | 43,321,185 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 143 | 258,189 | 0.06 | 27.86 | 3,983 | 7,192,010 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24 | 258,046 | 0.01 | 26.68 | 640 | 6,884,693 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 79 | 258,022 | 0.03 | 27.16 | 2,146 | 7,008,187 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 9,905 | 257,943 | 3.99 | 27.84 | 275,793 | 7,182,113 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 651 | 248,038 | 0.26 | 26.91 | 17,516 | 6,673,735 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 324 | 247,387 | 0.13 | 25.83 | 8,367 | 6,388,868 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5,972 | 9,550,108 | 0.06 | 27.86 | 166,354 | 266,023,988 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 980 | 9,544,136 | 0.01 | 26.68 | 26,146 | 254,638,503 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,298 | 9,543,156 | 0.03 | 27.16 | 89,578 | 259,203,569 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 412,596 | 9,539,858 | 4.52 | 27.84 | 11,488,241 | 265,625,898 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 27,125 | 9,127,262 | 0.30 | 26.91 | 729,828 | 245,579,024 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 13,447 | 9,100,137 | 0.15 | 25.83 | 347,274 | 235,014,678 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 585 | 1,533,928 | 0.04 | 27.86 | 16,296 | 42,728,485 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 96 | 1,533,343 | 0.01 | 26.68 | 2,561 | 40,909,745 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 323 | 1,533,247 | 0.02 | 27.16 | 8,773 | 41,644,828 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 40,412 | 1,532,924 | 2.71 | 27.84 | 1,125,224 | 42,682,429 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,657 | 1,492,512 | 0.18 | 26.91 | 71,490 | 40,157,677 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,316 | 1,489,855 | 0.09 | 25.83 | 33,986 | 38,476,101 | |
| 2012-10-31 |
|
4 | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 103,608 | 463,839 | 28.76 | 3.00 | 310,824 | 1,391,517 | |
| 2012-10-31 |
|
4 | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 4,282,419 | 17,888,512 | 31.47 | 3.00 | 12,847,257 | 53,665,536 | |
| 2012-10-31 |
|
4 | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 336,639 | 1,922,230 | 21.23 | 3.00 | 1,009,917 | 5,766,690 | |
| 2012-07-13 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 21,082 | 156,821 | 15.53 | 41.20 | 868,578 | 6,461,025 | |
| 2012-07-13 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 864,918 | 5,942,594 | 17.03 | 41.20 | 35,634,622 | 244,834,873 | |
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Option (Right to Buy) |
D - Sale to Issuer | -12,500 | 0 | -100.00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Option (Right to Buy) |
D - Sale to Issuer | -12,500 | 0 | -100.00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Option (Right to Buy) |
D - Sale to Issuer | -25,000 | 0 | -100.00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -4,023 | 0 | -100.00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -147,292 | 0 | -100.00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -46,195 | 0 | -100.00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -998 | 0 | -100.00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -205 | 0 | -100.00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -116,454 | 0 | -100.00 | 32.00 | -3,726,528 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -4,922,226 | 0 | -100.00 | 32.00 | -157,511,232 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -1,646,964 | 0 | -100.00 | 32.00 | -52,702,848 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -99,636 | 0 | -100.00 | 32.00 | -3,188,352 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -65,882 | 0 | -100.00 | 32.00 | -2,108,224 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -60,827 | 0 | -100.00 | 32.00 | -1,946,464 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -2,302 | 0 | -100.00 | 32.00 | -73,664 | ||
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 380 | 247,063 | 0.15 | 32.94 | 12,518 | 8,138,922 | |
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17,026 | 9,086,690 | 0.19 | 32.94 | 560,882 | 299,340,103 | |
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2,732 | 246,683 | 1.12 | 32.21 | 87,992 | 7,945,166 | |
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 546 | 243,951 | 0.22 | 32.04 | 17,493 | 7,815,922 | |
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 122,268 | 9,069,664 | 1.37 | 32.21 | 3,938,008 | 292,115,738 | |
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24,454 | 8,947,396 | 0.27 | 32.04 | 783,479 | 286,664,726 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 517 | 243,405 | 0.21 | 34.46 | 17,815 | 8,387,176 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 23,104 | 8,922,942 | 0.26 | 34.46 | 796,111 | 307,464,059 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,972 | 242,888 | 0.82 | 34.25 | 67,541 | 8,318,914 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 540 | 240,916 | 0.22 | 33.11 | 17,882 | 7,977,668 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 555 | 240,376 | 0.23 | 34.47 | 19,129 | 8,285,160 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 88,028 | 8,899,838 | 1.00 | 34.25 | 3,014,959 | 304,819,452 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24,136 | 8,811,810 | 0.27 | 33.11 | 799,237 | 291,793,395 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24,769 | 8,787,674 | 0.28 | 34.47 | 853,726 | 302,889,154 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3,212 | 239,821 | 1.36 | 33.92 | 108,951 | 8,134,728 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 897 | 236,609 | 0.38 | 33.67 | 30,198 | 7,965,513 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 370 | 235,712 | 0.16 | 32.59 | 12,058 | 7,681,501 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 175 | 235,342 | 0.07 | 31.53 | 5,517 | 7,419,863 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 143,388 | 8,762,905 | 1.66 | 33.92 | 4,863,721 | 297,237,738 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 40,073 | 8,619,517 | 0.47 | 33.67 | 1,349,070 | 290,178,626 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 16,526 | 8,579,444 | 0.19 | 32.59 | 538,558 | 279,591,211 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7,797 | 8,562,918 | 0.09 | 31.53 | 245,824 | 269,971,679 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 627 | 235,167 | 0.27 | 30.22 | 18,946 | 7,105,877 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 26,033 | 8,555,121 | 0.31 | 30.22 | 786,621 | 258,504,103 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 214 | 234,540 | 0.09 | 29.98 | 6,415 | 7,030,829 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8,867 | 8,529,088 | 0.10 | 29.98 | 265,807 | 255,677,324 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,402 | 234,326 | 0.60 | 29.86 | 41,861 | 6,996,599 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 58,198 | 8,520,221 | 0.69 | 29.86 | 1,737,699 | 254,400,167 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 460 | 232,924 | 0.20 | 29.90 | 13,752 | 6,963,379 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 19,087 | 8,462,023 | 0.23 | 29.90 | 570,615 | 252,976,409 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 116 | 232,464 | 0.05 | 28.50 | 3,306 | 6,624,620 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,737 | 232,348 | 0.75 | 28.90 | 50,196 | 6,714,416 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 172 | 230,611 | 0.07 | 28.41 | 4,886 | 6,550,529 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4,811 | 8,442,936 | 0.06 | 28.50 | 137,101 | 240,601,724 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 72,073 | 8,438,125 | 0.86 | 28.90 | 2,082,773 | 243,845,780 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7,124 | 8,366,052 | 0.09 | 28.41 | 202,358 | 237,638,544 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 536 | 230,439 | 0.23 | 28.28 | 15,159 | 6,517,184 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 754 | 229,903 | 0.33 | 28.25 | 21,300 | 6,494,530 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 22,241 | 8,358,928 | 0.27 | 28.28 | 629,011 | 236,403,858 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 31,273 | 8,336,687 | 0.38 | 28.25 | 883,431 | 235,503,071 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 722 | 1,488,539 | 0.05 | 28.28 | 20,419 | 42,098,265 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,014 | 1,487,817 | 0.07 | 28.25 | 28,644 | 42,029,342 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5 | 229,149 | 0.00 | 28.00 | 140 | 6,416,172 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 369 | 229,144 | 0.16 | 27.99 | 10,330 | 6,414,863 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 935 | 228,775 | 0.41 | 28.03 | 26,208 | 6,412,540 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 188 | 8,305,414 | 0.00 | 28.00 | 5,264 | 232,551,592 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 14,078 | 8,305,226 | 0.17 | 27.99 | 394,112 | 232,503,971 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 35,727 | 8,291,148 | 0.43 | 28.03 | 1,001,424 | 232,400,049 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7 | 1,486,803 | 0.00 | 28.00 | 196 | 41,630,484 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 514 | 1,486,796 | 0.03 | 27.99 | 14,389 | 41,622,705 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1,305 | 1,486,282 | 0.09 | 28.03 | 36,579 | 41,660,336 | |
| 2012-04-24 | 3 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
0 | ||||||||
| 2012-04-23 | 3 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
0 | ||||||||
| 2012-04-23 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
0 | ||||||||
| 2012-04-23 | 3 | INCY |
INCYTE CORP
Common Stock |
0 | ||||||||
| 2012-04-23 | 3 | XOMA |
XOMA Corp
Common Stock |
0 | ||||||||
| 2012-04-23 | 3 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
0 | ||||||||
| 2012-04-23 | 3 | GHDX |
GENOMIC HEALTH INC
Common Stock |
0 |
